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ABSTRACT 
In the last decade, the majority of radiotherapy treatments are delivered via advanced 
radiotherapy technologies such as intensity-modulated radiation therapy (IMRT), 
volumetric-modulated arc therapy (VMAT) and stereotactic body radiation therapy 
(SBRT). The unique properties of these modalities such as small and irregular field 
shapes, continuously varying fluence/dose rates, and beam delivered at several 
different angles and from non-coplanar directions produces non-uniform, modulated 
intensity and conformed absorbed dose distribution which in turn improves the 
outcome of the treatment. However, the complexities associated with these 
technologies can create large deviations in treatment dose, requiring extensive dose 
measurement verification and quality assurance (QA) procedures to ensure the 
patient’s treatment is performed correctly and safely. There is therefore a significant 
need for real-time detectors that provide dose verification of a patient’s cancer 
treatment. 
This thesis focuses on characterisation of two real-time detectors based on two 
different solid-state materials: silicon and CVD diamond. The first part of the thesis is 
dedicated to characterisation of single angular-independent silicon based detectors 
referred to as edgeless and their application in dose verification of SRS treatment. 
Edgeless detectors were originally developed by VTT within the framework of the 
European collaboration MEDIPIX (CERN – Geneva) for use in high energy physics 
applications. They are fabricated by creation of a 3D junction realised on thin p-type 
and n-type substrates. One of advantages of the edgeless detector is its small size which 
makes it ideal for small field dosimetry. The sensors have been characterised in terms 
of electrical and charge collection efficiency characteristics using Ion Beam Induced 
 ii 
 
Charge techniques and Technology CAD simulations. The investigation of angular 
response of edgeless detectors within a MV photon energy range demonstrates a 
negligible angular dependence of less than 2% for the complete solid angle. In 
addition, the radiation hardness study shows that angular response of edgeless diode 
is not affected significantly by radiation damage. The full dosimetric characterization 
of edgeless diodes demonstrates a good agreement of the edgeless diodes’ response 
with a reference detector to within +/-2%. The edgeless diode has also been 
successfully implemented as a QA device for dose verification in oncological and 
functional brain SRS throughout several Cyberknife® generations. A preliminary 
design of a 2D array version of an edgeless detector was also developed and evaluated 
clinically under non-coplanar SRS treatment conditions. Although the diodes did not 
show any relevant response variation when used in a 2D array configuration as a 
function of the beam angle, the diodes of the array detector used in this experiments, 
were not preirradiated with significant accumulated dose, and they exhibited a high 
DPP dependence which lead to an increased response of the detector comparing to the 
reference dose (TPS). The second part of the thesis focused on dosimetric evaluation 
of a PTW microDiamond detector in different orientations (face-on and edge-on) in 
small fields. A microDiamond detector in an edge-on orientation was able to obtain 
improved FWHM and penumbra characteristics compared to the results in a face-on 
orientation. Moreover, a microDiamond detector demonstrated almost angular-
independent response in edge-on orientation with a maximum variation of only 
approximately 2%. 
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1 INTRODUCTION 
1.1 Background 
According to the World Health Organization (WHO), cancer is the second major cause 
of death in the world, and causes approximately 9.6 million deaths in 2018 worldwide 
(1). Approximately one third of cancer cases can be treated properly if they are 
diagnosed at an early stages of the disease (2). There are three main treatment 
approaches to treat cancer: surgery, chemotherapy and radiotherapy. The treatment of 
cancer with surgical methods can be achieved by physical removal of the diseased 
tissues or organ. With Chemotherapy, a patient is given one or more anti-cancer drugs 
to stop the spread of cancer cells. Radiotherapy is a type of treatment technique in 
which diseased tissues (e.g. tumour tissues) is exposed to ionising radiation to destroy 
their deoxyribonucleic acid (DNA) and subsequently kill cells. It has been estimated 
that slightly more than 50% of patients with cancer are treated by radiation therapy 
during their treatment (3, 4). The main task of radiation therapy is to ensure the 
effective delivery of the radiation dose to the tumour while sparing the healthy tissue 
near the tumour tissue. The new developments of sophisticated external beam radiation 
therapy modalities, such as Intensity-Modulated Radiation Therapy (IMRT) and 
Volumetric-Modulated Arc Therapy (VMAT) and Stereotactic Body Radiation 
Therapy (SBRT), are becoming increasingly widespread in the treatment of inoperable 
tumours. These treatments modalities are characterized by small and irregular field 
shapes, continuously varying fluence / dose rates, and beam delivered from several 
different angles and from non-coplanar directions. The complexities of these radiation 
modalities can result in large uncertainties in dose delivery, requiring extensive dose 
measurement verification and quality assurance (QA) procedures to ensure the 
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patient’s treatment is performed correctly and safely. The QA devices that are adopted 
for the dose measurement verification are required to be energy-, dose rate-and 
angular-independent. In addition, they should have the ability to obtain high spatial 
resolution measurement without perturbing the radiation beam. 
1.2 Thesis aim and objectives 
This thesis comprises two parts: the first part focuses on development, characterization 
and clinical adoption of silicon-based diodes (termed edgeless) to be used as angular-
independent detectors in different external radiation therapy treatments (IMRT, 
VMAT and SRS). In the second part, an experimental evaluation and characterization 
of a PTW microdiamond detector in both edge-on and face-on orientations are 
completed in the context of small field dosimetry for non-coplanar, non-isocentric 
treatments. 
The overall aims of this thesis will be approached with the following objectives: 
 
1. Examine the electrical properties and charge-collection efficiency of 
an edgeless diode through IV and CV tests, IBIC measurement and 
Technology Computer Assisted Design (TCAD) simulation. 
2. Extend the evaluation of the edgeless diode by exploring its full 
dosimetric characterization under linear accelerator irradiation 
conditions. 
3. Explore the validation of using the edgeless diode for quality 
assurance in two different clinical radiation treatment scenarios: 
robotic stereotactic radiosurgery and high dose treatment of brain 
functional disorders 
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4. Explore implementation of edgeless diode alongside other solid-state 
detectors for reference and relative dosimetry in a small radiation 
field. 
5. Evaluate the preliminary 2D edgeless array in non-coplanar SRS 
treatments. 
6. Present a dosimetric comparison between the performance of the 
PTW microdiamond in face-on and edge-on orientations with the 
evaluation of the effect of the detector orientation on angular response 
in small field dosimetry. 
 
1.3 Thesis outline 
The aim and the main objectives of the study are presented in chapter 1 whilst chapter 
2 introduces a general background and literature review of radiation therapy, medical 
radiation dosimeters and small field dosimetry. The characterization of the edgeless 
diode performance in term of current-voltage (IV) and capacitance-voltage (CV) 
characteristics and charge collection efficiency is introduced in Chapter 3. The 
evaluation in this chapter is performed using experimental methods (IV and CV tests, 
IBIC measurement) and TCAD simulation. Chapter 4 describes the full dosimetric 
characterization of the edgeless diode as angular-independent device developed for 
external beam radiation therapy. The edgeless diode is characterized in terms of dose 
linearity, angular dependence, dose rate, dose per pulse dependence, percentage depth 
dose and output factor. This chapter also deals with the radiation damage of the device 
and its effects on angular response. Chapter 5 explores the feasibility of implementing 
edgeless diode detectors as a quality assurance tool for the Cyberknife® system. The 
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edgeless diode probe is tested in terms of basic QA parameters such as measurements 
of tissue-phantom ratio (TPR), output factor and off-axis ratios for different fixed cone 
size collimators and an Iris collimator. The measurements in this chapter were 
performed in both water and water-equivalent phantoms. In addition, this chapter 
examines three patient-specific plans delivered on a lung phantom with and without 
motion to verify the ability of edgeless diodes to work as patient-specific QA devices. 
In Chapter 6, the potential of edgeless diodes is evaluated for QA of very high dose 
patient-specific treatment plans by measuring the dose delivered to functional 
neurological disorder patients. Chapter 7 examines the ability of edgeless diode and 
various other detectors to determine the output factor for several small field sizes 
according to the recommendations and requirements of the IAEA-AAPM TRS-483 
code of practice. In this chapter also, edgeless and other detectors are employed to 
determine the beam quality specifier (TPR20,10 (10)). In addition, TPR20,10(S)10 values 
at different field sizes and using various analytical expressions (based on the 
measurement performed using several detectors),are examined. The preliminary 
design of a 2D edgeless array has been developed and examined in Chapter 8. 
Investigation has been performed by delivering several real patient plans on a 
Cyberknife® system with a detector array embedded inside EasyCube and Rando 
phantoms. In Chapter 9, the evaluation of aPTW microDiamond detector in both 
edge-on and face-on orientations is presented. In addition, the suitability of an edge-
on orientation and advantages over the recommended face-on orientation is explored. 
Chapter 10 presents a summary of the main findings of the thesis. Some 
recommendations for future work are provided to improve the design of 2D edgeless 
detector arrays for clinical implementation.
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2 LITERATURE REVIEW 
2.1 Radiation therapy 
Radiation therapy is a technique in which ionising radiation is projected towards 
diseased tissues (e.g. tumour tissues) to destroy the deoxyribonucleic acid (DNA) of 
the target cells and subsequently kill them. Radiation therapy is generally divided into 
two main classes: internal radiation therapy (also termed ‘brachytherapy’) and external 
beam radiation therapy (EBRT) which is sometimes termed ‘Teletherapy’. In 
brachytherapy, a radioactive “seed” is inserted inside tumour tissue, which is then 
irradiated by the radioactive seed for a pre-set treatment time. In EBRT, a linear 
accelerator (LINAC) is used to irradiate the abnormal tissues. Conventional LINACs 
usually produce two types of radiation (photon and electron beams) with different 
energy ranges: 6 MV, 10 MV and 18 MV for photon beams and 6 to 20 MeV for 
electron beams. The radiation dose in EBRT is usually delivered in discrete 
fractionations with a time gap between fractions. EBRT technology has undergone 
many developments in past few years and sophisticated techniques are available 
commercially, for example, Intensity Modulated Radiotherapy (IMRT), Volumetric 
Modulated Arc Therapy (VMAT) and Stereotactic Radiosurgery (SRS). 
2.1.1 Intensity Modulated Radiotherapy 
Intensity Modulated Radiotherapy (IMRT) is one of the most developed forms of 
Three-Dimensional Conformal Radiotherapy (3D-CRT) (5-9). It was developed 
independently by Cormak (1987) and Brahma (1988) (10). Unlike conventional 3D-
CRT, the dose in IMRT has non-uniform intensity (5). IMRT depends on an Inverse 
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Planning System (IPS) which optimizes the intensity of radiation fields to define the 
dose distribution at the target volume (11). It can be defined as the delivering of non-
uniform dose distribution via multiple beam directions of radiation treatment (12). 
Two systems are required in order for IMRT to be used in clinics: (1) a computer 
system for  treatment-planning which is capable to calculate the variable intensities of 
the dose distribution from multiple directional beams in order to have maximum dose 
in the target volume and minimum dose in normal tissue, and (2) a delivery system 
that can deliver variable intensities of radiation dose(5). The dose can be delivered in 
IMRT using several methods. One method is by using a large number of discrete multi-
leaf collimator (MLC) shapes per field, with the beam turned off between segments. 
This method is also termed “step and shoot”. In another method, which is called 
“dynamic sliding window”, the beam is delivered while the leafs slide continuously 
across the radiation field with varying rates to deliver the desired modulated dose from 
the beam (6, 13). This method can speed up the delivery of treatment dose as well as 
offering higher spatial resolution. However, accurate synchronization of leaf positions 
with beam-on time is required (13). 
2.1.2 Volumetric Modulated Arc Therapy 
The concept of VMAT was first mentioned in the literature in 1995 by Yu (11, 14-16). 
In contrast to IMRT, a superior beam modulation with VMAT can be performed by 
continuously rotating the gantry linear accelerator around the patient  with continuous 
varying of dose rate, beam aperture shapes, and speed of gantry rotation during the 
treatment delivery(17-19). This technique results in reduction of the treatment time, 
about 1.5- 3 minutes for a 200-cGy fraction, which in turn reduces the intra-fraction 
movement and patient discomfort (20). In addition, the number of required Monitor 
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Units (MUs) for VMAT treatment is also smaller compared to IMRT which results in 
increasing the delivery efficiency. Wolff et al. investigated the performance of VMAT, 
static gantry IMRT and TomoTherapy and found that VMAT is the most efficient 
among these modalities in terms of monitor units deliverable and treatment times 
needed (21). 
2.1.3 Stereotactic Radiosurgery 
Stereotactic radiosurgery (SRS) is radiation therapy method developed to treat 
intracranial lesions (e.g. arteriovenous malformation) without surgical incision (22, 
23). It has many advantages over the surgical resection technique which include: no 
general anaesthesia is required, it is a non-invasive procedure so there is less risk of 
bleeding and infection and less complications than surgical incision (12, 24-26). The 
treatment is performed by using stereotactic techniques which comprise referencing 
systems or features to precisely localize and define the target tissues in the patient’s 
body. SRS can use external features such as a metallic ring attached to the patient’s 
head (stereotactic frame helmet), or internal features such as a bony structure within 
the patient’s head (e.g. cranial bones). Medical imaging devices (X-ray, CT or MRI), 
are also used in the process of localizing the targets. The capability of SRS to deliver 
narrowly-collimated beams can produce concentrated doses within the treatment 
volume, characterized by a sharply steep dose gradient at the edge of the target volume 
which can spare surrounded healthy tissue. If radiation dose is delivered in one fraction 
then the treatment procedure is called Stereotactic Radiosurgery (SRS) but if it is 
fractionated into multiple fractions it is usually called Stereotactic Radiotherapy (SRT) 
(27). SRT is also the treatment of choice for some diseases other than brain tumors, as 
it has the ability to avoid complications to normal tissue that could be developed by a 
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large single dose used in SRS (27). Due to the high dose and high geometrical accuracy 
requirement (errors must be less than 1 mm) the treatment planning and delivery must 
be accomplished with high precision and accuracy (12, 25, 27). 
The first stereotactic radiosurgery technique was developed in 1951 by Lars Leksell, 
a Swedish Neurosurgeon (23, 27). His main aim was to develop a non-invasive method 
to treat inaccessible intracranial lesions without surgical incision (25, 26). The first 
SRS system consisted of a stereotactic frame that was made from a metallic material 
and an orthovoltage (300-kV) x-ray tube. The purpose of the stereotactic frame is to 
provide a fixed reference of the target volume in relation to the machine, and to 
immobilise the patient head during the treatment. The x-ray tube irradiates the patient 
with multiple well-collimated beams from different directions which are converged 
into a common point within the lesion (5, 25-29) . Stereotactic Radiosurgery using 
protons and helium ion beams has also been developed (23). In 1968, Leksell made a 
major modification to his first SRS system by replacing the original radiation source 
(an  X-ray tube) by an isotope machine and called the resultant system the “Gamma 
Knife®(24). 
The GammaKnife® (sometime called the Leksell Gamma Knife) is SRS system that is 
composed of 201 60Co sources organized on a hemispherical cast-steel device called a 
“helmet”. The main role of the helmet is to work as a collimation device as well as to 
focus the Co60 radiation to a common point (isocenter) (27). The Co60sources, which 
are placed 40 cm away from the isocenter, are collimated by small primary collimators 
made in the helmet and by the metallic material of the helmet itself. As the target 
volumes in patients vary in their sizes, the GammaKnife system is usually equipped 
with different helmets of different primary collimator sizes (4, 8, 14 and 18 mm) to 
take into account this variation. During the treatment, the point of interest inside the 
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target volume is located at the isocenter. If the target has an irregular shape, this usually 
requires it to be treated with multiple isocenters and with different primary collimator 
sizes.  
2.1.3.1 Linac–based SRS 
Further progress in SRS was made in 1980 by Larson (a Swedish Physicist) by using 
the linear accelerator (linac–based SRS) instead of Co60 sources. In linac–based SRS, 
the treatment dose is delivered using highly collimated photon beams in multiple non-
coplanar arcs which are focused to the isocenter of the linac. Due to the development 
of the immobilization system in linac–based SRS, it has been become possible to 
implement the dose fractionation concept also in SRS. The Micro-multi-leaf 
collimation system (2.5 mm to 5 mm leaf width) in conventional linac–based SRS such 
as TrueBeam (Varian Medical Systems, California, USA) and Elekta (Stockholm, 
Sweden) is very efficient and sophisticated and allows for using SRS outside the 
intracranial area. In addition, it makes the irradiation of irregular targets more accurate 
and efficient. Several specialized and dedicated linac-based SRS modalities have 
recently been developed such as TomoTherapy® CyberKnife®, Vero®, and Halcyon® 
2.1.3.2 Cyberknife 
Cyberknife (Accuray – California, US) is a robotic linear accelerator which is designed 
to perform stereotactic radiosurgery treatments exploiting the combination of an 
advanced robotic arm (originally developed for the automotive manufacturing 
industry) and a stereoscopic medical imaging recognition technology to achieve a high 
level of precision and accuracy in radiotherapy(25, 30-35). It was originally designed 
to overcome the limitation of framed SRS (e.g. GammaKnife and conventional 
LINAC). The first generation of Cyberknife was developed in early 1994 by 
 43 
 
neurosurgeon John Adler in a collaboration established between Stanford University 
and Accuracy, Inc. (36). The ability of the Cyberknife system to deliver a frameless 
treatment has improved flexibility of the treatment dose fractionation as well as the 
extension of this technique to extracranial targets. Unlike the other SRS modalities 
which can only treat targets of size up to 3 cm, Cyberknife has the ability to deal with 
lesion sizes of up to 6 cm. 
Cyberknife consists of a compact, lightweight 6 MV linear accelerator mounted on an 
industrial robotic manipulator arm (Kuka, Augsburg, Germany), which has the ability 
to rotate and translate with six degrees of freedom.  
The Cyberknife LINAC is capable to produce a photon beam with a dose rate of up to 
1000cGy/min. Unlike conventional LINACs, it does not have bending magnets and 
flattening filter. The beam can be collimated using fixed circular collimators of 
different sizes (5- 60 mm) or by an Iris collimator which consists of a variable-aperture 
diaphragm that can be controlled remotely and adjusted automatically to provide 
twelve different sizes. The Manipulator arm has high position precision with a 
reproducibility of 0.12 mm. It gives the LINAC the ability to deliver a photon beam 
toward any point in the space without the need to have a unique isocenter. The 
positioning system of the LINAC is organised as a multiple concentric hemispherical 
distribution of nodes centred at the target location.  
The imaging guidance system of Cyberknife consist of two x-ray sources mounted on 
the treatment room ceiling and positioned at 45o relative to the vertical axis of the 
room. Both sources produce square beams that are directed toward two amorphous 
silicon flat panel detectors placed underneath the flooring surface. During the 
treatment, several x-ray images are taken and compared with a pre-treatment Digitally 
Reconstructed Radiograph (DRR), using image registration algorithms, and the 
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position of the robotic arm is adjusted according to the results of this comparison. 
Cyberknife implemented several image-tracking algorithms (e.g. 6D Skull, Xsight 
Spine, Xsight Lung, Fiducial Marker and Synchrony) which are used to maintain the 
required accuracy and precision of the treatment setup.  
6D Skull tracking: 
This method is used with intracranial and head and neck lesions. The bony structures 
of the skull are used to track the above-mentioned parts of the body as they are 
considered fixed relative to the skull. It is named “6D skull” because the correction is 
implemented in 6 motion directions (3 translation and 3 rotation).  
Xsight Spine Tracking: 
This tracking algorithm utilizes the bony structures of the spine for tracking tumours 
located in the spine or near the spine. A correction filter is used to correct for the 
distortion in the x-ray images which occur due to the lack of rigidity in the structure 
of the spine. 
Xsight Lung Tracking: 
It is used to track the respiratory motion of soft tissue lesions in the lung without using 
implanted fiducial markers. Thereby it reduces the treatment time as well as 
eliminating complications that might occur due to the fiducial implantation such as 
pneumothorax. 
Fiducial Marker Tracking: 
This method is applied with soft tissue that is not fixed to any reference bony structure 
(e.g. skull and spine). Examples of such soft tissue are liver, prostate and pancreatic 
cancers. Three cylindrical seeds made from gold with diameter 0.8-1.2 mm and length 
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3-6 mm are implanted into soft tissue to give an internal reference frame. The process 
of fiducial implantation inside the lesion is usually done with the aid of an imaging 
device. 
Synchrony: 
The Synchrony method is a combination of x-ray imaging and external optical markers 
(Light Emission Fibre (LED) markers) which are placed on to the patient skin (chest 
wall) and tracked by an infrared tracking camera, to track the respiratory motion of the 
tumour. Tracking is realised using an adaptive algorithm which requires a few 
respiration cycles for training and constructs the predicted motion path of the 
subsequent respiration cycles. This method maintains the LINAC dynamically aligned 
with the moving tumor during respiration. 
2.2 Current radiotherapy QA and dosimetry tools 
The application of advanced External Beam Radiation Therapy (EBRT) modalities, 
such as IMRT, VMAT and SRS is becoming increasingly widespread in the treatment 
of inoperable tumors (37, 38). These treatments are characterized by small and 
irregular field shapes, continuously varying fluence/dose rates, and steep dose 
gradients (18, 39, 40) in order to produce highly conformal target coverage and sparing 
of normal tissue (41). The complexities of treatment planning in this regime can result 
in large uncertainties in dose delivery, thus requiring extensive quality assurance (QA) 
in the form of dosimetry to ensure patient safety. The suitability of a dosimeter for QA 
purposes in advanced EBRT techniques is determined by satisfying several 
parameters, i.e., dose linearity, high spatial resolution and angular, energy and dose 
rate independence  (42). Currently, the dosimetric measurements are performed using 
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single element (“point”) dosimeters (such as single ionization chambers, TLD, 
diamond and Metal-oxide Semiconductor Field-effect Transistors (MOSFETs), 2D 
array dosimeters (such as 2-D diode and ionisation chamber arrays, Gafchromic film) 
and 3D dosimeters (such as Gel). The following section discusses briefly the available 
dosimetric tools adopted in external beam radiation therapy. 
2.2.1 Point dosimeters 
A ”point” detector is device that measures the absorbed dose in one point in the target 
space. It is capable of creating signal which is a function of time (43). While “point” 
detectors have been successfully implemented in in vivo dosimetry, they are labour-
intensive and determine the dose only at a single point, which provides inadequate 
information about the dose distribution inside the patient. Below is a brief description 
of the most common types of point dosimeters for treatment dose verification. 
2.2.1.1 Ionization Chambers 
Ionization chambers (IC) are the “gold standard” detectors in radiotherapy dosimetry 
and they demonstrate stability, reproducibility, ease of calibration and linear response 
(44).Owing to their accurate and reliable measurement, they are used for calibration 
for other type of dosimeters. The principle of IC operation is based on the ionization 
of atoms in the active volume material (which is usually air or liquid) and collection 
of the consequent current at the electrodes (anode and cathode)(5, 45, 46). When 
radiation hits an IC, interactions occurs with atoms of air in the active volume. These 
interactions lead to creation of electron-ion pairs which are proportional to the energy 
absorbed by air. Under an appropriate applied voltage (around 100-500 V), the created 
positive and negative charge carriers drift to the electrodes. Movement of these charge 
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carriers will produce constant current which can be measured by an electrometer 
(45).Most of ionization chambers are unsealed, which make their measurement 
affected by the surrounded pressure and temperature. For this reason, a correction for 
pressure and temperature is important. Many types and shapes of ionization chamber 
are commercially available. The most common types of ionization chambers are: 
parallel- plate ionization chambers and cylindrical ionization chambers (47, 48). 
Cylindrical ionization chamber are made from different material such as A-150 
(muscle-tissue equivalent plastic), C-552 (air-equivalent Plastic) and PMMA. They 
are usually fitted with a build-up cap around the walls of the chamber. The purpose of 
the cap is to create charged particle equilibrium. Cylindrical chambers typically have 
a relative large size which makes them not suitable for dose measurement of steep 
gradient areas such as the surface of the body (48-50). Parallel-Plate ionization 
chambers are usually constructed with different shapes and dimensions from the 
cylindrical ICs. Their flat shape and thinner front window make them good for 
measurements of steep dose gradients (surface dosimetry). Because they have 
improved spatial resolution they are usually used for measuring absorbed dose as a 
function of the depth. Some parallel plate chambers are required to be corrected for a 
fluence perturbation as they are manufactured with an inadequate guard width (49). 
One such parallel plate chamber is the Attix chamber which has the advantage of a 
large guard ring. Another brand of chamber is called Markus and has disadvantage of 
having over-response in the build-up region which can be corrected by Velkley 
correction(48, 51). 
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2.2.1.2 Diamond dosimeters 
Diamond detectors have been of high interest in dosimetry for radiotherapy. Because 
they have atomic number z = 6,close to that of human tissue (Zeff ≈ 7.42), they are 
consider as near-tissue-equivalent detectors(52, 53). Diamond detectors are suitable 
for small field beams such as in SRT/SBRT due to their small sensitive volumes (1.4 
mm3) and they have capability to provide high spatial resolution measurements (53, 
54). the constant ratio of carbon-water stopping power in the  energy range 1-20 MeV 
gives the diamond detectors additional advantages over silicon detectors in 
applications of electron dosimetry (55). Diamond detectors are energy-independent in 
the clinical range and have high sensitivity comparing to ionisation chamber(56). The 
relative high energy required (13 eV) to generate electron-holes pairs give them the 
electrical properties similar to insulators and makes them insensitive to radiation 
hardness. Due to a high band gap, diamond detectors produce very low leakage current 
and can be operated under both biased and unbiased conditions. One limitation of their 
widespread adoption in clinical applications is dose rate dependence, high cost of 
manufacturing and low sensor-to-sensor performance reproducibility (57-59). 
2.2.1.3 Silicon-based dosimeters 
Silicon detectors are one of most common semiconductor detectors adopted for 
radiotherapy dosimetry (47, 60). The density and relatively low average ionization 
energy required to produce an electron-hole pairs (3.6 eV) make silicon diodes very 
sensitive and very small sensitive volumes can be manufactured (61, 62). The mass 
collision stopping power ratio of electrons for silicon–water makes silicon diodes 
almost completely energy independent in MV range energies(63), unless very low 
energy photons beams are used whereupon the photoelectric effect becomes dominant. 
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additional advantages of silicon detectors comprise high spatial resolution, high 
sensitivity, small size, compact, unbiased, robust, no air pressure variations and online 
measurement (48, 60, 64-66).The structure of a silicon diode is based on a p-n junction 
which can be fabricated in different geometries(67, 68). The common structure of a p-
n junction is a planar implantation or dopant deposition on a silicon substrate doped 
with impurities from group III (e.g. 1015 to 1017 atoms cm-3 of boron) or group V (e.g. 
1014 to 1016  atoms cm-3 of phosphorus) to become either p-type or n-type(64, 68, 69).  
The superficial region is doped with the opposite type of dopant to create the p-n 
junction. In equilibrium (no bias applied externally), the depletion region is limited to 
a thin volume underneath the junction generated by the diffusion of majority carriers 
of both types out from this region. This process stops when a space charge distribution 
generates enough electric field to keep the charges separated. The movement of 
electron-hole pairs and minority carriers produce radiation-induced current only in the 
depleted region which is a very thin layer close to the physical junction (60, 64, 65, 
69-72). When no bias is applied, the sensitivity of a silicon detector is directly related 
to its active volume (V) which can be found from the product of the detector area and 
the diffusion length of minority carriers 	𝐿 = 	 	Dn/pτn/p .  Where Dn/p is the diffusion 
constant and τn/p is the minority carrier lifetime for electrons (n) or holes (p) (220). 
The sensitivity of silicon diodes (defined as the ionization charge collected per unit 
absorbed dose, nC/cGy)(73)depends on several factors such as temperature, dose rate, 
accumulated dose, energy and angle of incident radiation(64, 73). 
Although preirradiated p-type diode shows flat dose rate, the n-type diode has been 
reported to be dose-rate dependence (65, 73, 74).  
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Rikner and Grusell have found that the sensitivity of the both n and p-type diodes are 
decreased with accumulated dose, but as p-type diode is less affected by radiation 
damage, they exhibit less accumulated dose dependence (75). 
During in vivo dosimetry, silicon diodes are usually placed on a surface of the patient 
which causes an increase in the temperature of the diode to approximately 33 oC. 
Grusell et. al. found that the sensitivity of Si diodes increases with temperature by a 
factor of 1~3% per 10 oC (76). Silicon diode sensitivity also varies with energy of the 
radiation beam (64, 77). The major reason for the energy dependence of the diode, 
particularly in low-energy photon beams, is the material of high atomic number such 
as the protective housing, electrode attachment, and build-up material that surrounds 
the silicon die. Also, the diode itself contributes in this dependency (64, 77). For this 
reason, diode detectors are calibrated for each energy beam and (in most lower energy 
applications) at a specific depth level relative to a phantom surface. However, in 
megavoltage photon beams this effect is negligible. 
2.2.1.3.1 Angular dependence of silicon detectors 
The signals generated by these detector created mostly from secondary electrons 
produced by the incoming x-ray beam outside the detector’s sensitive volume. In 
conventional passive silicon diodes or MOSFETs, the active volume of the detector is 
asymmetric and surrounded by inactive silicon and packaging materials providing 
different attenuation of photons or secondary electrons from different directions and 
different to the attenuation in water. Therefore, the response of the standard silicon 
detectors vary with the angle of the radiation beams, up to ±25% (78),which is 
undesirable for dosimetry applications and reduce its accuracy. 
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A solution to the problem of angular dependence of the diode is proposed by 
Westermark et al. who attached two diodes back-to-back(59).A similar approach is 
proposed for MOSFET dosimeters in a face-to-face configuration (79, 80). However, 
this approach is unfeasible when assembling large detector arrays for 2D dose mapping 
for volumetric dose reconstruction. 
Angular response is also reported on diamond-based detectors (59, 81)which represent 
a tissue-equivalent sensor in a megavoltage photon beam but still suffer from 
drawbacks such as large dose rate dependence (59). Jursinic et al. evaluated the 
performance of Sun Nuclear (Melbourne, FL) devices such as MapCHECK in terms 
of angular dependence with a variation as large as ±10% between 0◦ and 180◦(78, 
82).This deviation has been mitigated by introducing an extra layer of copper at the 
top of junction of the diode which mitigates the angular dependence with an 
improvement from ±10% to ±1.25%. The limitation of such a technique is the strong 
radiation field perturbation due to the presence of the high Z copper layer. ScandiDos 
(Uppsala Science Park, Sweden) in collaboration with the sensor and actuators division 
of Acreo—Swedish ICT (Kista, Sweden) has also developed a new silicon technology 
process to create angular-independent detectors. The technology suggested by Norlin 
et al.(83)adopts the use of custom-grown silicon on insulator (SOI) substrates to create 
a cubic structure with dimensions ranging from 300 to 410 µm using micro electro 
mechanic systems (MEMS) technology and p–n junctions on five sides. 
The angular dependence obtained with the ScandiDos system is promising, with a 
variation of the response within ±1.1% within the range±30◦ in the forward 
hemisphere. This solution has limitations in the packaging of the detector which 
creates dose enhancement (approximately +15% at 90◦) due to the existence of high 
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atomic number materials (such as gold and nickel) used for wire bonding of the 
detector to its printed circuit board (83). 
The angular response of commercially available diodes in 3D dose reconstruction can 
be disregarded when using a cylindrical phantom with a 2D diode array rotated 
synchronously with the linac gantry as it is proposed by PTW (Germany) in the 
OCTAVIUS 4D phantom (84).This solution leads to the beam being constantly at 
normal incidence to the plane of the 2D diode array, but also requires expensive and 
accurate mechanical engineering for manufacturing of the phantom and a sophisticated 
electronic control system design for rotation of the phantom synchronously with the 
linac gantry head. 
When a physical equalization of angular response solution is not available, a numerical 
correction of the response from the detector array is an effective alternative. This 
approach is adopted by several research groups and companies for the optimisation of 
commercially available silicon diode device such as Delta (80) (ScandiDos, Uppsala—
Sweden), ArcCHECK (SunNuclear, FL), and ion chamber base device such as I’mRT 
MatriXX (IBA Dosimetry, Schwarzenbruck, Germany). Before the application of the 
correction algorithm, Delta (80), which is based on p-type silicon diodes, displays a 
response variation of ±4% over a ±180◦ rotation (85). The correction algorithm reduces 
this variation to ±0.5% as reported in the device user manual. ArcCHECK, which is 
based on n-type silicon diodes mounted onto a cylindrical surface, suffers from an 
angular dependence of approximately ±7% measured by a wide field size (20 × 20 
cm2)(86).The angular dependence can be moderated (within ±2% deviation) by an 
approach similar to the Delta approach once the gantry head position is known. I’mRT 
MatriXX, based on an ion chamber array, shows an average angular dependence 
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variation of approximately +3.5% over±180◦ with a variation peak of +11% at 180 ◦ 
corresponding to the beam irradiated from the rear side of the detector plate (87, 88). 
2.2.2 Two Dimensional dosimeters 
Currently, 2-dimenstional array detectors are the most common dosimeters used in 
treatment dose verification. The multiple dosimetric elements of a 2D- array allow 
them to measure the dose distribution in a shorter time than a single detector. However, 
they can provide dose verification in a single plane only and are not able to obtain full 
3-D measurements. There are several detector types that can be designed and 
fabricated as two-dimensional dosimeters. Some of these dosimeters are briefly 
described in the following sections. 
2.2.2.1 Film dosimeter 
The film dosimeter is one of the first dosimeters used in the radiation detection field. 
It is used in medical dosimetry and treatment quality assurance, because it has 
excellent spatial resolution which gives them the ability to observe the 2D dose 
distribution. There are two types of film dosimeters: radiographic film and 
radiochromic film (47, 49, 89, 90). 
The oldest type of the films dosimeter is the radiographic film. This type requires 
chemical processing to produce the image of dose distribution(69). It requires a high 
level of care while handling because it is sensitive to light and moisture absorption. 
The dynamic range of film is limited; energy dependence is noticeable at the low 
energies of the photon beam due to their high effective Z number relative to soft tissue, 
and the response depends on several, difficult to control, parameters(47, 49, 89, 90). 
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Radiochromic film is a new version of the film dosimeter. The most commercially 
available style of the radiochromic film is GafChromic™ film. The un-exposed film 
is colourless but when exposed to radiation it turns a dark colour.  The film is made 
from tissue-equivalent material which usually composed of 9.0% H, 60.6% C, and 
11.2% Nand 19.2% O. GafChromic™ film shows very high resolution because it is 
grainless. For this advantage, it is often used in high dose gradient regions such as 
stereotactic fields. Other advantages of GafGhromic™ are: no requirement for 
chemical processing, easy handling, insensitivity to room light (dark room not 
required) and relatively low spectral sensitivity variation (47, 49, 89, 90). 
2.2.2.2 Silicon-based 2D array pixelated detectors 
2.2.2.2.1 Electronic Portal Imaging Devices (EPIDs) 
EPIDs have been routinely used, instead of film, to provide on-line images to assist 
with alignment of patient position during radiotherapy treatment (91, 92). The earlier 
portal imaging devices were composed of an array of liquid-filled ionization chambers 
or camera-based fluoroscopic detectors (93, 94). These types of EPIDs create low 
contrast and spatial resolution compared to film (95). The latest EPIDs consist of flat 
panel amorphous silicon detectors which provide better spatial resolution and contrast 
than the earlier generations devices. Using a-Si EPIDs as 2D dosimeters for dose 
verification measurement (in-vivo and pre-treatment) has been widely studied, as these 
devices exhibit advantageous properties such as: high resolution, large sensitive area, 
digital format, widespread availability, robustness, and easy setup (96-99). 
There have been several approaches developed to convert the measured EPID image 
to portal dose. One approach is to use empirical model to convert the images of EPID 
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to a portal doses (100, 101). Another approach is to use Monte Carlo simulation to 
model the EPID response (101-103).  
The dose verification measurement (pre-treatment and in vivo dosimetry) using an 
EPID can be generally performed by two different methods (forward and backward) 
(43). In the forward method, the measured portal dose images are matched to the dose 
calculated at the EPID plan produced by TPS or other independent algorithms(43). In 
the backward method, the dose inside the patient or phantom are  reconstructed using 
the portal dose images (104, 105). The advantage of this method is the capability of 
comparing the delivered dose to the one calculated by TPS directly (43, 96). In 
addition, the verification of 3D dose distribution inside the patient or phantom can 
possibly be performed with backward method. Conversely the forward method can be 
utilized where the dose can be only measured in one plane (43, 96). McNutt et al. 
developed an “extended volume” method where the EPID is consistently within the 
volume and the portal dose is predicted using convolution/superposition algorithms 
(106).  
The most prominent drawback that affects the dosimetry of standard EPIDs is their 
over-sensitivity to low energy photon beams due to the non-water equivalent layers in 
their constructions (97, 107). In addition, the optical scatter of their phosphor 
scintillator used to produce optical signal from the MV beams also restrict their 
dosimetric performance. 
2.2.2.2.2 Sun Nuclear MapCheck 
MapCheck is 2-D diode array detector designed by Sun Nuclear (Melbourne, USA) 
for QA application of planar IMRT dosimetry (108). The detector consists of 445 n-
type diodes with a total array area of 22 x 22 mm2. The sensitive area of the each pixel 
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is 0.8 x 0.8 mm2, with the diode pitch size in the central 10 x10 cm2 area being 7.07 
mm and increasing to 14.14 mm outside this area (108). It has been noticed that n-type 
diodes of the MapCheck detector have higher radiation hardness than the other 
commercial n-type produced before 2011. The sensitive areas of the MapCheck diodes 
are covered by a 2 cm build-up layer and 2.2 cm water-equivalent backscatter 
materials. A MapCheck detector is suitable for absolute and relative IMRT dosimetry. 
Letourneau et al. evaluated the performance of MapCheck for routine IMRT dosimetry 
and they observed that the detector exhibits a good linearity with dose up to 295 cGy 
and its response can be reproduced within a standard deviation of 0.15%. However, 
the application of the MapCheck in QA of VMAT and SBRT is limited due to the large 
pitch and the angular dependence of the diodes(108). 
2.2.2.2.3 Sun Nuclear ArcCheck 
ArcCheck is silicon diode array dosimeter developed by Sun Nuclear (Melbourne, 
USA) for 3D dose verification of helical radiotherapy modalities such as 
TomoTherapy. The dosimeter consists of 1383 diodes arranged in a helical shape 
inside an annular PMMA cylindrical phantom. The diameter and length of ArcCHECK 
dosimeter is 26.6 cm and 21 cm respectively. It consists of a central cavity of 15 cm 
in diameter to place the ionization chamber inside it for absolute dosimetry. The active 
volume of each diode is 0.8 mm2 with 1 cm diode pitch (109-111). The 
ArcCHECKsystem can obtain sufficiently high resolution measurements from every 
gantry angle with fast dose verification and real-time readout. Adopting ArcCHECK 
as a QA tool for dose verification in TomoTherapy instead of MapCheck can reduce 
the routine procedures of QA to less than half, with reproducible responses and good 
accuracy. The implementation of an ArcCHECK dosimeter in QA of IMRT and 
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VMAT have been investigated by Aristophanous et al. They found that this system is 
suitable for these modalities, however, the sensitivity of the device might be affected 
by field size dependence (112). 
2.2.2.2.4 Magic Plate 121 (MP121) 
MP121 is a prototype 2D array silicon detector designed and developed by the Center 
for Medical Radiation Physics (CMRP) at the University of Wollongong and 
manufactured at foundry SPA-BIT in the Ukraine(113). It consists of 11 x 11 p-type 
diodes with total array area of 10 x 10 cm2 at a pitch size of 10 mm. The dimension of 
each MP121 diode is 1.5 x 1.5 x 0.425 mm3 with an active area of 0:5mm2. Each 
individual MP121 diode is manufactured on a p-type silicon epitaxial layer 50 um thick 
(100 Ω cm) grown onto of a 375 µm thick p-type substrate of low resistivity (0.001 Ω 
cm). MP121 diodes were produced with p-type substrates and epitaxial layers to 
reduce the effect of radiation damage on the response of the diode (63, 65, 74, 114). 
The diodes are fabricated using ion implantation technology and then embedded on a 
0.64 mm thick Kapton carrier using “drop-in” proprietary CMRP technology (115) . 
This technology is developed to reduce energy dependence and dose enhancement of 
the high Z materials that are typically used to package silicon diodes. The MP121 can 
be connected to a DAQ system using two SCSI-2 connectors. The detector was 
designed to be operated in passive mode with 0 V applied to the diodes in order to 
reduce the leakage current generated in the p-n junction. 
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2.2.3 Three dimensional dosimeters 
2.2.3.1 Delta4 
The Delta4 system was developed by ScaniDos (Uppsala, Sweden) for real-time 
pretreatment 3D dose distribution verification of IMRT and VMAT treatments (116). 
This system is able to obtain dose measurements of radiation beams from different 
locations. The Delta4 system consist of 1069 p-type diodes fabricated in two crossing 
orthogonal planes and placed in a PMMA phantom (22 cm diameter and 40 cm length). 
The cylindrical- shape sensitive area of the diodes has a dimension of 78 mm2 with 
diode pitch size in the central 6 x 6 cm2 area being 7.07 mm and increasing to 10 mm 
in the remainder of the area (116). The cylindrical shape of the dosimeter with 
orthogonal arrangement of the diodes allow for 3D dose measurement. The Delta4 
system comes with an inclinometer to obtain angular information of the linac during 
the delivery via an independent method. Bedford et al. found that the uniformity of the 
Delta4 response was within 0.5 % for different segment MUs and dose rates. Also, the 
uniformity of the angular dependence was within 0.5% across the gantry angle range. 
However, Delta4 cannot be applied in small field dosimetry as it has large diode pitch 
size (5 mm)(116).  
2.2.4 SRS 2D dosimeters 
2.2.4.1 SRS MapCHECK 
The SRS MapCHECK from Sun Nuclear (Melbourne, USA) is composed of 1013 
diodes with a sensitive volume of 0.007 mm3 and area of 0.48 × 0.48 mm2 for each 
element (117). The detector elements are mounted on two face-to-face (7.7 × 7.7 cm2) 
printed circuit boards (PCBs), hence diodes are placed in the same plane with a spacing 
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of 2.47 mm between each diode (117). In order to provide build-up and backscatter, 
SRS MapCHECK is sandwiched between two PMMA slabs of  2.2 cm thickness. 
Saeed et al. evaluated the performance of SRS MapCHECK for routine SRS dosimetry 
and they observed that the detector can be operated with a maximum repetition rate of 
3400 MU/min. The angular response of the SRS MapCHECK was compared with 
ionization chambers and scintillators and agreed with them to within 2.1% (117). 
2.2.4.2 Octavius 1000 SRS  
The Octavius 1000 SRS array was developed for plan verification in stereotactic 
radiosurgery and QA of small fields. The 1000 SRS system consist of  977 liquid-filled 
ionization chambers with a total array area of 10 x 10 cm2. The volume of each 
ionization chamber is 0.003 (2.3 mm × 2.3 mm × 0.5 mm) (118). The detector can be 
placed in a slab phantom or inside an Octavius phantom which comes with an 
inclinometer to obtain angular information that can be sent to the array via BluetoothTM 
(118). Miljenko M et al. evaluated the performance of 1000 SRS array and found that 
the reproducibility of system was within 0.3 and 0.5 for short-term and long-term 
periods (119). In addition, the dose linearity and dose rate dependence was also 
measured, at the range of 0.5–85 Gy and 0.5–10 Gy min−1 respectively, and the 
agreement with ionization chamber was within 3% (119). A clinical evaluation was 
done by the same research group by comparing the Gamma index measurements 
obtained from an Octavius 1000 SRS with TPS,   PTW Octavius Seven29, and EDR2 
film data. They found that Octavius 1000 SRS array agrees with the above devices for 
>90% of the pixels using 2%, 2 mm tolerance criteria (119). 
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2.3 Small field dosimetry 
2.3.1 Introduction 
Advances in radiation therapy technology have resulted in development of 
sophisticated treatment techniques such as intensity-modulated radiation therapy 
(IMRT), Volumetric modulated arc radiotherapy (VMAT) and Stereotactic 
Radiosurgery (SRS)(120, 121). These techniques can be delivered by conventional 
linear accelerators using mini or micro-multileaf collimators (MLCs) such as High-
Resolution Multileaf Collimator (BrainLAB AG, Feldkirchen, Germany) or on 
dedicated treatment modalities such as Leksell GammaKnife® (Elekta Instrument AB, 
Stockholm, Sweden), CyberKnife® or TomoTherapy® (Accuray Inc., Sunnyvale, CA, 
USA). These developments have led to the use of radiation beams that are 
characterized by non-uniform, small and narrow fields with sub-centimetre sizes in 
conventional radiotherapy machines (IMRT and VMAT) and only a few millimetres 
field sizes in specialized and dedicated SRS equipment (Cyberknife and 
Gammaknife)(122-125). A “small” field refers to the field size of the radiation beam 
being smaller than the lateral range of secondary electrons. For MV photon dosimetry, 
a field size of 3x3 cm or less is considered to be a small field (126, 127). The 
implementation of such small fields improves the conformity of the radiation beam 
which in turn improves the treatment outcome. However, small fields are accompanied 
with significant dosimetric challenges and difficulties since the physics and dosimetry 
on which the standard radiation field relies does not hold for small field sizes(128, 
129).The most predominant challenge is the loss of lateral electronic equilibrium, 
which occurs when the lateral dimensions of the radiation beam are smaller than the 
range of charge particles (depositing electrons). Other challenges are source occlusion 
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which creates a pronounced and overlapping penumbra, volume averaging due to the 
large size of the detector compared to the small field size, fluence perturbation caused 
by detector and the variation in the spectrum due to a strong component of 
disequilibrium. Due to these effects, the uncertainty in clinical dosimetry is 
significantly higher even if standard procedures are adopted and errors are noticeably 
larger when compared with dosimetry of standard fields. 
2.3.2 The challenges and difficulties in small fields 
2.3.2.1 Loss of Lateral Charge-Particle Equilibrium (LCPE) 
Lateral Charge-particle equilibrium is associated with the range of charged particles 
which depends on the energy of the beam and the properties of  the irradiated medium 
(composition and  density) (42). LCPE occurs when the beam half-width or  lateral 
dimensions of beam is smaller than lateral range of secondary electrons (130) (42). 
The dose measurement in the presence of LCPE becomes more difficult as state of 
equilibrium does not exist - the number of the charged particles entering and leaving 
the volume is not equal. This can occur, for example, in a non-water-equivalent 
detector which has different densities resulting in an increased number of  inwardly-
rather than outwardly-scattered particles  (130). As the energy of charged particles 
increases, their practical range increases, therefore, the field size where lateral charge-
particle equilibrium fails is also increased. Li et al. found that the LCPE can be 
determined using the ratio of absorbed dose to kerma, D/Kcol (131). The smallest 
beam radius that make D/Kcol = 1 is defined as the lateral charge-particle equilibrium 
range (rLCPE). According to IAEA TRS-483 therLCPE is related linearly to the beam 
quality by the following expression.  
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rLCPE(cm) = 8.369.TPR20,10 – 4.382 
Where TPR20,10  is the ratio of the absorbed dose determined on the beam axis at depth  
of 20 and 10 cm for constant source to detector (SDD) distance and at reference field 
size. 
2.3.2.2 Source occlusion  
The radiation source in medical linear accelerators is not a point source, but a focal 
spot (typical between 0.5 and 4 mm) that can be defined from the FWHM of the 
primary photon (bremsstrahlung) fluence distribution(132-134). At small field sizes, 
the radiation source is partially blocked by collimating device as it is seen from the 
point of the measurement at the isocentre. This effect is usually known as source 
occlusion. 
During source occlusion, the radiation beam that reaches the point of measurement is 
reduced and its intensity will be inversely proportional to the size of the radiation 
source  (42). In addition, source occlusion creates overlapping of penumbra which will 
result in an abrupt reduction in the output factor in very small field sizes (135-137) 
(see Figure 1). A greater reduction in the radiation beam along the central axis is 
observed in the case of higher energy beam or in a lower density material. In both these 
cases the effect of LCPE is more prominent.  
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Figure 1. Overlapping of penumbrae at small field sizes (42). 
 
According to a Monte Carlo study done by Scott et al. increasing the focal size from 
0.1 to 1 mm will reduce the kerma on a central axis by 6% for a field size of 0.5 cm 
(138). The source occlusion is dependent on the geometry of the linac head and the 
set-up geometry as well. As the measuring of the focal spot size is usually difficult, a 
Monte Carlo modelling of the phase-space files with focal spot FWHM of 1-1.5 mm 
is resulted with an accurate percentage depth dose (PDD) and beam profile in water 
(139). 
2.3.2.3  Radiation energy spectrum hardening in small fields 
The energy spectrum of the photon beam varies when changing the dimensions of the 
beam fields (140). The average energy of photon fluence increases at any point on the 
photon beam axis when the field size is reduced, due to the following reasons (140): 
1. The occlusion of the primary photon source and shielding of the photons 
scattered from the linac head by the collimator which defines the radiation 
fields.  
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2. The reduction of the phantom scatter amount for small fields compared to 
broad fields. 
This effect will result in a change of the ratio of mass energy-absorption coefficients 
and stopping power ratios between water and dosimeter material (141). 
 
2.3.2.4 Volume averaging 
To obtain accurate dose measurement, the detector is required to be irradiated 
uniformly by the radiation beam. The dose is measured by averaging the signal 
obtained from the entire active volume (142). In small field sizes that are close to the 
size of sensitive volume, the detector average signal that is produced from both the flat 
part of the beam profile and penumbra results in a reduction of net signal. In addition, 
the variation of the signal over the sensitive volume will result in a flattened and 
broadened beam profile (143-146). If measurement of output factor in a small field is 
performed with a large detector where the dose is not uniform over its sensitive 
volume, an overdose might be delivered to treated target and the surrounding healthy 
tissues due to underestimation of the output factors. This also will cause inaccurate 
estimation of dose by the treatment planning system, which will lead to significant 
deviation of the treatment outcome. One of solutions for this volumetric effect is to 
reduce the size of the ionization chamber, but this will also decrease its signal to noise 
ratio (SNR) which will increase the uncertainties in the measurement. Using a 
semiconductor detector will reduce the partial volume effect but other issues 
associated with this type of detectors (such as dose-rate dependence and energy 
dependence) will create other uncertainties which will also affect the accuracy of the 
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measurement. Another approach is to model the convolution kernel of the detector 
which will allow correction of the detector response (142) (147). 
2.3.2.5 Fluence perturbation 
Fluence perturbation generally occurs from a tissue-inequivalent detector of finite size 
(148). It is usually defined as deviation from Bragg-Gray cavity theory or the ideal 
dosimeter behavior. Based on the Bragg-Gray cavity theory, ionization created in the 
cavity (e.g. gas-filled IC) placed within a medium is in relationship with the absorbed 
dose in the surrounding medium (46). The cavity is required to be small so that it does 
not modify the fluence and distribution of charge particles that would exit if the cavity 
was not placed in the medium (46). The secondary electrons perturbation depends on 
the geometry and components of detector, the energy and field size of the radiation 
beam and the medium surrounding the detector. When the size of detector becomes 
smaller than the charged particle range, the Bragg-Gray theory conditions cannot be 
satisfied (148). The perturbation due to the detector presence in the small field is 
difficult to quantify as the main cause of the effect is disturbance of the particle fluence 
(42). As the perturbation is strongly dependent on the structure and density of the 
dosimeter and the medium, the use of a correction method (e.g. replacement correction 
factor) is not possible (42). Alternatively, a modelling of perturbation correction 
factors can be calculated and applied to the reading of the dosimeters. However, these 
correction factors depend on the experimental design for which they are modeled 
(149).   
2.3.2.6 Positional accuracy 
The SRS treatment usually delivers high doses (up to 80 Gy) to sub-centimeter targets 
(150). The estimation of the dose treatment planning system by either calculation or 
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beam modelling depends on the measured beam data which must be obtained 
accurately (124). One of the factors that affects the accuracy of the small field 
measurement is spatial misalignment of dosimeter at the isocenter or a on the beam 
central axis (CAX). Misalignment in SRS treatment might also occur due to 
displacements in rotation axis of the gantry or the collimator, asymmetry of collimator 
jaws and focal spot displacement. The alignment accuracy should be better than 1 mm 
for SRS treatment. Paskalev et al. found that positional misalignment by 0.2 mm can 
cause 5% difference in measured dose in a 3 mm field size and 4% in a field size of 
1.5 mm(124).  
Alignment of detector in small beam fields using the machine’s light fields or laser 
beam is not accurate enough. Checking the maximum signal using real-time detectors 
(e.g. diodes) by obtaining the beam profile from different directions (at the depth of 
the measurement) gives more accurate results (141). Film and electronic portal 
imaging devices (EPIDs) can also be used to align the detector along the central axis 
of the beam. 
2.3.3 Relative dose measurement of small fields: output factor and beam profile 
The output factor is a crucial parameter which must be characterized for each linear 
accelerator and collimation system to obtain accurate commissioning data for the 
treatment planning system (151). Determination of the output factor is commonly 
reported as the ratio of the detector readings at a given field size to the reading over a 
reference field size (152).  However, in  small fields the direct relative readings of a 
detector cannot be used solely to determine accurately the output factor (153, 154). 
Several studies have been reported on the measurement of the output factors in small 
fields using various detector types such as ionization chambers, solid-state detectors 
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(e.g. silicon-based diodes, CVD diamond), film and scintillators (59, 129, 154-166). It 
can be concluded from these studies that the large volume detectors (comparing to the 
range of secondary charge particle of specific beam energy) such as air-filled 
ionization chambers, underestimate small fields; while small size volume detectors 
(such as solid-state detectors) which are fabricated from denser materials (compared 
to the density of water) tend to overestimate the small field output factor. One approach 
to mitigating the variation of the detector response in small field sizes is to perform a 
“daisy-chaining” (intermediate-field) method. In this method, an ionization chamber 
is used to measure the output factors for field sizes where the volume averaging effect 
can be seen, and then employ a solid-state detector such as a silicon diode for the 
measurement of the smaller field sizes (167, 168). Then the measurements obtained 
from the solid-state detectors are renormalized to the ones obtained by the ionization 
chamber. Other method has been proposed by several researchers to determine the 
output factor of small fields. In this method, the value of the dose-area product (DAP), 
determined by a large area ionization chamber (LAC), is used with the 2-D dose 
distribution (measured by film in the same plane as the LAC), to determine the 
absorbed dose in the area of interest (169, 170). In their recent TRS-483 (141) code of 
practice for small field measurements, the IAEA-AAPM introduced a new formalism 
developed by Alfonso el. at. (126) to determine the output factors for small field 
beams. In this formalism, the ratio of detector readings is multiplied by a detector-
specific correction factor to correct for the variation in detector response. Many 
researchers have determined field correction factors for several detectors 
experimentally using perturbation-free (except for volume-averaging) dosimeters (e.g. 
film, scintillators, alanine) or small size dosimeters with well-known output correction 
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factors (liquid-filled ionization chamber or unshielded diodes) (156, 171, 172). Field 
correction factors can be also derived using Monte Carlo calculations (173, 174) 
The dose profile is the distribution of the radiation dose on a plane, at a specific depth, 
perpendicular to the central axis of the radiation beam. The measurement of the beam 
profile is considered a crucial problem as it is associated with several challenges 
introduced primarily by the large size of the detector. Besides that the finite size of a 
detector introduces a large uncertainty in measuring penumbra width, it also creates 
severe dosimetric errors in small fields as the penumbra contributes of an important 
part of the beam field.  Research was done by Garcia-Vicente et al.  about the effect of 
detector size on the dose received by an organ at risk (OAR) (175). They compared 
the profiles obtained by a 5.5 mm detector (Ionization Chamber) and a 2 mm detector 
(Diode) and they found that the dose (received by OAR) reported by the 5.5 mm 
detector (large detector) is higher than the one measured by the 2 mm detector. Another 
investigation has been done by Laub and Wong about the effect of detector size in 
small fields and steep dose gradients in IMRT (162). These researchers made a 
comparison between measured profiles obtained by film with calculated profiles based 
on measurements obtained by the ionization chamber of commissioning of IMRT tool. 
Discrepancies of 10 % were observed between the measured and calculated beam 
profiles. Measurements of absolute dose (by intensity modulated beams) with 0.6 cm3 
Farmer Chambers showed 6% discrepancies between measured and calculated values 
(at the isocenter). The same measurement has been done with a 0.015 cm3 “pinpoint” 
ion chamber and 2% discrepancies were observed. Dawson studied the penumbral 
shape produced by 60Co, 6 MV and 31 MV x-ray using three commercial detectors 
(two Ionization chambers and a diode) and a number of in-house ionization chambers 
of 0.3 and 1.4 cm inside diameters (176). They noticed a linear increase in the 
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penumbral width with increasing inside diameter of the ionization chamber. Another 
investigation of penumbral width was done by Metcalfe et al. (146). Penumbral 
distribution was measured by TLD, silicon detector and Film. The sensitive width 
dimensions of the dosimeters were 2.5, 2.0 and 1 mm respectively. The widths of the 
penumbra (80-20 %) were 3.6, 3.6 and 3.4 mm respectively.  
2.3.4 Ideal detectors for small filed measurements 
As small field dosimetry is complicated, there is no single ideal detector which satisfies 
all requirements of small field dosimetry. Therefore, it is recommended as “good 
practice” to employ multiple detector types in relative and reference dose measurement 
of small beams (177). Ideally, the detectors used for small field measurement in should 
be energy-, angular- and dose-rate-independent. In addition, they should have the 
ability to obtain high spatial resolution measurement and should not be perturbing the 
radiation beam fluence (144, 178) (42).  
The detectors that are clinically adopted for small field treatment, such as in the quality 
assurance of SRS treatment, are ionization chambers, Gafchromic films, diode 
detectors, diamond detectors and Thermoluminescent dosimeters (TLDs) (138, 178-
182). All these detectors vary in their performance and exhibit some advantages and 
disadvantages.  
Although ionization chambers are considered a reference standard in radiotherapy 
dosimetry (138, 183) (42), their relative large size of sensitive volume introduces 
severe volume-averaging effects for the smallest field sizes, which overestimates the 
penumbra of the field and underestimate the output factor (182) (42). Additionally, 
mini-chambers suffer from reduction of their sensitivity and increased noise level due 
to their small sensitive volume size  (42). Radiochromic films have been widely used 
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in small field dosimetry because of their near water-equivalent material and the ability 
to measure dose profiles with high spatial resolution (184, 185). They are also angular 
-independent but suffer a lack of reproducibility which depends on processing 
conditions and procedures. Diamond detectors have gained high interest in small field 
measurement recently for their near tissue-equivalence, high spatial resolution and 
real-time readout(179). However, they are expensive and exhibit doserate-dependence 
(58, 178) and inter-device reproducibility. Silicon diodes are one of the most common 
detectors adopted for small field dosimetry. The relatively low average ionization 
energy required to produce an electron-hole pair in silicon (3.6 eV), and its density, 
makes silicon diodes very sensitive and very small sensitive volumes can be 
manufactured (63). The mass collision stopping power ratio of electrons for silicon–
water makes silicon diodes almost completely energy-independent for MV range 
energies (63). However, the application of silicon in small field measurement, 
especially in non-isocentric, non-coplanar and Flattening-filter-free (FFF) modalities 
such as CyberKnife, is limited by directional and dose rate dependence.  
2.3.5 Codes of practice (CoP)dedicated for small field dosimetry 
One of the main goals of Codes of Practice (CoP) or protocols (e.g. TG-51 and IAEA 
TRS 389) (186) (183) is to standardize clinical procedures (e.g. calibration of absorbed 
dose, quality assurance and dose verification measurement) to reduce the potential 
uncertainty in dosimetry processes. There are efforts of several different national and 
international committees to establish protocols and reports on small field dosimetry 
(e.g. IPEM Report 103 and ICRU Report 91) (42) (187). Recently, the International 
Atomic Energy Agency (IAEA) in collaboration with the American Association of 
Physics in Medicine (AAPM) has published an international code of practice (TRS 
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483) dedicated to small static beams dosimetry. It is considered be the first 
comprehensive code of practice covering the most common practical issues in this area 
of dosimetry. The CoP is based on new concept and formalism introduced by Alfonso 
et. al.(126) for the relative and absolute determination of the absorbed dose to water in 
small static and nonstandard fields. In this formalism, the relevant radiation fields are 
divided in to two types: small beam field (such as 6 cm circular field size in 
Cyberknife, 1.8 cm field size in Gammaknife and 5 x 20 cm field size in 
TomoTherapy), and composite fields (such as dynamic and step-and-shoot fields).  
Several definitions have been introduced in this formalism and they are as below: 
ƒref refers to the conventional reference field of the standard dosimetry protocol at 
which the calibration coefficient of the ionization chamber for absorbed dose to water  
is determined. 
ƒmsr refers to the machine-specific reference field in nonstandard radiotherapy 
modalities inwhich the conventional reference field cannot be established. 
ƒclin refers to the clinical beam field where the absorbed dose to water is required to be 
determined. 
The absorbed dose to water for an msr field is related to conventional reference one 
through: 
  (1) 
 
 is the absorbed dose to water at the reference depth in water, in a beam of 
quality Qmsr and reference field fmsr.  
 is the reading of the detector in the field fmsr. 
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 is the calibration coefficient in terms of absorbed dose to water for an 
ionization chamber at a reference beam quality Q0. 
is the beam-quality correction factor, which corrects for the differences 
between the reference beam quality Qo at the standards laboratory and the beam quality 
Q of the conventional reference field fref. 
is a factor that corrects for the differences in the response of the detector 
between the conventional reference field and machine-specific reference field and can 
be found through: 
  (2) 
 
This correction factor can be obtained through experimental measurement of 
calibration coefficients in the two fields: fref and fmsr. Or instead, Monte Carlo 
simulation can be used to calculate it. It can be applied with assumption that the 
variation in the beam quality between the clinical linear accelerators are small.  
The relative dose at fclin in respect to fmsr can be found through: 
  (3) 
 
Where is the ratio of absorbed dose in the machine-specific reference field 
to the absorbed dose in the clinical radiation field size of interest, which is commonly 
called field output factor. In the case of small and nonstandard field measurement, the 
traditional output factor does not reflect the true dose, therefore, an output field 
correction factor is required to be applied to convert detector readings ratio into the 
true dose ratio which is as follows: 
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  (4) 
 
Where corrects for the inequivalence in ratio of detector readings to the 
dose ratio in water. However, Alfonso et al. show that if correction factor for a given 
detector is close to unity, the reading of the detector is accurate enough to be used 
without correction (126). 
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3 CHARACTERISATION OF AN ‘EDGELESS’ DOSIMETER FOR 
ANGULAR INDEPENDENT MEASUREMENTS IN ADVANCED 
RADIOTHERAPY TREATMENTS 
 
This work has been published in IEEE Transactions on Radiation and Plasma Medical 
Sciences as: 
Alhujaili, S., Davis, J., Davies, J., Lerch, M., Rosenfeld, A. and Petasecca, M. (2019). 
Characterization of an edgeless Dosimeter for Angular Independent Measurements in 
Advanced Radiotherapy Treatments. IEEE Transactions on Radiation and Plasma Medical 
Sciences, 3(5), pp.579-587. 
 
3.1 Introduction 
In modern radiotherapy modalities such as IMRT, VMAT and SRS, the dose delivered 
to the target volume is shaped using a multileaf collimator (MLC) and the beams are 
delivered of at many angles around the patient. Verification of such treatment 
modalities requires three-dimensional reconstruction of the dose for comparison with 
the dose maps calculated by the treatment planning systems (TPS). Real time 3D dose 
reconstruction requires the use of a dosimeter embedded in a water-equivalent 
phantom. Silicon diodes are the detectors of choice for such real-time radiotherapy 
dosimetry due to the small size of their sensitive volume, high spatial resolution and 
high sensitivity. But silicon diode detectors suffer from angular and dose rate 
dependence. In this chapter, the performance of angular independent edgeless diodes 
are evaluated from a radiation detector point of view using techniques adopted in high 
energy physics detectors for evaluation of charge collection, basic electrical properties 
and radiation hardness. A model of the edgeless device was developed in order to 
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simulate its behaviour using Synopsys TCAD and this has been validated against 
experimental measurements. 
3.2 Material and method 
3.2.1 Detector and Readout system 
3.2.1.1 Edgeless detectors 
Edgeless detectors were developed in 2006 with the purpose of fabricating large area 
(tens of cm2) pixelated detectors for imaging applications such as crystallography and 
proton tomography (188, 189). Recently, further developments have been introduced 
by VTT (Finland) using a standard floating zone silicon wafer instead of a SOI 
substrate. In order to activate lateral junctions, this technique needs an ion-coupled 
plasma etching procedure rather than laser ablation for isolating single diodes from the 
wafer and ion implantation (190, 191). By adopting this procedure, VTT and CMRP 
have together developed a set of edgeless diodes for medical dosimetry purposes. 
Single edgeless detectors were manufactured using both n-type and p-type silicon 
substrates of 500 µm and 100 µm thicknesses with different sensitive areas or chip 
sizes: 0.5 × 0.5 mm2 and 1 × 1 mm2, referred to as XS and S, respectively. The p-n 
junction is realized by N+ implantation on the top side; the substrate is polarized by a 
uniform P+ implantation of the back side and all the lateral edges are as shown in the 
cross section of Figure 2. 
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Figure 2. Schematic representation of the substrate-junctions configurations of an edgeless Diode; 
(a), (c), (e), and (g) show the top view; (b), (d), (f), and (h) show the cross sectional view; (i) shows 
the color coding of the implantation types and materials used for the representation of the devices. 
 
Another topology is with the junctions swapped (P+ on the top side and N+ at the 
edges) to investigate the role of the majority and minority carriers and the effect of 
different drift velocities on the angular response. This process leads to the creation of 
a 3D junction with a very peculiar electric field distribution which improves the charge 
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collection efficiency of the detector in passive mode. The geometry and junction 
configurations of the samples used in this project are summarised in Table 1. 
 
Table 1: Summary of the edgeless diode samples. 
Sample ID Dimensions (mm2) 
Substrate 
thickness 
(µm) 
Substrate 
type 
Top 
implantat
ion type 
Peripheral 
implantation 
type 
Resistivity 
(KΩ cm) 
NP-XS-100 0.5 x 0.5 100 p-type n+ p+ 7 
NP-S-500 1 x 1 500 p-type n+ p+ 7 
PP-XS-100 0.5 x 0.5 100 p-type p+ n+ 7 
PP-S-100 1 x 1 100 p-type p+ n+ 7 
NN-XS-100 0.5 x 0.5 100 n-type n+ p+ 12 
NN-XS-500 0.5 x 0.5 500 n-type n+ p+ 12 
PN-XS-500 0.5 x 0.5 500 n-type p+ n+ 12 
 
3.2.1.2 Detector packaging 
The packaging of the detector plays a critical role in developing a complete angular-
independent detector even though the diode itself shows angular-independent 
response. The packaging should be also robust, flexible, and manufactured from tissue-
equivalent material. The proposed solutions described in this study use the “drop-in” 
radiation sensors packaging technology developed at CMRP and successfully 
implemented in many applications such as the fabrication of MOSkin detector probes 
and the MagicPlate-121 (113, 192, 193). The drop-in technology based on assembling 
the detector on a flexible carrier from which the detector die hangs down. The diodes 
are fitted with  thin Kapton pigtails which provide the required mechanical support for 
the chips, simultaneously sealing and connecting the sensor to the readout electronics 
without the use of any high Z-material (Kapton effective atomic number for photons 
is 6.35 as calculated by the compositional data provided by NIST Physics Laboratory).  
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3.2.1.3 TERA readout system 
The TERA readout system was adopted to read out the signal created by the edgeless 
and Magic Plate-121 detectors. The TERA chip is a Very Large Scale Integration 
Application Specific Integration Circuit (VLSI ASIC) developed by a collaboration 
between the Istituto Nazionale di Fisica Nucleare (INFN) – Torino Division and the 
University of Torino Microelectronic group for monitoring and control of   a hadron 
therapy beam. The TERA device has the ability to read out the signal with zero dead-
time and without the requirement of an external trigger. The TERA ASIC was 
originally developed to be used with MagicCube (pixel ionization detector) and 
MatriXX  (IBA, Schwarzenbruck, Germany) detection systems (194). It has two chips 
with64 parallel inputs which give it the ability to readout currents from 128 channels. 
TERA architecture is based on a current-to-frequency converter followed by a digital 
counter, and its operation relies on the charge-balancing or recycling-integrator 
technique (194, 195).  
 
 
Figure 3. Schematic diagram of aTERA readout (194) 
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When radiation interacts with the detector material, an electrical current is produced 
in the detector bulk. This current is integrated using a fixed capacitor of 600 fF (Cint) 
in the operational trans-conductance amplifier (OTA) (Figure 3). The integrator 
produces a voltage ramp, and this voltage signal is compared to the adjustable 
threshold voltage of an analogue comparator. If the ramp voltage is above the threshold 
voltage, the comparator sends a pulse (VB) to the pulse generator (PG). The PG creates 
two pulses: one for the digital counter and the other is sent to a subtraction capacitor 
(Csub). As Csub is connected to circuit of the Cint, a fixed amount of charge is subtracted 
from it. This will lead to a reduction in the voltage across Cint. This reduction is 
proportional to two factors: (1) ratio of Csub/Cint and (2) voltage height of the pulse. This 
cycle is repeated until the input current is null (194-196).  The TERA chip shows a 
linearity deviating by only approximately 1.5% over input range of 104. The average 
open-circuit current (“background current”) is approximately 230 fA.  ADAQ is also 
used to control a rotatable phantom via a user interface which allows for phantom 
positioning at a selected angle or synchronized with linac gantry rotation. 
3.2.2 TCAD model validation 
Using the specifications and junction profiles provided by VTT, the edgeless device 
was modelled in Synopsys TCAD, as shown in Figure 4. The Device Simulation for 
Smart Integrated Systems (DESSIS) toolkit solves the Poisson and Continuity 
equations for electrons and holes under proper transport equation approximations (e.g. 
drift-diffusion) in order to calculate electric potential, field and macroscopic electrical 
behaviour of the edgeless device. The Shockley-Read-Hall statistical physics model 
was activated to describe carriers’ generation/recombination occurrences. A fixed 
charge concentration of 5x1010 was instantiated for all Si/SiO2 interfaces to better 
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approximate the pre-irradiated conditions of the edgeless device (197). Given that the 
model is a 2D representation of the edgeless device, a geometric scaling factor (AF) 
representing the width of the device, was used to allow for a comparison between 
experimental and simulated results. 
TCAD allows the possibility to integrate a model simulating the effect of radiation 
damage in silicon. Prediction of the radiation damage effects in a detector after 
exposure to a high intensity radiation field (gamma photons for this specific study) is 
important to establish its usability and response stability after a certain time under 
operating conditions. 
 
Figure 4.Cross sectional model of the PP edgeless diode. The phosphorus implantation (n+) along the 
back and sides is depicted in dark blue and boron implantation (p+) on the top in red. A SiO2 
passivation layer (orange/brown) surrounds the device and providesa barrier for aluminium contacts 
(grey).  
 
3.2.3 Electrical characteristics 
The performance of a silicon-diode detector, as for any other solid-state detector, can 
be affected by many factors such as the environmental conditions around the detector, 
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geometry and electrical properties. The electrical properties such as capacitance, 
depletion voltage and leakage current play a vital role in a silicon detector 
performance, as they can contribute to the noise formation of detectors, charge-
collection efficiency and spatial resolution. Measurements of the electrical 
characteristics were performed with two main objectives. Firstly, to determine the 
appropriate operating conditions of the edgeless device and secondly to validate the 
TCAD model of the edgeless device.  
3.2.3.1 I-V characteristics 
The voltage characteristics of silicon detectors help to assess the uniformity of the 
detectors within a batch, and determine the optimum detector operation voltage, which 
gives a high signal-to-noise ratio, as well as determines the width of the depletion layer 
and any radiation damage effects after the detectors have been irradiated. 
 
Figure 5:The experimental se-up for I-V characteristics measurement 
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The I-V characteristics were obtained using a Keithley high-voltage source coupled 
with a Keithley 199 System DMM/scanner and Keithley 614 electrometer (see Figure 
5). During the measurement, the detector was placed inside a light-tight chamber to 
reduce the amount of photocurrent generated by external light. Measurements were 
performed at atmospheric pressure and typical lab temperature (~295 K) to create the 
conditions in which the detectors will be used during clinical applications.  
 
Figure 6: The LabVIEW software interface  
 
 LabVIEW software (see Figure 6) was used to perform automated measurements to 
be performed, with the current of the detector to be recorded over an increasing bias. 
A negative bias (from 0 to -20 V) was applied on the bulk p+ substrate, and current 
was measured across the junction defined by the n+ region.  
3.2.3.2 Capacitance-Voltage (C-V) characteristics 
The C-V characteristic is an essential test to evaluate the effects of radiation on the 
effective doping concentration of the device. Furthermore, C-V tests can give 
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information about depletion-layer width and the total electrostatic potential between 
the p-side and the n-side neutral regions under thermal equilibrium.  
 
 
Figure 7:TheC-V characteristics test softwareinterface. 
 
Capacitance-Voltage (C-V) characteristics of the edgeless detector was measured 
using a Bontoon 7200 Bridge Capacitance Meter at 1 MHz and C-V software (see 
Figure 7). As with the I-V test, the detector was placed in a light-tight chamber and 
then a measurement was taken before any detector was connected to the capacitance 
meter. Using the known geometry of the edgeless devices, measurements are presented 
in the form of leakage current density. CV measurements were performed with and 
without the edgeless devices mounted, in order to correct for any capacitance 
contributions from the packaging.The C-V software allowed for automated 
measurement, having a similar interface to the LabVIEW software. 
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3.2.4 Charge collection characteristics 
The charge collection performance of p-type edgeless diodes (PP and NP) was carried 
out using the Ion Beam Induced Charge (IBIC) facility at the Australian Nuclear 
Science and Technology Organisation (ANSTO).IBIC is a method that exploits 
focused beams of charged particles produced by an accelerator to induce charge 
collection in semiconductor devices to study their electrical properties. The heavy ion 
beam is raster-scanned over the semiconductor device, which leads to production of 
an electrical signal which is correlated with the beam position at successive instants in 
time.  From this, the electrical response of a radiation detector to induced charge at a 
given location near the surface can be deduced from the results. All IBIC 
measurements were performed utilising the heavy ion microprobe of the ANTARES 
10MV Tandem Accelerator (198).The IBIC experiments on the edgeless diodes were 
performed using a 5.5 MeV helium ion beam having a range of 28 µm in silicon (199). 
The amount of energy deposited within the edgeless diode for each ion traversal, was 
measured with a standard charge-sensitive preamplifier, a shaping amplifier and a 
multi-channel analyser (MCA). Calibration of the data acquisition system is performed 
using a Hamamatsu 300 µm thick windowless silicon PIN diode with a known CCE in 
conjunction with a pulse generator. All analysis of IBIC results was performed using 
MATLAB to create energy deposition spectra and median energy maps. Although the 
dosimetry uses continuous current mode, investigating the behaviour of the edgeless 
diodes in term of CCE as function of angle using a spectroscopic technique will give 
an insight about shape and distribution of the electric field and depletion layers. To 
perform this investigation, the orientation of the edgeless diode surface with respect to 
 85 
 
the ion beam was varied between 0 and 45 degrees, under an applied bias of 0, 10, 20 
and 30V. 
3.3 Results 
3.3.1 Electrical characteristics and TCAD model validation 
The experimental and TCAD-based simulation results of the leakage current density 
as a function of applied bias are presented in Figure 8. The leakage current density 
saturates at approximately 12 nA/cm2 above an applied bias of 10 V, providing a good 
indication of the optimum operating conditions for the edgeless device. Wu et al. report 
values of leakage current density, measured in VTT for 5x5 mm2 devices, of 
approximately 10nA/cm2(197) which is in good agreement with the measurements 
reported in this study.  
 
Figure 8: Experimental (Black) and TCAD-simulated (red) I-V characteristics of an edgeless Diode 
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The CV results (experimental and simulated) are presented in Figure 9. The TCAD 
model presents a capacitance at 0 V of 6 · 10-16 F/m2 which is within 10% of the 
measured capacitance. As with the previous result, the capacitance plateaus at 
approximately 0.5 · 10 -15 F/m2above 10 V. Except for the region between 2 and 10 V, 
CV trend and absolute value are in agreement within 10% up to a bias of 50 V. The 
agreement between the experimental and simulated results presented in Figure 8 and 
Figure 9 demonstrate the reliability of the geometrical structure and doping profiles 
adopted in the TCAD model in representing the behaviour of the edgeless diode. 
 
Figure 9: Experimental (Black) and TCAD-simulated (red) C-V characteristics of the PP edgeless 
diode. 
 
Figure 10 shows the comparison of the depletion region between the NP (above) and 
the PP (below) diodes at 0 V bias. The NP has a depletion layer growing from the top 
side with a thickness of approximately 25 µm and is limited to the region underneath 
the n+ doped region. The depletion extends as a function of applied bias, with full 
depletion at approximately 15 V. It should be noted that even at 0V, a large proportion 
of the edgeless device volume is already depleted. This, in addition to the negligible 
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baseline signal generated by leakage current, makes the zero-bias condition ideal for 
dosimetric applications. The behaviour of the PP diode is similar to that of its NP 
counterpart. The depletion region (white line) at 0V extends about the n+ doped region, 
and thus encompasses the walls and bottom layer of the diode. The depletion region is 
relatively uniform, except in the corners of the device. 
 
 
Figure 10: TCAD-derived electrostatic potential of anNP diode (top) and PP diode (bottom) under an 
applied bias of 0V. The depletion region is indicated in white. 
 
Figure 11 shows the distribution of the electric field in a 0V bias for both the NP 
(above) and the PP (below) structures. The extension of the depleted region is 
approximately the same around the junction as expected, given the equal phosphorous 
concentration in both the top and lateral junctions of the NP and PP, respectively. 
Although the PP diodes shows the largest extension of the “active” junction which 
makes the drift region wider than that of the NP diodes, the non-uniformity of the 
electric field at the corner regions of the PP device makes this option less desirable for 
an angular independent dosimeter. The non-uniformity of the PP device results in 
variances in the charge collection as compared to the NP diode. 
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Figure 11: TCAD-derived electric field distribution of the NP edgeless diode (top) and PP edgeless 
diode (bottom). Both PP and NP diodes are under an applied bias of 0 V. 
 
3.3.2 Charge collection characteristics 
The energy deposition spectra for the 500 µm thick PP and NP edgeless diodes for 5.5 
MeV He2+ ions at normal incidence to the front side (p+ for PP and n+ for NP 
detectors) under an applied bias of 0 V, are presented in Figure 12 and Figure 13, 
respectively. 
Given the relatively short range of the incident ions compared to the thickness of the 
diode, the CCE of the edgeless diodes, whilst good, is less than ideal. The broadness 
and multiple peaked structure of the collected charge spectra is indicative of 
undesirable spectroscopic performance. 
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Figure 12: The energy spectrum of a PP edgeless diode. 
 
The largest observed CCE in region III of Figure 12 and Figure 13 corresponds to 
86.4% (4.93 MeV) for PP and 100% (5.5 MeV) for NP devices, respectively. PP device 
it corresponds to ions incident directly to small area N+ region in a front side of the 
device (max CCE) and a region between the N+ and P+ regions providing less CCE 
due to diffusion charge collection with a stronger build-up of electric field. In the case 
of the NP devices, the sharp peak is expected as ions are incident to n-p junction where 
build-up of electric field is maximum and minority charge carriers (electrons) are 
drifting without recombination. The region II for PP diode correspond to a sharp peak 
at 4.05 MeV (CCE: 37.6%), due to a combination of attenuation through the 
aluminium bonding pad of the top contact and minority carrier generated in the 
substrate recombining before being collected by n+p junction at the back side of the 
diode. Region II of the NP diode corresponds to a peak generated by the attenuation 
through aluminium. 
 90 
 
 
Figure 13. The energy spectrum for the NP edgeless device. 
 
To better illustrate the regions of interest previously discussed, windowed median 
energy maps of the PP and NP are presented in Figure 14 (2 - 3.5 MeV), Figure 15 
(3.5 - 4.5 MeV and 3.5 - 5 MeV) and Figure 16 (4.5 - 5.5MeV and 5 - 5.5 MeV). 
 
Figure 14: Windowed median energy mapsof Region I for the PP (left) and NP (right) edgeless 
diodes (500 um thick) windowed at 2-3.5 MeV. 
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Figure 15: Windowed median energy maps of Region II for the PP (left) and NP (right) edgeless 
diodes (500 um thick) windowed at 3.5-4.5 MeV (PP) and 3.5-5 MeV (NP). 
 
 
Figure 16: Windowed median energy maps of Region III for the PP (left) and NP (right) edgeless 
diodes (500 um thick) windowed at 4.5-5.5 MeV (PP) and 4.5-5.8 MeV (NP). 
 
Figure 17 provides the combined MCA He2+ ion spectra of the PP device at 0, 20 and 
45 degrees angle of incidence to the front surface of the devices. As the angle of 
incidence increases in PP devices, both the major peak (region II) and high energy tail 
(region III) are shifting to lower energy. It can be explained by increased energy loss 
of incident particles within the aluminium contact pad traversing longer paths at 
increasing angles (~153.8 keV/um) (199). Additionally higher statistical contribution 
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of the high energy tail in comparison to normal ion incidence is due to ions incident to 
the side of n+ region of the device.  
 
Figure 17: Energy spectrum for the PP edgeless diode at 0V for 5.5 MeV He2+ ions at 0, 20 and 45 
degrees angle of incidence. 
 
The same features are evident in Figure 18, which depicts the energy deposition spectra 
of the NP device at 0 and 45 degrees angle of incidence. The NP diode demonstrates 
an improved CCE over the PP diode described previously. Overall, the energy spectra 
observed for both PP and NP diodes shows an almost negligible effect of the 
orientation of the detector on the CCE and also demonstrates a very efficient collection 
mechanism from the active edges of the devices. 
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Figure 18: Energy spectrum for the NP edgeless diode at 0V for 5.5 MeV He2+ ions at 0 and 45 
degrees angle of incidence. 
 
3.4 DISCUSSION AND CONCLUSION 
An edgeless diode developed by VTT in collaboration with CMRP to provide angular-
independent dosimetry for advanced external beam radiation therapy has been 
characterised using a combination of experimental and simulation-based techniques. 
Two p-type edgeless devices PP (p+ on top) and NP (n+ on top) were modelled using 
Synopsys TCAD and validated against experimental (I-V and C-V) measurements. 
The model was successfully used to characterize the shape and distribution of the 
electric field in the detector, highlighting the difference between two edgeless (PP and 
NP) devices. IBIC measurements performed upon the PP and NP edgeless devices 
demonstrate that both devices exhibit good CCE, indicative of the quality of the 
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manufacturing process and the edgeless device structure. The PP device demonstrates 
decreased CCE at the corners of the device. A comparison of the result with the TCAD 
simulation indicates that the cause is the comparatively weak and non-uniform electric 
field distribution of the devices in a passive operational mode, which could potentially 
cause a small angular dependence corresponding to the 45/135 degree positions of the 
beam. The NP diodes shows a more regular and uniform CCE across all angles of ion 
incidence on the front side of the detector using the IBIC technique, confirming the 
uniform and regular electric field distribution simulated by the TCAD model. 
Whilst preliminary IBIC and TCAD-based studies demonstrated that the non-
uniformity of electric field distribution due to the device architecture (doping/electrode 
configuration) does have an effect on device performance, there seems to be no 
appreciable impact on angular dependence. Thus, based upon the findings of this work, 
future work will concentrate upon the use of p-type edgeless devices with the NP 
junction configuration for QA work in radiotherapy. 
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4 ANGULAR INDEPENDENT SILICON DETECTOR FOR DOSIMETRY IN 
EXTERNAL BEAM RADIOTHERAPY 
 
This work has been published in Medical Physics as: 
Petasecca, M., Alhujaili, S., Aldosari, A., Fuduli, I., Newall, M., Porumb, C., Carolan, M., 
Nitschke, K., Lerch, M., Kalliopuska, J., Perevertaylo, V. and Rosenfeld, A. (2015). Angular 
independent silicon detector for dosimetry in external beam radiotherapy. Medical Physics, 
42(8), pp.4708-4718. 
 
4.1 Introduction 
The previous chapter focused on the characterization of edgeless diodes in term of 
their electrical properties and charge collection efficiency which was performed using 
IBIC measurement and TCAD modelling. In this chapter, the edgeless detector 
technology was investigated, in combination with an innovative packaging technology 
referred to as “drop-in” which has been patented by CMRP in order to assemble single 
thin silicon diodes within a plastic carrier without the use of high atomic number 
materials typically required for wire bonding in semiconductor technology. Dosimetric 
characterization was performed with the aim of verifying the suitability of the edgeless 
diodes as a QA tool in advanced radiotherapy treatments (IMAR, VMAT and SRS). 
The parameters tested were:  
1. percentage depth dose (PDD) 
 
2. dose rate 
 
3. linearity 
 
4. output factor 
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5. angular dependence 
 
6. radiation hardness 
 
4.2 Material and Method 
4.2.1 Treatment unit and detectors 
All data of this study was obtained using a 6MV photon beam produced by a Varian 
Clinac iX machine equipped with a MLC Millennium-120 (Varian Medical Systems, 
California, USA and BrainLAB, Feldkirchen, Germany, respectively). A description 
of the edgeless diodes and TERA readout system was presented in section3.2.1. The 
edgeless measurements were compared to the measurements performed by a PTW-
Markus ionisation chamber (PTW Freiburg—Germany) and EBT 3 film (Ashland Inc., 
Wayne, NJ, USA). 
4.2.2 Rotatable phantom 
The rotatable phantom used for these measurements consists of a plastic drum 
(PMMA) designed for rotating a detector placed at its centre between±180 degrees. Its 
density is 1.17 g/cm3, (near-tissue equivalent for 6 MV photon energy) and it has a 
cylindrical shape with a radius of 15 cm and length of 40 cm (Figure 19), which is 
similar to the thoracic duct length in an adult person. It can be rotated in a clockwise 
direction. The movement of the phantom can be controlled either manually or 
automatically. It has several inserts of different sizes to accommodate different types 
of detectors, including single diodes such as the one used in this work. The detector is 
sandwiched by 25 mm thick solid water slabs (brown plastic) to ensure that water 
scattering condition close to the detector is accurately mimicked. The angle of the 
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phantom is determined by using a SICK ATM 60 SSI absolute optical encoder. The 
measuring step of the encoder is 0.043o with accuracy of ±0.25o.The encoder was used 
with RS422 as a digital configuration interface. The phantom rotates by the means of 
a NEMA-24 stepper motor with a torque of 2.74 Nm. The stepper motor operates using 
a high current power supply and a GECKO stepper motor controller mastered by a 
Field Programmable Gate Array which synchronises the position of the phantom with 
the digitalisation of the readout current of the detector.  A timing belt of 620-650 mm 
has been used to connect the motor to the rotatable phantom for better gearing and 
control of the motion. 
 
Figure 19. Rotatable phantom with the solid water insert to accommodate Kapton probes 
 
4.2.3 Radiation hardness 
Silicon-based detectors exhibit a change in their sensitivity with accumulated dose due 
to the presence of defects generated in the substrate and at the silicon-silicon-oxide 
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interface by the interaction with ionising radiation (114).As the carrier lifetime in 
silicon detector is inversely proportional to the concentration of deep level defects in 
both types of substrates (n and p-type), the decreasing of carrier life time is the main 
factor in degradation of the sensitivity of the diode with dose accumulation (200). 
A change in minority carrier lifetime will lead to decrease the effective active volume 
of the diode, reducing the sensitivity and increasing the asymmetry of the conventional 
detector. This asymmetry will potentially increase the variation of angular response 
because of an increase in the passive silicon volume which shows different radiation 
attenuation than water. To evaluate the effect of the accumulated dose on the absolute 
and angular response of the edgeless detectors, measurements of the diodes’ responses 
were obtained before and after dose irradiations at increments of 10, 20, and 40 kGy 
from a Co-60 gamma photon source (ANSTO, Lucas Heights—Australia) for all types 
of edgeless detectors. The measurements were performed by placing the edgeless 
detector in the centre of the rotatable phantom. The data were obtained by delivering 
a dose of 100 MU at a field size 10 × 10 cm2 under a 6 MV linear accelerator at a dose 
rate of 600 MU/min.  
4.2.4 Percentage depth dose (PDD) 
The percentage depth dose (PDD) is a curve that correlates the dose deposited by the 
photon beam within a medium as it varies with depth along the axis of the beam. It is 
one of the important parameters that determines the suitability of the sensor as a 
radiation dosimeter. It has been shown in literature that PDD measurements obtained 
by silicon-based detectors are in good agreement with those obtained using ionisation 
chamber for MV photon energy. However, a small over-estimation (<2.5%) is 
usually seen in silicon detectors at deeper depth in water due to dose rate dependence 
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of their response (59, 74, 201).The pre-irradiated edgeless diodes, in PDD 
measurement, were inserted into a solid water phantom (Standard Imaging— 
Madison, WI). Several solid water slabs (30 × 30 cm2) of different thicknesses were 
used to provide a proper scattering condition and to obtain PDD measurements at 
several depths (0.7 up to 30 cm). A 10 cm thick slab was used for back-scattering. 
The measurements were performed with 10 x 10 cm2 field size at 100 cm source to 
surface distance (SSD).  In each single measurement, the diodes were irradiated for 
100 MU by 6 MV photon beams. PTW 30013 (PTW-Freiburg, Germany) ionisation 
chamber was used as benchmark detector. This chamber is waterproof, fully guarded 
ion chamber with acrylic wall and sensitive volume of 0.6 cm3. 
4.2.5 Output factor (OF) by edgeless detectors and EBT3 film 
The Output factor is defined as the ratio of absorbed dose at the given field size to 
absorbed dose at the reference field size(154).The reference field size used in this work 
was 10 ×10 cm2 at isocentre (SSD) of 90 cm. The output factor measurement was 
performed by placing pre-irradiated diodes at the central point of the field at depth of 
1.5 cm within solid phantom. The response of the dosimeters were investigated at 
several field sizes ranging from 0.5 × 0.5 cm2 to 10 × 10 cm2. Special attention was 
given to the small fields measurements as the performance of silicon diodes can be 
influenced by severe over-response due to lack of lateral charged particle equilibrium. 
Gafchromic EBT3 film was used as the reference dosimeter for the output factor 
measurements. The EBT3 films were cut into several pieces (20 × 20 cm2) and placed 
at the centre of the solid water phantom which was positioned at the isocentre of the 
linear accelerator. Each film has been scanned six times using anA3 flatbed scanner 
(Epson Expression 10000XL) and only last three scans were analysed to ensure a 
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proper scanner warm-up and better film analysis consistency(202).The scanning of the 
films was performed in 48-bit RGB color mode with a resolution of 70 dpi (0.362 mm 
equivalent pixel size). The red channel was solely used for conversion of the pixels to 
dose based on the calibration curve. A median filter of 3 x 3 pixels was applied to 
reduce the noise in scanned images of the films. Films were scanned  in the central 
region of the scanner bed while maintaining a consistent orientation to decrease optical 
nonuniformity (202). Analysis of the images of the films was carried out using both 
ImageJ version 1.43U (National Institutes of Health, USA) and Matlab™ software 
(The Math Works, Inc., Natick, MA). The error-bar values for the film dosimetry 
measurements (reported in the final plot by the dot size and approximately equivalent 
to ±1.9%) are determined from the uncertainty confidence limits (two standard 
deviations) resulting from the conversion of pixel value to dose by the optical density 
function and taking into account the second-order polynomial function used to fit the 
measured data of the dose calibration curve (203). 
4.2.6 Dose per pulse dependence (DPP) 
The sensitivity of silicon detectors varies with the dose per pulse which is due to the 
changing dose rates in a pulsed radiation beam that is produced by a linac (204). 
Riknerand Grusell (1983) found that n-type diodes are more dependent on DPP 
variations than p-type diode by increasing their sensitivity with increased DPP (73, 
205). In addition, they found that preirradiated diodes show less DPP dependence. The 
dose per pulse can be varied by changing the source to surface distance (SSD) or by 
using attenuators within the radiation field such as MLCs or wedges. However, the 
attenuator might lead to a change in the response of the detector by changing the energy 
spectrum of the radiation beam, so the approach adopted for varying the dose per pulse 
 101 
 
is based on variation of the distance of the detector from the source. The Dose per 
pulse dependence measurements were performed in the range between 0.9 × 10−5 and 
2.7 × 10−4 Gy/pulse. DPP reference measurements were obtained, at a depth of 1.5 cm 
in the phantom, by normalizing the response of diode to the response of PTW 30013. 
Dose rate at reference position for 10 ×10 cm2 field size of a 6 MV photon beam at 
SSD of 100 cm is 2.78 ×10−4 Gy/pulse. The variation of the instantaneous dose rate 
was acquired by changing SSD from 100 up to 350 cm with a nominal dose rate of 600 
MU/min. This method (74) has been implemented as it avoids the variation of the 
radiation spectrum and can be utilized to investigate only the dose rate dependence 
with the assumption that the dose per pulse dependence of ion chamber is within 
experimental uncertainties (±1%)(206). 
4.2.7 Detectors’ response linearity 
The linearity test evaluates the response of a detector as a function of accumulated 
dose. A silicon diode detector should shows a linear response with absorbed dose in 
any given range because it is a device sensitive to dose rate and not to integrated dose. 
Linearity measurement of the edgeless diodes was performed under standard 
conditions (6 MV photon beam, 1.5 cm depth in the solid water phantom, and field 
size of 10×10 cm2) by measuring the response of the diode from 25 up to 500 cGy. 
Linearity measurements in reference conditions (6 MV FF photon beam, 5 cm depth 
in the solid water phantom, 100 cm SSD and field size of 10×10 cm2) were also used 
to determine the calibration factor of the sensor (in cGy/pC) and its intrinsic 
uncertainties. 
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4.2.8 Angular dependence 
Angular dependence was tested by placement of a diode probe in the centre of the 
rotatable phantom aligned with its centre at the isocentre of the Linac. The phantom 
has been designed to accommodate a 2D array and maintain it perpendicular to the 
beam during intensity-modulated radiotherapy or volumetric arc radiotherapy 
treatment plan verifications. In this project, the phantom was used only to achieve an 
accurate rotation of the sample with respect to the beam which was stationary and 
corresponding to the gantry vertical position (0◦). The phantom stepper motors are 
driven by a custom designed automatic control system with a bidirectional rotational 
accuracy of 0.25◦. Alignment is achieved by placing the sample in the centre of rotation 
of the phantom and at the isocentre of the Linac by the lasers (the phantom is 
completely transparent and the sample is clearly visible). For finer alignment, a 5×5 
mm2 beam defined using the jaws, has been set and a scan is also performed by moving 
the phantom’s support couch laterally and longitudinally to maximize the response of 
the detector. Accuracy achievable with such a method is approximately ±1 mm which 
corresponds to a variation of the detector response of approximately ±0.2% at the 
nominal depth of 150 mm, (corresponding to the cylindrical drum radius). 
The angular dependence measurements were normalized to the response at 0◦, 
corresponding to the detector top junction facing the beam as shown in Figure 20 (a) 
and (b). The phantom is then rotated from 0◦ to 180◦ transversely in steps of 22.5◦. 
Axial angular response has not been evaluated considering that there are no 
asymmetrical structures in the diodes in that direction and no difference in response is 
expected except for the variations induced by the substrate attenuation which are also 
measurable in the transverse axis. Figure 20 (b) shows that the transverse direction is 
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more asymmetric because of the presence of the bonding pad of the peripheral junction 
which could potentially perturb the electric field distribution. 
 
Figure 20:(a) Schematic diagram of the drop-in technology adopted for packaging of the edgeless 
detectors. The angular diagram embedded in the picture shows the transverse angles adopted to test 
the angular response of the diode probe on a Linac; (b) diagram showing a 3D representation of the 
diode and the corresponding “axial” and “transverse” angle directions. 
 
4.3 RESULTS 
4.3.1 Radiation hardness 
Figure 21demonstrates the variation in the response of different edgeless diodes as a 
function of the accumulated dose produced by irradiating the diodes with aCo-60 
source. N-type substrate devices display a significant variation in their response as a 
function of the dose and stabilization cannot be observed with radiation damage rate, 
which is consistent with other published data for FZ n-type pad detectors(114, 207). 
Approximately 14% reduction in response is observed by p-type devices after 40 kGy, 
with a behaviour that suggests non-stabilization of the response. The high resistivity 
(7 and 12 kΩcm) of n-type and p-type substrates, respectively, plays acritical role in 
 104 
 
the detector response stabilization, and 40 kGy is not adequate to stabilize the variation 
of the length of carrier diffusion. 
A variation in response of approximately 5% has been noticed in the PP-XS-100 diode 
with N+ peripheral junction after 40 kGy dose.  This effect is due to the ratio of the 
large area of the N+ peripheral p–n junction to the volume of diode; even though the 
carrier lifetime reduces by a similar amount in the other NP samples. The larger area 
of the collecting junction of the PP diodes allows for more robust charge collection 
efficiency when operated in passive mode. 
 
 
Figure 21.  Response degradation as a function of the irradiation photon dose from Co-60 source. 
 
4.3.2 Percentage depth dose 
 
Figure 22 depicts the comparison between PDD obtained by pre-irradiated (40 kGy) 
edgeless diodes, in a solid water phantom, with one obtained by ionisation chamber 
(PTW-Markus) under the same irradiation conditions. The PDD measurement of both 
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n-type and p-type the diodes show a maximum discrepancy of approximately +4.5%, 
however, a disagreement of ±2.5% can be seen for the diodes of PN and PP 
configurations. Error bars for edgeless diodes were calculated as two standard 
deviations over five repetitions. 
 
Figure 22. PDD measured for the whole set of edgeless detectors at 6 MV photons, 10 ×10 cm2 field, 
and SSD 100 cm, in comparison with ion chamber PDD. 
 
4.3.3 Output factor 
Figure 23 demonstrates the response of two different sets of diodes with sensitive areas 
0.5 ×0.5 and 1 ×1 mm2. The responses of the diodes were repeated five times and error 
bars were calculated as 2 standard deviations. The output factors of diodes of sensitive 
area 0.5 × 0.5 mm2 agree within +2% with those obtained by EBT3 for a square field 
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size of 5 mm relative to the 10 x 10 cm2. 1 × 1 mm2 samples show an over-response 
of approximately +4%, in agreement with previous results (165, 203, 208). 
 
 
 
 
Figure 23: Field size dependence response of edgeless detectors compared to EBT3 film normalized 
to response of a10 ×10 cm2 field size. 
 
4.3.4 Dose per pulse dependence 
Figure 24 demonstrates the DPP results of four edgeless diode samples, normalized to 
2.78 × 10−4 Gy/pulse, representing the response of the ion chamber at 1.5 cm depth to 
a 6 MV photon beam with field size of 10 × 10 cm2. The error bars representing the 
uncertainties of the measurements are two standard deviations of three repetitions. 
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Dose per pulse dependences of diodes were tested after 4 MRad of irradiation by a Co-
60 source. Pre-irradiation helps the p-type substrate diodes to mitigate the DPP 
dependence but it makes n-type substrate diodes more sensitive to dose rate changes 
(73).This is confirmed by the measurement of the NN-XS-500 and by the PN-XS-500 
samples which over-respond at low dose rates. NP and PP devices show a relative 
decrease in response within 10% and 15% at the lowest dose rate, respectively. Such 
a result for the p-type detectors is in agreement with the data measured by Wilkins et 
al. (74) on commercially-available single diodes for dosimetry in external beam 
radiotherapy. 
 
 
Figure 24: Dose per pulse response for the edgeless detectors normalized to the dose measured by IC 
at 2.78 ×10−4 Gy/pulse (dose/pulse estimated at the depth of 1.5 cm, SSD of 100 cm, and field size 
10 ×10 cm2); the inset shows the DPP response of the sample NN-XS. 
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4.3.5 Dose linearity 
Figure 25 shows the dose linearity of the samples for accumulated doses ranging from 
25 to 500 cGy. The slopes of the linear fit represent the conversion factor from charge 
to dose for the samples summarized in Table 2. The conversion factors show that the 
sensitivity, keeping the total volume and junction depth constant, is strongly related to 
the junction polarity and substrate type. Specifically, the p-type substrate with the N+ 
lateral junction is the most effective combination due to the large junction area/volume 
ratio. 
 
Figure 25: Integral dose response for edgeless diodes. 
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Table 2: Linear fit parameters. 
Sample R2 
Conversion 
factor 
(count/cGy) 
Charge/unit dose 
(pC/cGy) 
PP-XS-100 0.946 1528.7± 137 152.9± 0.1 
NP-XS-100 0.999 1186.3± 1.5 118.6± 0.01 
PN-XS-500 1 1122.5± 0.8 112.2± 0.01 
NN-XS-500 0.958 359.6± 33 35.9± 0.33 
 
4.3.6 Angular dependence 
Figure 26 and Figure 27show the response of all detectors as a function of the incident 
beam angle from 0◦ to 180◦, in the transverse direction, after preirradiation. Data 
corresponding to the response between 0◦ and −180◦ are not reported because they were 
symmetrical to the response between 0◦ and +180◦ within 1%. Across almost the entire 
range of angles, the angular response for the diode probes is within±2%. The 90◦ angle 
data points represent the position of maximum variation of the response with a drop of 
−3% for the PN and −4% for the PP samples. As expected, there is a clear correlation 
between volume of the diode and angular response. For samples PP and NP, 0.1 mm 
thick and area 0.5 × 0.5 mm2 (corresponding to minimum volume), variation in angular 
response is minimal. PP_XS_100 response is slightly more uniform than NP_XS_100 
(Figure 26) demonstrating that maximizing the n+−p junction area/diode volume ratio 
is of some advantage. The same behaviour is observed for the NN_XS_100 diode 
having the best angular response between the n-type detectors with the maximum p + 
n junction area-volume as presented in Figure 27. A much larger attenuation effect was 
also observed for the response of thicker substrates (NN_XS_500 and PN_XS_500)at 
90◦ and 180◦ positions in comparison to thinner substrates (NN_XS_100). 
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Figure 28shows the comparison of each detector’s angular response before and after 
irradiation. Sample NP_XS_100 (Figure 28.a) shows the smallest variation of angular 
dependence, as expected due to small volume of the diode and the positive effect of 
the large area ohmic p+ contact. Diodes PP and NN (Figure 28.b and d respectively) 
show a larger impact of radiation damage which is associated, most probably, with the 
buildup charge in the field oxide; this hypothesis requires further investigation, which 
is beyond the aims of this work. 
 
 
Figure 26: Angular dependence of P-type substrate devices. 
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Figure 27: Angular dependence of N-type substrate devices. 
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Figure 28: Comparison of the angular response for (a) NP, (b) PP, (c) PN, and (d) NN edgeless 
diodes with different sizes before and after irradiation with 40 kGy a Co-60 gamma source 
 
4.4 DISCUSSION 
The edgeless detector probes show ±2% agreement of the measured PDD compared to 
an ion chamber downstream of dmax regardless of their size or geometry configuration. 
Thin substrates (p-type and n-type samples) show an agreement with the ion chamber 
response in the buildup region within +2%, while all the samples with thick substrates 
show slightly larger discrepancies up to 4% at depth 7 mm. Such an effect is related to 
the excess of charge contribution due to the backscattering from silicon in thick 
devices which becomes predominant at low depth due to the lack of charged particle 
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equilibrium. For the output factor, the devices with the smallest volume (XS) show 
+2% discrepancy when compared to EBT3 film for small square field sizes (between 
0.5 and 5 cm). The dose rate dependence is also a crucial parameter for solid-state 
detectors and was investigated via their dose per pulse variation. The edgeless diode 
probes with a p-type substrate show the best performance while the n-type substrate 
displayed higher sensitivity. The p-type substrate is also the best candidate from the 
radiation hardness point of view: all NP and PP devices are found to be more radiation 
hard than the n-type substrate devices, with a decrease of the response of 5%–15% 
after 40 kGy irradiation dose by Co-60 photons. The high resistivity substrates used 
for this preliminary study of 7 and 12 kΩ cm, for the p-type and n-type, respectively, 
have been chosen to guarantee a large current from the detectors with a high signal to 
noise ratio, but resistivity should be reduced to improve the stability of the detector 
response after preirradiation. 
The presence of a uniform and large ohmic contact on a diode (Figure 2.d and f) shows 
the best performance in terms of stability of the response of the samples as 
demonstrated by the linearity measurements. 
The angular dependence of the samples is, as designed, minimal (within 2% for most 
probes) but the PP and NN diodes with the smallest area (XS configuration) and the 
largest junction area/volume ratio demonstrated the best angular response with a 
variation of ±1% over 180◦ after preirradiation. 
In summary, the best candidate for production of minimal angular dependence diodes 
is a P-type thinned (0.1 mm) substrate diode with a small sensitive area (XS 
corresponds to 0.5 × 0.5 mm2) and N+ peripheral junction (PP). The substrate 
resistivity based on the experience gained with the development of epitaxial and bulk 
silicon detectors at CMRP and results published by other research groups involved in 
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development of diodes for radiotherapy dosimetry(114, 209) should be reduced down 
to 10–50 Ω cm to allow for a large signal to noise ratio and also to increase the stability 
of the response as a function of accumulated dose. 
4.5 CONCLUSIONS 
Silicon diodes utilizing new fabrication technology has been characterized with the 
aim of reducing the angular response of passive diodes for dosimetry and quality 
assurance of radiotherapy treatment such as arc modulated radiotherapies. The new 
fabrication technology has led to the development of the edgeless detector. When 
combined with the advanced “drop-in” packaging technique, dosimetric diode probes 
are isotropic in their response, which makes them suitable for use as single diode 
probes as well as in 2D diode arrays. They are linear, with small dose rate dependence 
and excellent reproducibility. Reducing the initial resistivity of device to 10–50 Ω cm 
would make the edgeless diodes even more suitable for dosimetry applications. 
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5 QUALITY ASSURANCE OF CYBERKNIFE ROBOTIC STEREOTACTIC 
RADIOSURGERYUSING AN ANGULARLY-INDEPENDENT SILICON 
DETECTOR 
 
This work has been published in Journal of Applied Clinical Medical Physics as: 
Alhujaili, S., Biasi, G., Alzorkany, F., Grogan, G., Al Kafi, M., Lane, J., Hug, B., Aldosari, 
A., Alshaikh, S., Farzad, P., Ebert, M., Moftah, B., Rosenfeld, A. and Petasecca, M. (2018). 
Quality assurance of Cyberknife robotic stereotactic radiosurgery using an angularly 
independent silicon detector. Journal of Applied Clinical Medical Physics, 20(1), pp.76-88. 
 
5.1 Introduction 
The Cyberknife Robotic SRS allows conformal dose distributions and adopts hypo-
fractionation regimes which require accurate Quality Assurance (QA) to avoid plan or 
operator mistakes. Effective QA of small field, multidirectional and non-isocentric 
photon beams requires radiation dosimeters that have small sensitive volume, angular 
independence and operate in real time. The aim of this chapter is to evaluate the 
implementation of the edgeless diodes in a Cyberknife for machine and patient QA. 
The edgeless diode probes were tested in terms of basic QA parameters such as 
measurements of tissue-phantom ratio (TPR), output factor and off-axis ratio. In 
addition, three patient-specific plans have been delivered to a lung phantom with and 
without motion and dose measurements have been performed to verify the ability of 
the diodes to work as patient-specific QA devices.  
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5.2 Materials and methods 
5.2.1 Detectors 
A description of the edgeless diodes and TERA readout system was presented in 
Section3.21.  Additional measurements using stereotactic diodes PTW 60016, SNC 
Edge, PinPoint ionization chamber (PTW 31014), and EBT3 Gafchromic film were 
performed for intercomparison and validation of the results obtained with edgeless 
diodes. The main features of these detectors are summarized in Table 3. 
 
Table 3: Properties ofthe detectors used in this work 
 
 
Detector material density (g/cm3) Zeff 
Active volume 
dimensions 
Package 
material 
Reference 
# 
PTW60016 p-type Silicon 2.33 14 
 
 
Disk, 0.6 mm 
Radius, 0.03 mm3 
volume 
 
 
 
RW3, 
epoxy 
 
(210) 
SNC Edge 
n-type 
Silicon 
 
2.33 14 
Square,0.8x 0.8 
mm,0.03mm 
thick,0.019 mm3 
volume 
Brass (211) 
edgeless 
p-type 
silicon 
PP-XS- 100 
2.33 14 
 
0.5 mm width, 0.5 
mm length, 0.5 
mm thick, 0.125 
mm3 volume 
Kapton (115) 
PTW 
31014 Pin-
Point 
Air 0.001 7.64 
Cylindrical,1 mm 
Radius, 5 mm 
length, 0.015 mm3 
volume 
PMMA, 
Graphite 
 
(210) 
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5.2.2 CyberKnife Robotic SRS systems 
CyberKnifeis an SRS machine that consists of a portable linear accelerator mounted 
on an industrial robotic arm (manipulator). By utilizing a set of collimators and a 
sophisticated imaging-based tracking system, CyberKnife can produce small, 
noncoplanar radiation beams and deliver them to a target located near to critical 
structures. There are two different collimation systems: one system is a collection of 
fixed collimators (cones) which are manufactured from metallic material with 12 
different diameters (from a diameter of 5 to 60 mm). The second system is an Iris 
collimator, a variable aperture diaphragm which adopts 12 tungsten–copper alloy 
segments arranged into two different banks of six segments rotated by approximately 
15degrees from each other. By using these segments, the Iris collimator can be shaped 
into approximately circular shape with a diameter varying from 5 to 60 mm. The 
measurements of this study were performed on two different versions of Cyberknife: 
G4 and M6. The M6 machine, located at Sir Charles Gardiner Hospital in Perth 
(Australia), produces a photon beam with dose rate up to approximately 1000 MU 
min−1 while the CyberKnife G4, located at the King Faisal Specialist Hospital and 
Research Centre in Riyadh (Saudi Arabia), is limited to a maximum dose rate of 
approximately 800 MU mi −1. While basic dosimetric measurements with the 
edgeless diodes were performed on the G4 machine, the phantom study measurements 
were performed using both the M6 and G4 generations Cyberknife. 
5.2.3 Plastic and Water Phantoms 
Relative dose measurements were performed using medium and large sizes PTW MP3 
motorized water tanks (PTW, Freiburg, Germany). Both tanks include three stepper 
motors which allow the detector to be moved in three different directions. The speed 
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and positioning accuracy of the stepper motors is approximately 50 mm/s and ±0.1 
mm, respectively. Both tanks are positioned above an electromechanical lifting 
carriage to give the ability to adjust the height relative to the beam source. Solid water 
slabs (Best Medical, Nashville, TN, USA) of different thicknesses and 30 × 30 cm2 
area have also been used. 
5.2.3.1 Timber lung phantom 
Cyberknife is also used for treating clinically-suitable lung lesions, particularly when 
the lesion is in proximity to organs at risk. This is possible thanks to its capability of 
accurately tracking motion of the target volume(212). In order to test the edgeless 
detectors for patient-specific QA, two timber phantoms were manufactured to mimic 
a lung with and without an internal lesion. The heterogeneous phantom, which presents 
the internal lesion, is composed of two cubic blocks of timber (with a density of 
approximately 0.3 g/cm3) with one hemisphere of solid water in each block positioned 
at the center of the phantom. The solid water insert mimics a lesion of a diameter of 
approximately 2 cm inside the lung. 
The detectors are positioned between the timber blocks with one hemisphere above 
and one below, to form a spherical lesion with 1 mm gap (Figure 29). The 
heterogeneous phantom was manufactured in the University of Wollongong 
mechanical workshop and has dimensions of 9.45 × 10 × 14.7 cm3 with two slabs of 
solid water, 2 cm thick above and below the timber blocks to mimic the attenuation 
from the chest wall muscles and backscattering from the back muscles. In this work, 
we used also a homogenous version of the timber phantom with the same dimensions 
and configuration of the heterogeneous phantom but without the internal lesion. 
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(a) 
 
(b) 
Figure 29: a) schematic diagram of the heterogeneous timber lung phantom; b) heterogeneous 
timber phantom with detectors placed around the internal lesion. The gold markers in the phantom 
are visible as small imperfections of the wood surface. 
 
5.2.4 Linearity and Calibration Factor 
Calibration and verification of the response linearity of the edgeless diodes was 
performed under reference calibration conditions with the CyberKnife head 
perpendicular to the phantom at a source to axis distances (SAD) of 800mm and using 
 120 
 
the fixed cone of 60mm diameter as suggested by the IAEA-483(152). The detectors 
were placed at a depth of 1.5cm and calibrated by irradiating each device in increments 
of 100 cGy up to a total accumulated dose of 400 cGy. Each Irradiation step was 
repeated three times to evaluate the repeatability of the measurement. 
5.2.5 Angular dependence for noncoplanar irradiations 
The angular dependence for noncoplanar irradiations was investigated by placing the 
diode within a solid phantom at 1.5 cm depth with couch rotated by at 45 degrees. The 
measurement was performed by irradiating the diode sample with 6 MV FF photon 
beam at 100 SSD and 10 x10 cm2 filed size. The response of each sample was 
measured three times to evaluate the repeatability of the measurement. 
 
5.2.6 Dose per pulse dependence 
Silicon diode sensitivity under linear accelerator beams shows dependency on the 
instantaneous dose rate (dose per pulse, DPP). Although the DPP dependence of the 
edgeless detectors has been established for standard 6MV-FF linear accelerators as 
described in the previous chapter, the use with CyberKnife requires further 
investigation due to the larger dose per pulse delivered and the presence of a large low-
energy photon component in the beam spectrum. In this work, the DPP was 
investigated in the range of 2.64 x 10-4 – 1.67 x 10-3 Gy/pulse and obtained by varying 
the source to surface distance from 500 mm to 1200 mm, with the detectors at a depth 
of 15 mm in a solid water phantom and collimated by the 60 mm fixed cone. The 
nominal dose rate was 800 MU min-1. The DPP dependency was calculated by 
normalizing the diodes response to 7.62 x 10-4 Gy/pulse, corresponding to the Pinpoint 
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ion chamber (PTW, Freiburg, Germany) response in reference conditions at an SSD 
of 800 mm. 
5.2.7 Field size factor measurement 
The field size factor is a parameter which must be characterized for each machine and 
collimation system adopted. The measurement of the field size factor was carried out 
in a medium-size MP3 motorized water tank at the CyberKnife facility. The edgeless 
diode was attached to a plastic holder, allowing it to be remotely controlled for 3D 
movement in the water phantom with a step resolution of 0.1 mm. The diode was 
placed at a depth 15 mm and its lateral position was adjusted remotely to obtain 
maximum signal corresponding to the center of the collimated radiation field. The 
alignment procedure was repeated for each field size. For field size, 200 MU was 
delivered with a dose rate of 800 MU min−1. The field size factors for ten different 
field sizes (5, 7.5, 10, 15, 20, 25, 30, 35, 50, 60 mm) were measured using the Iris 
collimator. The measurements were performed at three different SDDs: 650, 800, and 
1000 mm and normalized to the data of the reference field size (60 mm). The diode 
was aligned using a motorized two-axis platform. The measurements were repeated 
three times to estimate the uncertainty and reproducibility of the detector response. 
The edgeless data were compared to those taken with SN edge detector (Sun Nuclear, 
Melbourne, FL, USA). 
5.2.8 Tissue-Phantom ratio (TPR) measurement 
The tissue-phantom ratio was measured using a large size (60 × 60 × 60 cm3) MP3 
motorized water tank (PTW) to allow for more uniform scattering conditions. The 
diode's positioning and alignment were as described for the field size factor 
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measurements. In each measurement, 200 MU was delivered at SDD of 800 mm and 
three different field sizes (10, 30, 60 mm), collimated using the Iris collimator. The 
tissue-phantom ratio was measured at 13 depth points, from surface to 200 mm deep. 
Edgeless diodes measurement were repeated three times to estimate the uncertainty 
and the reproducibility of the detector's response and these were compared with PTW 
60016 data measured under the same conditions. 
5.2.9 Beam profile measurement 
Profile measurements were performed with the diode embedded in a solid water 
phantom equipped with a two-axis stepper motor stage. After the alignment, performed 
with the same procedure adopted for the OF and TPR measurements, the CyberKnife 
head was kept static with the radiation beam perpendicular to the phantom surface. 
The diode was moved across the beam at constant speed (a margin of a few centimeters 
ensured speed stabilization). The radiation field sizes measured were 5, 10, 30, and 60 
mm collimated by Iris collimators at an SDD of 800 mm and a depth in the solid water 
of 15 mm. 
5.2.10 Patient-Specific QA Measurement 
In order to assess the performance of the edgeless detectors in patient-specific QA, the 
timber phantoms were imaged with a Philips Brilliance Big Bore CT Simulator 
(Philips Electronics N.V., Amsterdam, Netherlands) and Toshiba Aquilion LB 
scanner. The phantoms were scanned with four diodes inserted for an accurate 
localization of the sensors and to determine the doses expected in such positions by 
treatment planning system (TPS). Three fiducial markers were placed in the phantoms 
to track and correct their position during the treatment, with the help of the dual 
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orthogonal x-ray imaging system. The treatment plans were generated using Multiplan 
(Accuray Inc., Sunnyvale, CA, USA). The software uses two different dose calculation 
methods to evaluate the radiation dose absorbed in a medium. One method is Ray 
Tracing (RTrac) which adopts a classical semi-analytic method using experimental 
data such as off-axis ratio, TPR, and output factor to calculate the dose kernel and the 
effective path length to correct for heterogeneities (213). The second method is Monte 
Carlo which adopts a virtual source (phase space file of the linac head) to calculate the 
dose (213). Three plans of uniform coverage were created using the RTrac method. 
Plan 1 and Plan 2 were created using the heterogeneous phantom (Fig. 30) and 
delivered by the CyberKnife G4 and M6, respectively. Plan 3 was created with the 
homogenous phantom and delivered on Cyberknife M6 with and without breathing 
motion (simulated by a 3D sinusoidal movement of the phantom). This patterned 
motion is tracked by the Synchrony Respiratory Motion Tracking System in order to 
assess the effect of flashing due to the image-guided tracking system and of the 
microphonic noise introduced by the moving platform. In all plans, the gross tumor 
volume included the target volume (solid water sphere) and the four diodes. The 
edgeless detector locations were individually contoured on the CT images of the 
phantoms in order to precisely evaluate the doses at their locations in the plan and 
compare them with doses measured experimentally at the corresponding locations in 
the phantom. At each detector location, average, minimum, and maximum doses were 
estimated with the TPS. 
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Fig. 30:Treatment plan created by Multiplan®forthe heterogeneous timber phantom. The diode 
samples are numbered from 1 to 4. 
 
Fig. 30 shows the positions of the detectors inside the heterogeneous phantom: two 
edgeless diodes were placed inside the spherical solid water target volume whereas the 
remaining diodes were placed in timber in order to evaluate whether the detector would 
be able to distinguish the higher dose deposition expected inside the lesion. The plans  
were incorporated into 50 sets of beams. Each set (called a node) contains one or more 
beamlets which are delivered to the target through unique linac head positions in space. 
The full set of nodes is called a “path set” which is usually constructed and optimized 
by the TPS (with no or marginal control from the operator) to deliver the plan. The 
details of the plans are summarized in Table 4 
 
 
 
1 2 3 4 
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Table 4:Summary of treatment plans delivered by Cyberknife. 
 
5.2.11 Patient-specific QA measurement using EBT3 
Gafchromic EBT3 film was used as benchmark for the patient-specific QA 
measurements. The film was cut into 7 × 7 cm2 pieces, placed inside the phantoms and 
irradiated under the same irradiation conditions of the edgeless diodes. Each piece was 
prescanned and scanned 36 h after the irradiation by an Epson XS11000 with 48 bit 
depth color and a resolution of 72 DPI. In order to minimize the effect of optical 
nonuniformity, the films were scanned taking care of the orientation and the position 
on the scanner bed. In order to take into account warming-up effects of the scanner, 
each film was scanned six times and only the last three images were used to evaluate 
the optical density. The calibration curve was obtained by irradiating eleven 3 × 3 cm2 
film cuts from 0 to 1000 MU and scanned using the same protocol. The images of the 
films were analyzed using ImageJ version 1.43U (National Institutes of Health, 
Bethesda, MD, USA). 
 
 
Plan 
No. 
Cyberknife 
model 
phantom 
TPS Dose at each detector 
location (Gy) for one 
fraction 
Delivery 
time per 
fraction 
(Min) 
No. of 
nodes 
No. of 
beams 
Type of 
collimator 
          S1     S2     S3     S4     
1 G4 heterogeneous       6.705.93   5.89  5.96        23 50 68 Iris 
2 M6 heterogeneous       5.88       6.70   5.92    5.70 23 50 68 Iris 
3 M6 homogenous       7.30      9.10   9.13     7.92        24 50 68 Iris 
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5.3 Results 
5.3.1 Linearity and calibration factors 
Figure 31(a) shows the dose linearity of the edgeless detector from 100 to 400 MU 
with 100 MU increments. The adjusted regression coefficient R2 is 1 and vertical error 
bars are calculated as two standard deviations over 3 repetitions. From the slope of the 
linear fit, the conversion factors from counts to dose for each sample is 1259 ± 6.4 
count/cGy (126.4 ± 0.65 pC/cGy). 
 
(a) 
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(b) 
 
Figure 31: (a) Linearity response of edgeless diode; (b) angular dependence of the silicon diodes 
for a non-coplanar irradiation by a Varian True Beam at 6MV, 10x10 cm2 field size and couch 
positioned at 45 degrees. 
 
5.3.2 Verification of angular dependence for noncoplanar irradiations 
Figure 31(b) shows the angular dependence of the sample response when rotating the 
linac gantry from −180 to +180 degrees around a cylindrical phantom. The detector 
has its electrical connection tail along the axis of the phantom which is placed on the 
patient couch. The couch is rotated by 45 degrees. The diode shows a variation within 
±1.5% also for a noncoplanar beam delivery and in agreement with the results obtained 
by Petasecca el al. (115). 
5.3.3 Dose per pulse dependence 
Figure 32 shows the DPP response of the edgeless detectors, normalized to 7.26 × 10−4 
Gy/pulse representing the response of the IC at a depth of 15 mm, SSD of 800 mm, 
and a fixed cone of 60 mm diameter. The error bars representing the uncertainties of 
the measurements are two standard deviations over three repetitions. The outlier point 
 128 
 
at 3.3 x 10-4 Gy/pulse is possibly due to an experimental artefact while performing the 
measurement over a time frame of several weeks. In our experimental setup we cannot 
take into account momentarily fluctuations of the beam using an external ionisation 
chamber so we are sensitive to such sudden variations in respect to reference data from 
the hospital. The diodes show a variation in response of approximately −2% when the 
DPP is reduced by a factor of 65% of the dose rate at reference calibration conditions 
(from 7.26 to 4.5 × 10−4 Gy/pulse). A 65% reduction in the dose rate corresponds to 
the dose rate variation from a beam collimated by a 60 mm diameter cone to a fixed 
cone of 5 mm diameter. Such variation suggests that no corrections are required for 
the response of the edgeless detectors in low-dose rate conditions. When the SSD 
decreases, the variation in the response of the detector increases by a factor of 
approximately +5%, suggesting that for very short SSDs (from 700 to 650 mm), a 
correction factor should be taken into account to correct for the dose rate dependence 
of the detector. Applying a correction factor is possible only if the position of the linac 
head in respect to the target is known. Although this is feasible for machine QA 
procedures, it makes results more complicated for patient-specific QA. 
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Figure 32: Dose per pulse measurement for edgeless detectors normalized to a 
IC measurement at 7.26 × 10−4 Gy/pulse corresponding to a depth in water of 15 mm, SSD of 800 
mm where detector was placed and delivered with the fixed cone of 60 mm diameter. These settings 
are generally recognized as the standard reference calibration conditions. 
 
5.3.4 Field size factor 
Figure 33shows the field size factors measured by the edgeless detector with Iris 
collimator. The x-axis shows the diameter of the equivalent circular field size ranging 
from 5 to 60 mm at SDD of 650, 800, and 1000 mm. The response of the edgeless 
diodes has been compared to SNC Edge diode. The overresponse of the SNC Edge 
diodes in the smallest fields has been corrected for by applying the corresponding field 
correction factors reported by Francescon (214-216). The edgeless diodes show an 
agreement with SNC Edge diodes in the field size range of 25 to 60 mm with 
discrepancies within ±1%, while at smaller field sizes from 5 to 20 mm, discrepancies 
do not exceed ±2.6%. 
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(a) 
 
(b) 
 
(c) 
Figure 33. field size factor for edgeless and SNC Edgediodes for Iris equivalent 
circular field of 0.5 to 60 mm) at: (a) 650 mm SAD, (b) 800 mm SDD, (c) 1000 mm. 
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5.3.5 Tissue-Phantom Ratio (TPR) 
Figure 34 shows the comparison of edgeless diode TPR experimental data with data 
from a PTW 60016 diode, obtained with Iris-collimated field sizes of 10, 30, and 60 
mm diameter. All measurements were performed in a large size water phantom at 
depths from surface to 200 mm. For this set of measurements, the diodes were attached 
to the “bird cage”, a tool provided by Accuray Inc., to align them at the center of 
radiation field and to help maintain the SDD as well. The response of the detectors at 
each depth is normalized to the measurement taken at 15 mm. Data shows an 
agreement within 2.2% for all the depths except when the detector was placed at the 
water surface, where the discrepancy is approximately 18.4%. This is due to the 
minimum buildup created by the packaging of the PTW 60016 which is of the order 
of a few mm of solid water while the edgeless detector is packaged with only 0.07 mm 
of water-equivalent buildup material. 
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(a) 
 
(b) 
 
 
(c) 
Figure 34: Measured TPR by edgeless and PTW 60016 diodes at15 mm depth and 800 SAD 
mm for Iris circular field sizes of: (a) 10 mm, (b) 30 
mm, (c) 60 mm. 
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5.3.6 Beam profiles measurements 
Figure 35 shows beam profiles measured by edgeless diode and compared to SN 
EDGE diode. A set of four Iris collimator field sizes are reported with diameter of 5, 
10, 30, and 60 mm, measured at a depth of 15 mm at a SDD of 800 mm. The data are 
normalized to the central axis response. 
 
Figure 35. Off-Axis-off ratios (%) measured by edgeless and SNC Edgediodes with Iris collimator 
field sizes of 5, 10, 30, and 60 mm. 
 
Table 5 shows full width half maximum (FWHM) and penumbra width (80%–20%) 
of the profiles which have been obtained by using an interpolation-shape-preserving 
fit (with a resolution step of 0.01 mm). Figure 35 and Table 5 show an agreement 
between the FWHM recorded by the edgeless and the SNC EDGE diodes within 2.3% 
for all the beam profiles. It can be also noticed that edgeless, as expected, was 
consistently measuring FWHM value which are always slightly larger than nominal 
field size values at all field sizes. On the other hand, the SNC Edge detector has 
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measured FWHM (9.92 mm) at 10 mm field size, smaller than nominal field value, 
which leads to create a relative large difference in penumbra width (0.148 mm) 
between edgeless and SNC Edge at this field size measurement. 
Table 5. Experimental results of full width half maximum (FWHM) and 20%–80% penumbra for 
both edgeless and SNC Edgediodes, measured with Iris-collimated field sizes of 5, 10, 30, and 60 
mm. 
	 SNC	Edge	 edgeless	 SNC	Edge–	edgeless	difference 
Field	size	
(mm)	 FWHM	 penumbra	 FWHM	 penumbra	
∆FWHM	
	(%)	
∆Penumbra	
(%)	
∆Penumbra	
(mm) 
5	 5.23	 2.08	 5.33	 2.04	 -1.972	 1.92	 0.040 
10	 9.92	 2.59	 10.15	 2.44	 -2.333	 5.72	 0.148 
30	 31.49	 2.97	 31.60	 3.02	 -0.377	 -1.54	 -0.046 
60	 61.135	 5.04	 61.37	 5.04	 -0.39	 0.08	 0.004 
 
5.3.7 Patient-specific QA measurement 
Table 6 summarizes the doses measured for four plans by the edgeless diodes 
alongside the doses calculated by the TPS and measured with EBT3 films placed at 
the same plane where the diodes were positioned. Plan 1 and Plan 2 have been 
delivered using the Cyberknife G4 to homogeneous and heterogeneous phantoms, 
respectively. In this case, the phantoms were static and image guidance was used only 
to drive the Cyberknife to the target where three fiducial markers have been implanted 
near the centre of the phantom. In order to evaluate the effect of microphonic noise 
and possible radiofrequency interference with the edgeless diode response, Plan 3 was 
delivered by the CyberKnife M6 to the homogeneous phantom in static and dynamic 
conditions and tracked by the Synchrony Respiratory Motion Tracking System. The 
dose measured with the edgeless diodes shows agreement with the TPS data with a 
maximum discrepancy of approximately 4.7%. The maximum discrepancy between 
film and TPS (Ray tracing) is approximately 3.1% which is smaller than that reported 
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in other literature (Wilcox et al.)(217). The largest discrepancy corresponding to doses 
measured with the sensor number 2 which is placed across the border of the target (at 
the edge of the solid water sphere of 2 cm diameter, in the region of steepest dose 
gradient where measurement is very sensitive to the positioning of a small volume 
diode). 
 
Table 6: Treatment plans created by Multiplan® for homogeneous and non-homogeneous phantoms. 
Diode # 
Deliv
ery 
mode 
TPS (Gy) edgeless (Gy) 
Film 
(Gy) 
TPS - 
edgeless 
differenc
e 
(%) 
film - 
edgeless 
differenc
e 
(%) 
TPS - 
film 
differenc
e 
(%) 
Pl
an
 1
 1 
St
at
ic
 5.97 5.74 5.84 3.75 1.59 2.19 
2 5.89 5.75 5.99 2.25 4.01 -1.83 
3 5.93 5.93 6.00 0.10 1.20 -1.12 
4 6.70 5.88 6.00 2.87 1.91 0.97 
Pl
an
 2
 1 
St
at
ic
 5.70 5.61 5.72 1.67 2.05 -0.39 
2 5.92 5.64 6.11 4.72 7.59 -3.11 
3 6.70 5.96 6.08 1.51 1.87 -0.37 
4 5.88 5.66 5.84 3.74 3.11 0.65 
Pl
an
 3
 
no
-m
ot
io
n 1 
St
at
ic
 7.92 8.27 - -4.45 - - 
2 9.13 9.48 - -3.78 - - 
3 9.10 9.17 - -0.806 - - 
4 7.30 7.12 - 2.396 - - 
Pl
an
 3
 
m
ot
io
n 1 
Sy
nc
hr
on
y 7.92 8.13 - -2.77 - - 
2 9.13 9.17 - -0.373 - - 
3 9.10 9.32 - -2.43 - - 
4 7.30 7.13 - 2.34 - - 
 
The discrepancies recorded by the edgeless detectors in respect to TPS data can also 
be addressed considering that no correction has been applied to the detector for dose 
rate dependence. The plans selected for this experiment are all “body path” plans with 
a source-to-target distance (SAD) which varies between 80 and 100 cm. Because of 
the variation in distance, we have a small variation in the dose rate dependence 
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(approximately 2% for this distance range), which may affect some of the irradiation 
beams delivered at SADs larger than 80 cm. 
 
5.4 Conclusions 
Real-time dosimetry and QA of SRS treatments performed by means of a robotic linear 
accelerator are challenging due to the small field sizes and non-isocentric beam 
delivery. In this work, an innovative edgeless diode has been tested to estimate the 
diode's accuracy for small field dosimetry and its use as a real-time device for patient-
specific QA of SRS treatments delivered by Cyberknife. The combination of the 
edgeless implantation process with the drop-in packaging technology has been proven 
to be an effective solution for fabrication of angularly independent point dosimeters. 
The dosimetric accuracy of the edgeless detectors has been tested by measuring output 
linearity, TPR, field size factors, and beam profile on Cyberknife which is equipped 
with both fixed cones and Iris collimators. The results were compared to 
commercially-available unshielded diodes (PTW 60016 and SN Edge) commonly used 
in commissioning and routine QA of Cyberknife machines. The field size factor 
measured by the edgeless diodes (correction- free) agrees within 2.6% when 
compared to the SN EDGE diodes corrected by the appropriate coefficients.  
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6 ON THE EVALUATION OF EDGELESS DIODE DETECTORS FOR 
PLAN-SPECIFIC QA IN HIGH-DOSE STEREOTACTIC 
RADIOSURGERY 
 
This work has been submitted to Physics in Medicine & Biology (PMB) journal as: 
Alhujaili, S., De Martin, E., Davies, J., Biasi, G., Fumagalli, M., Ghielmetti, F, Marchetti, M., 
Gallo, P., Davies, J., Alnaghy, S., Carrara, M., Fariselli, L., Rosenfeld, A. and Petasecca, M. 
(2019). On the evaluation of edgeless diode detectors for plan-specific QA in high-dose 
Stereotactic Radiosurgery. 
 
6.1 Introduction 
Stereotactic Radiosurgery (SRS) is one of most recent non-invasive techniques that is 
used to treat many functional brain disorders (218). SRS has the ability to deliver 
radiation to match the locations and dimensions of the planned targets. These anatomic 
targets may include trigeminal nerve and other ganglia (for facial pain syndromes), the 
thalamus (for tremor or pain), the hypothalamus (for pain) and the hippocampus (for 
epilepsy)(219).  This results in producing the required radiation effect that can correct 
the malfunctioning of several neurological areas in the brain which lead to relief the 
symptoms. The total radiation dose varies depending on the functional treatment and 
fractionation protocol with dose ranges from 70 up to 160 Gy in a single fraction (218, 
220). Narrow radiation fields are used to achieve a conformal dose distribution to the 
target and they require exceptional care in quality assurance (QA) assessment, 
including patient positioning and accuracy of the dose delivered. As Codes of Practice 
have outlined, the challenges posed by small field dosimetry are beam-related, owing 
to partial occlusion of the primary source and lack of charged particle equilibrium on 
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the beam central axis (141, 187, 221)]. Complexity in small field dosimetry also comes 
also from detector-related issues such as the detector dimensions with respect to the 
radiation field and the perturbation it introduces on photon and secondary electron 
energy fluence. Gamma Knife® and CyberKnife® are the most common machines 
adopted to perform SRS. They deliver dose from multiple focused cobalt-60 sources 
or by a linear accelerator assembled on a robotic arm, respectively (the description of 
these modalities was presented in section 2.1.3). This chapter focuses on verification 
of dose distribution performed using CyberKnife®.  
In contrast to oncological SRS where the dosimetric quality assurance practice is well 
established, most of SRS of functional brain disorders treatments are delivered without 
performing pre-treatment QA measurements and only rely on treatment planning 
system estimation of dose. Few centres have implemented routine QA procedures 
using EBT3 films, exploiting the advantage that they are an angular-independent 
dosimeter and capable of obtaining high spatial resolution measurements(222-224). 
However, their application in functional brain SRS is disadvantaged by non-linear 
response and the lack of reproducibility which depends on processing conditions and 
procedure (223, 224). Furthermore, they are recommended for use in the range of 0.01 
Gy to 30 Gy, inadequate to measure brain functional treatment doses (224). Re-scaling 
of monitor units is the common practice and consists of reducing the dose to a value 
within the sensitive range of film. However, this approach poses problems in the case 
that the minimum number of monitor units required by the linac to maintain a stable 
output during irradiation is not reached or small monitor unit (MU) beamlets are cut 
off by the MU threshold filtering (225). Recently, an EBT-XD film with a sensitive 
range of up to 40 Gy was proposed (224). Investigations have shown agreement to 
within 1.0 mm between TPS-calculated and film-measured isodoses in the range of 2 
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to 24 Gy, for a 25 Gy maximum point dose (226). Solid-state detectors, recommended 
for small-field dosimetry by the IAEA-AAPM code of practice, provide a range of 
advantages in SRS: a stable and nearly energy-independent response in megavoltage 
photon beams, high sensitivity and small sensitive volumes. Their potential is to 
outperform Gafchromic films due to a wider sensitivity and dynamic range and real-
time read-out. However, they require several correction factors to relate their readings 
to dose. Furthermore, solid state commercial devices are angular- and dose rate-
dependent (72). Being non-tissue-equivalent, their response is depth and field-size 
dependent owing to perturbations to electron and photon fluence spectra introduced by 
their sensitive volumes and the extra-cameral packaging materials (130, 227). 
Correction factors that account for this effect are detector-design, linac head-design, 
beam quality, field size and measurement conditions dependent (141). Thus, the design 
of a ‘correction-free’ detector would be advisable (135). To provide 2D dose mapping, 
solid-state detectors can be arranged in detector arrays with a sufficiently low pitch in 
order to resolve the steep dose gradients typical of small radiation fields adopted in 
SRS. Even so, their combined angular-dependent response would restrict their 
attractiveness in the case of non-isocentric deliveries. 
The aim of this chapter is to investigate the use of edgeless detector, for verification 
of machine QA and patient-specific brain functional treatment (i.e., trigeminal 
neuralgia and essential tremors) plans. Very high doses (70-160 Gy in a single fraction) 
were delivered using CyberKnife® by non-isocentric non-coplanar radiation fields to 
a target of 4-5mm in diameter. 
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6.2 Materials and methods 
6.2.1 Edgeless detector 
The edgeless samples (p-type), used in this study, and their associated DAQ system 
are described in section 3.2.1.  
6.2.2 Reproducing the reference dosimetry used for the treatment planning 
system 
The Beam parameters such as output factor, tissue-maximum ratio, off-axis ratios and 
dose linearity were obtained by edgeless detectors to be assured that they can replicate 
the relative dosimetry data used for commissioning the TPS. The experimental data 
obtained were compared to the measurements obtained by the reference dosimeter, a 
stereotactic PTW-60018diode. The  edgeless detector measurements were performed 
according to the methods proposed in previous works for evaluation of the 
performance of the edgeless detectors for small field dosimetry (228). 
6.2.3 Functional neurological disorder treatment verification: Phantom setup 
and treatment planning system 
In order to have an accurate localization of the sensors and to determine the doses 
calculated in such positions by the treatment planning system, the Alderson RANDO 
anthropomorphic phantom (Imaging Solutions – Australia) with the diodes inserted, 
was scanned by a Philips Brilliance CT Simulator (Philips Electronics N.V., 
Netherlands). The protocol of the simulation adopted the clinical parameters used for 
acquiring intracranial images (1 mm slice thickness, contiguous slices, 120 kVp, 400 
mAs).  No fiducials were used because the RANDO phantom has embedded bony 
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structures which are utilised by the system 6DSkull (Cyberknife® – US) as reference 
for alignment with the machine. The treatment plans were generated using Multiplan 
(Accuray Inc., Sunnyvale, CA, US) with the dose calculation method RTrac (Ray 
Tracing). RTrac adopts a classical semi-analytic method using experimental data such 
as off-axis ratio, TMR and output factors to calculate the dose kernel and the effective 
path length to correct for heterogeneities. The alternative calculation method adopts 
Monte Carlo and the definition of a virtual source (a validated and commissioned 
phase space file of the linac head is required) to calculate the dose. Although the MC 
method is more accurate in presence of heterogeneities such as in lung cancer 
treatments, it has minimal impact on brain treatment plans and is more time 
consuming, therefore the RTrac method was adopted for this work. 
Cyberknife®(CK) employs a multiple, non-isocentric, non-coplanar beam combination 
to create optimized dose distributions in a predefined target volume. The treatment 
parameters and appropriate sequence of beamlets are optimized by the TPS according 
to user-defined clinical objectives. In CK functional radiosurgery the target needs to 
receive the correct dose distribution (isodose shape) to optimize the OAR sparing. In 
this sense, different from the oncological field, the target coverage is irrelevant. A MU 
cutoff has been imposed to all plans to exclude beams with low MU, ensuring beam 
output stability as reported in Table 7. 
Accurate beam delivery is available through use of the 6DSkull tracking system for 
real-time image guidance. This system acquires intra-fraction live images of the bony 
anatomy of the patients’ skull at user-defined intervals and compares them to the CT 
digitally reconstructed radiographs. The calculated compensation data are then sent to 
the robotic manipulator and used to compensate movements of the patient’s head 
during treatment. In this way, the treatment beams can follow the target tumor with 
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sub-millimetric precision. All plans were delivered using the fixed collimator of 5 mm 
diameter. 
 
 
 
                     (a)                               (b) 
Figure 36: a) lateral view of the Rando phantom assembled with the probes A and C between layer 
3-4 and 4-5, respectively. Probe B is inserted in the hole adjacent to position A and fixed inside of 
layer 4 at a distance of 1 cm and 2 cm from probe A and C, respectively. b) Example of TPS plan 
with the regions of interest (ROI) corresponding to the detector locations highlighted by the circles 
in orange, red and green. 
 
6.2.4 Dose escalating plan and patient plans selection 
In order to assess the performance of the edgeless diodes, four plans were selected: 
three functional treatment plans and one phantom plan (Rando-plan) with 
progressively escalated doses of 75, 100, 140 and 200 Gy at the Planning Target 
Volume (PTV). The Rando-plan was designed to evaluate the performance of the 
detectors in measuring dosimetric extreme conditions with strong dose gradients and 
high dose delivered (up to 200 Gy) to a very small target size.  The functional plans 
are real patient plans transposed onto the Rando phantom, preserving beam ballistics 
and MUs. Three edgeless diodes were placed in correspondence of the centre of the 
PTV (position B – green circle ROI), at +1cm cranial direction (position A – orange 
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circle ROI) and approximately +2cm caudal direction (position C – red circle ROI) as 
shown in Figure 36.b. Table 7 summarises the main parameters of the plans after being 
transposed to the Rando phantom and recalculated by the TPS, while Figure 36 shows 
the positions of the detectors inside the phantom, respectively. 
To evaluate a correlation between the edgeless diode measurements and the number 
of directions of the incident beams, patient plans were selected with an increasing 
complexity. This is evident from the number of nodes (in Cyberknife a node is a set of 
beamlets which are delivered from a unique position in space) in plans 1, 2 and 3 
reported in Table 7. The mean dose delivered to the target is approximately 70 to 93 
Gy and uncorrelated with the number of nodes of the treatment.  
Table 7. Summary of the parameters of each patient plan 
Plan 
no. 
No. of 
nodes 
No. of 
beams MU Thresholds TPS dose at each detector location 
 Min Max 
Cranial (A) – (Gy) Target (B) – (Gy) Caudal (C) – (Gy) 
min mean max min mean max min mean max 
 1 88 170 1.7 250.0 3.5 4.9 6.6 75.3 85.6 93.0 2.8 3.6 4.3 
 2 93 161 14.2 234.5 9.4 11.1 14.0 86.5 92.4 98.3 2.2 3.0 3.8 
 3 96 198 10.0 112.5 8.4 9.8 11.9 71.5 74.6 78.9 1.8 2.3 2.9 
 Rando75 56 94 15.6 345.7 5.1 6.8 8.7 69.11 71.1 75.0 12.1 12.5 13.0 
 Rando100 56 94 20.8 461.0 6.8 9.1 11.6 92.1 94.8 100.0 16.2 16.7 17.3 
 Rando140 56 94 29.1 645.4 9.5 12.7 16.2 129.0 132.7 140.0 22.7 23.3 24.3 
 Rando200 56 94 41.6 922.0 13.6 18.2 23.2 184.3 189.6 200.0 32.4 33.3 34.7 
 
6.2.5 CC01 measurement on the EasyCube phantom 
The CC01ionisation chamber was inserted in the central adapter of the EasyCube 
phantom and irradiated with the same three functional plans (plan 1, 2 and 3) that were 
delivered to the edgeless detectors. The choice of the EasyCube phantom for the CC01 
measurements is due to the technical difficulties that we have encountered with 
inserting the chamber within the Rando without major modifications of the phantom. 
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As with the edgeless detectors, the EasyCube phantom was CT imaged while the 
chamber was inserted within the phantom to estimate the dose at the exact location. 
6.2.6 Gafchromic EBT3 film measurements 
The film calibration procedure was performed by inserting pieces of film (2 cm2) 
within a solid water phantom (5 cm depth) and irradiating them with 6 MV FFF beam.  
The dose measurement was performed according to the IAEA TRS 398 code of 
practice. All the film pieces were scanned prior to and after irradiation (after 2days) 
with a flatbed EPSON Expression 10000XL (Seiko Epson Corporation, Nagano, 
Japan).The scanning procedure was performed with a resolution of 150 dpi and 
without applying any corrections (229). In order to minimize the effect of optical non-
uniformity, the films were scanned taking care of the orientation and the position on 
the scanner bed. The images of the films (red channel only) were analysed with ImageJ 
version 1.43U (National Institutes of Health, USA) and Matlab™ software (The Math 
Works, Inc., Natick, MA). The optical density was calculated using the red and green 
channels according to the procedure reported by Cusumano el at. Study (230).  The 
overall accuracy of this dosimetric protocol, considering uncertainties related to the 
signal value determination, intrafilm and interfilm uniformity and fitting procedure for 
data is estimated to be of the order of approximately 1.3% (230). 
Two Gafchromic films have been evaluated with the Rando75 plan at the position 
corresponding to the caudal position C of the edgeless diodes. This position has been 
chosen because, according with the TPS calculation, the dose expected at that point is 
approximately 12 Gy, a value still representative of radiosurgical treatments but far 
from the saturation dose of Gafchromic films read with our sum signal technique(230).  
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The results are compared with both the TPS dose distribution and the edgeless diode’s 
reading. 
6.3 Results 
6.3.1 Reference beam data reproduced by edgeless detector 
Table 8shows the beam parameters and dose linearity measured by edgeless diode 
detector and compared with the reference dosimeter (PTW-60018) adopted for 
commissioning of the TPS. It is clearly seen that the dosimetric parameters of the 
Cyberknife® beam measured by the edgeless diodes agree with the clinical reference 
detector within the experimental uncertainties. This confirms the capability of the 
sensor to replicate the reference data for commissioning of the TPS. The calibration 
factor is within 5% of the data obtained in previous experiments (Chapter 5) with 
different generation machines, confirming the reproducibility and reliability of the 
diode’s response. 
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Table 8. Summary of the beam parameters and dose linearity data obtained by edgeless diodes. 
Beam 
parameter 
range of the 
data 
Statistical 
uncertainty maximum deviation 
(%SD) 
Output 
factor 
5 – 60 mm (field 
size) 0.26 
FS (60-15 mm): 0.12% 
FS (15-5 mm): 2.6% 
TPR 0 – 200 mm (depth) 0.31 
Depth (0 mm): 16.1% 
Depth (> 0 mm): 3% 
Off-axis 
ratios 
0.5 – 60 mm 
(field size) 0.52 
FWHM: 2.6% 
Penumbra: 0.21 mm 
Dose 
linearity 100-400 cGy 0.3 
Calibration factor: 134 pC/cGy 
(within 5% of previous work (228)) 
 
6.3.2 Patient specific dose verification 
Table 9 shows the data obtained by the edgeless diodes in the anthropomorphic 
phantom for the patient and escalated treatment plans. Each table reports minimum, 
average and maximum values of the absorbed dose calculated by the TPS within a ROI 
of 1 mm diameter (defined around the position of each detector). The centre of the 
PTV matches the detector in position B (Table 9). 
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Table 9. Comparison of data obtained by TPS calculations and edgeless diodes at the target (position 
B) of the RANDO phantom. 
Plan 
Dose 
prescription 
(Gy) 
TPS dose at target position B 
edgeless dose at target position 
B (mean±0.2 Gy) 
Δ[TPS-
edgeless] 
(Gy) 
Δ(%) 
min 
(Gy) 
mean 
(Gy) 
max 
(Gy) 
[mean-min ; 
max-mean] 
(%) 
1 90 75.3 85.6 93 12.0 ; 8.6 83.3 2.3 2.7 
2 90 86.5 92.4 98.3 6.3 ; 6.3 94.9 -2.5 -2.7 
3 75 71.5 74.6 78.9 4.1 ; 5.7 73.3 1.3 1.7 
Rando 
75 75 69.11 71.1 75 2.8 ; 5.4 71 0.1 0.1 
Rando 
100 100 92.1 94.8 100 2.8; 5.4 92.1 2.7 2.8 
Rando 
140 140 129 132.7 140 2.8; 5.5 130.8 1.9 1.4 
Rando 
200 200 184.3 189.6 200 2.8 ; 5.5 182.7 6.9 3.6 
 
The column “mean-min and max-mean (%)” represents the variation in percentage of 
the absorbed dose calculated by the TPS within the ROI. These values are used to 
evaluate the range of variation expected by the calculations and the agreement with 
the measurements. 
Table 10. Comparison of data obtained by TPS calculations and edgeless measurements at the cranial 
position A of the RANDO phantom. 
Plan 
TPS dose at cranial position A edgeless dose at 
cranial position A 
(mean±0.2 Gy) 
Δ[TPS-
edgeless] 
(Gy) 
Δ(%) 
min 
(Gy) 
mean 
(Gy) 
max 
(Gy) 
[mean-min ; 
max-mean](%) 
1 3.5 4.9 6.6 28.5 ; 34.6 4.6 0.3 6.1 
2 9.4 11.1 14 15.3 ; 26.1 11.3 -0.2 -1.8 
3 8.4 9.8 11.9 14.2 ; 21.4 9.5 0.3 3 
Rando 75 5.1 6.8 8.7 25.0 ; 27.9 5.9 0.9 13.2 
Rando 100 6.8 9.1 11.6 25.2 ; 27.4 7.9 1.2 13.1 
Rando 140 9.5 12.7 16.2 25.2 ; 27.5 10.1 2.6 20.4 
Rando 200 13.6 18.2 23.2 25.2 ; 27.4 14 4.2 23 
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Table 10 and Table 11 show the comparison between TPS and edgeless diodes in the 
cranial and caudal positions relative to the target, respectively. 
Table 11. Comparison of data obtained by TPS calculations and edgeless measurements at the caudal 
position C of the RANDO phantom. 
Plan 
TPS dose at caudal position C edgeless dose at caudal 
position C (mean±0.2 
Gy) 
Δ[TPS-
edgeless] 
(Gy) 
Δ(%) min 
(Gy) 
mean 
(Gy) 
max 
(Gy) 
[mean-min ; 
max-mean](%) 
1 2.8 3.6 4.3 22.2 ; 19.4 3.5 0.1 2.7 
2 2.2 3 3.8 26.6 ; 26.6 2.6 0.4 13.3 
3 1.8 2.3 2.9 21.7 ; 26.0 2.1 0.2 8.7 
Rando 75 12.1 12.5 13 3.2 ; 4.0 11.9 0.6 4.8 
Rando 100 16.2 16.7 17.3 3.0 ; 3.6 15.7 1 5.9 
Rando 140 22.7 23.3 24.3 2.5 ; 4.3 19.3 4 17.1 
Rando 200 32.4 33.3 34.7 2.7 ; 4.2 32.9 0.4 1.2 
 
Table 12 shows the absorbed dose calculated by TPS and measured by the ionisation 
chamber CC01 for the patient plans 1, 2 and 3 in the EasyCube phantom. The 
experiment could not be performed in the anthropomorphic phantom because the 
ionisation chamber could not be accommodated inside the Rando without major 
mechanical modifications. The measurements obtained with the ionisation chamber 
aim to evaluate if there are significant effects of the volume size and angular 
dependence of the ionisation chamber in measuring patient-specific QA on 
Cyberknife®. 
 
Table 12. Comparison of data obtained by TPS calculations and ionisation chamber CC01 in the 
target position using the EasyCube phantom. 
Plan 
TPS dose at target of EasyCube phantom CC01 at target 
(mean±0.1 Gy) 
Δ [TPS-
CC01] (Gy) 
Δ 
(%) min 
(Gy) 
mean 
(Gy) 
max 
(Gy) 
[mean-min ; 
max-mean](%) 
1 74.14 84.73 92.65 12.5 ; 9.3 79.51 5.22 6.1 
2 81.8 86.6 92.3 5.5 ; 6.6 78.5 8.1 9.3 
3 67.74 70.8 75.3 4.3 ; 6.3 62.46 8.34 11.8 
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Figure 37 shows the Gamma index maps of the film 1 and 2 calculated in respect to 
the TPS. The maps are obtained by applying a threshold of 20 cGy. The centre of the 
lesion in film 1 is located in pixel coordinates x=15 y=13 while in film 2 is located 
atx=15 y=16. 
  
(a) (b) 
Figure 37:The Gamma index maps of film 1 (a) and 2 (b) 
 
Two Gafchromic films were irradiated at different times inside the Rando Phantom 
and the results have been compared both with the TPS dose distribution and the 
edgeless diode’s reading at caudal position C according to a consolidated dosimetric 
protocol (231).   
Evaluation of the agreement between the planned and effectively irradiated dose maps 
has been performed using the gamma (γ) analysis tool by applying ΔDM = 4% of the 
maximum dose and ΔdM = 1 mm acceptance criteria and a threshold of 20cGy for 
dose comparison. The co-registration of the film and the TPS dose distribution maps 
was performed by a Matlab script developed in-house at Besta Institute (Milan); the 
code adjusts for any potential rotation/translation displacement. The matching method 
relies on the spatial correlation process and is capable to correct the displacement 
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variances with a accuracy of 0.5° and 0.25 mm(230). The obtained rates for γ <1, γ 
<1.5 and γ > 2 frequency parameters are reported in table 7 for both films. 
To establish a correlation, film data were compared to the readings of edgeless diodes 
that have values higher than 12.16 Gy, which (according to the TPS) is the minimum 
dose delivered to the diode volume. The results are also reported in Table 13.   
Table 13. Comparison of data obtained by Gafchromic film irradiation, TPS calculations and diode at 
caudal position C using the Rando phantom. 
Film	#	
g frequency	parameters	 																								Absolute	dose		
g<1 (%)	 <1.5	(%)	 g>2 (%)	 Gafchromic	(Gy)	
TPS	mean	
(Gy)	 Diode	(Gy)	
Film	1	 93.1	 99.7	 0.3	 9.92	 12.5	 11.9	
Film2	 92.3	 99.8	 0.2	 11.02	 12.5	 11.9	
 
A variation of approximately 10% is noticed between the two films data. This is due 
to the reproducibility of the scattering conditions when the RANDO phantom is 
assembled between each irradiation. For film irradiation, the phantom has to be 
unpacked, the film deposited on the slab and then re-packed again, sliding the slabs 
through the large nylon screws required to fix the phantom head. This procedure 
produces differences in the amount of air gap to which the film is exposed between 
successive measurements. Figure 36.a shows the RANDO phantom from a lateral 
prospective and it is evident there is a gap between two layers because of the presence 
of the film in the caudal position C. 
6.4 Discussion 
The measurement of patient-specific dose delivered to a phantom represents a major 
challenge for any commercially-available dosimeter. The measurement of three patient 
plans delivered to the EasyCube phantom equipped with a CC01 ionisation chamber 
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show a discrepancy of a maximum of -11.8. % when compared to the TPS. The 
disagreement is due to two major limitations of the CC01 for dosimetry in stereotactic 
radiosurgery for brain functional disorders: first, the volume averaging effect due to 
the very small field size at the target which makes the ionisation chamber under-
responding systematically in all patients (215). Additionally, there is an effect of 
angular dependence of the detector response (232). This effect produces an increasing 
discrepancy between TPS and measurements proportional with the complexity of the 
plan, estimated by the number of nodes used to deliver the dose. The correlation 
between discrepancy of the measurement and complexity of the plan for the three 
patients is approximately 0.997 indicating that there is a possibility that angular 
response dependence of the CC01 affects the accuracy in measuring dose in a non-
isocentric treatment modality. 
Table 9 shows that the edgeless diode positioned within the PTV of the plans can 
measure the dose within 3.6% for all the patients without an evident correlation 
between discrepancy, dose delivered, or complexity of the plans. The diodes placed at 
the margin of the PTV, in positions A and C, show discrepancies within 1 Gy for all 
measurements (see Table 10 and Table 11). Excluding the Rando140 and Rando200 
plans in the cranial position, where the diodes measure a discrepancy of -2.6 and -4 
Gy in respect to the TPS calculations, respectively. Although this disagreement seems 
large, it is well within the range of uncertainty calculated by the TPS within the ROI 
of 1mm diameter defined in the plan and positioned around the position of the sensor, 
which varies from 6.7 Gy and 9.6 Gy for Rando140 and Rando200, respectively. 
The same disagreement pattern between TPS and diodes is found in the caudal position 
for the plan Rando140 and Rando200. The overall discrepancy is within approximately 
4 Gy over 24Gy estimated by the TPS with a percentage difference of 17%. This may 
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suggest a slight misalignment between TPS ROIs and actual position of the detectors 
in this very high dose gradient region.     
The diode measurements are confirmed by the Gafchromic irradiation when the range 
of dose delivered was compatible with a discrepancy between film and diode of -16% 
and between film and TPS of approximately -21.1%. The results of the gamma pass 
rates in our study are consistent with previously published data but the intrinsic 
experimental limitations of the dosimetry procedure such as the comparison of a 2D 
irradiated dose map with the dose measured by the diodes in 3 points in space generates 
large discrepancies between film and diodes but also between film and TPS (233). For 
Cyberknife patient-specific QAs, no well-established tolerance criteria currently exist.  
6.5 Conclusion 
Stereotactic Radiosurgery using the Cyberknife® system is one of the options for 
treatment of functional neurological disorders. The high doses delivered to the patient 
(up to 90 Gy in a single fraction) and the proximity of nerves and the brainstem would 
benefit from a QA procedure that guarantees accuracy, precision and confidence in the 
clinicians. QA of such treatments is limited to machine operational verification as there 
is no commercial instrumentation able to measure simultaneously high doses absorbed 
in a small field using non-isocentric robotic delivery. In this work, we propose the 
edgeless diodes as a solution to fill the technological gap between complexity of the 
treatment delivery and quality control instrumentation available. The edgeless diodes 
are manufactured and packaged using a unique technology which minimises the beam 
perturbation and angular dependence of the detector response. The diodes show 
agreement within experimental uncertainties with state of the art reference dosimeters 
for machine QA and small field dosimetry as confirmed by the measurements of output 
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factor, off-axis and tissue-phantom ratios for fixed collimator cones from 5 to 60 mm 
beam diameter. In order to evaluate the performance of such detectors in patient-
specific QA of functional treatments, three patients and a set of dose escalated plans 
were measured on the anthropomorphic Rando phantom with three diodes, one placed 
within the PTV and the other two in proximity of the OARs. The dose measured by 
edgeless detectors agree with the TPS within 3.6% in the PTV for all set of plans. The 
same experiment performed on the same patient plans using a CC01 shows 
discrepancies up to -11.8%. The edgeless technology represents a viable solution for 
small field dosimetry in non-isocentric robotic delivery modalities and could be 
implemented in other advanced radiotherapy treatments such as non-coplanar 
volumetric arc and single isocentric brain metastasis. 
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7 EVALUATION OF COMMERCIAL AND RESEARCH LEVEL 
DOSIMETERSIN SMALL FIELD DOSIMETRY IN ACCORD WITH 
THE CODE OF PRACTICE TRS 483  
 
This work wasprepared for submission to Journal of Applied Clinical Medical Physics as: 
Alhujaili, S., Davis, J., Davies, Alharthi, T., Brace, O., Wilkinson, D., Rosenfeld, A. and 
Petasecca, M. (2019). Evaluation of commercial and research level dosimeters in small field 
dosimetry in accord with the code of practice TRS 483. 
 
7.1 Introduction 
One of aims of this chapter is to provide a set of data for field output factors using 
edgeless diode and a set of real-time detectors available on the market for small field 
dosimetry along with radiochromic EBT3 films under the recommended experimental 
conditions given in TRS-483. In addition, the TPR20,10 at various field sizes and their 
field size dependence were investigated. The beam quality index (TPR20,10) at a 
reference field size of 10 x 10 cm has also been analytically derived from the 
experimental data obtained at different field sizes (by several detectors) using 
Palman’s expression and compared with results obtained from other expressions 
reported in the literature. 
7.2 Materials and Method 
7.2.1 Treatment units and detectors 
This study was performed on three different Linear accelerators: Varian TrueBEAM™ 
and Varian Clinac IX™ machines (Varian Medical Sytems; BrainLAB, Feldkirchen, 
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Germany), located in the Illawarra Cancer Care Centre, Wollongong Hospital, 
Australia, and an Elekta Synergy (Elekta, Crawley, UK) located in the Oncology 
Department of Liverpool Hospital, NSW, Australia. The radiation beams and dose 
rates used in this work on the TrueBeam system were: 
• 6 MV WFF (600 MU min-1). 
• 6 MV FFF (1200 MU min-1). 
• 10 MV WFF (600 MU min-1). 
• 10 MV FFF (1400 MU min-1). 
 
And the one used on the Clinac IXthey were: 
• 6 MV WFF (600 MU min-1). 
• 10 MV WFF (600 MUmin-1). 
 
While beams and dose rates used on Elekta Synergy they were: 
• 6 MV WFF (550 MU min-1). 
• 18 MV WFF (550 MUmin-1). 
 
 
Figure 38:Experimental setup for dosemeasurements 
 
In this work, the responses of five dosimeters were investigated (Table 14). These 
consisted of two diode detectors: the Razor diode (IBA Dosimetry, Schwarzenbruck, 
Germany) and an edgeless diode. The other three detectors were: Radiochromic film 
EBT3 (Ashland Inc., Wayne, NJ, USA), a PTW microDiamond (PTW, PTW-Freiburg, 
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Germany) and a CC01 Ionization chamber (IBA Dosimetry, Schwarzenbruck, 
Germany). For all the beam data reported in this study, the same individual detectors 
with the same serial numbers (and same sample of edgeless diodes) were used for the 
investigations. An equivalent water phantom (Solid water®) was used in all the 
measurements (Figure 38), equipped with 5 adapters, each consisting of a slab 1 cm 
thick with different insert size and shapes, in order to accommodate each detector 
inside the phantom. The readings of the CC01 ion chamber, the PTW microDiamond 
and the Razor diode were carried out using a PTW Unidos webline electrometer (PTW, 
PTW-Freiburg, Germany) with the Razor diode and microDiamond operated at 0 V 
bias and the CC01 ion chamber operated at +300 V. The edgeless diode response was 
read out using TERA Acquisition system(234). All real-time detectors (edgeless, 
Razor, microDiamond and CC01) were placed in the radiation field with their axes 
positioned perpendicular to the central axis of the beam. For each point measurement, 
the response of the detectors was measured with a delivered dose of 100 MU. As the 
accurate positioning of the detector across the central axis of the radiation beam is 
crucial for small field measurement, the detectors were aligned in two steps. Initially 
the detector was aligned at the isocenter, using the room lasers and light field. Then 
each detector was moved in both cross-plan and in-plane directions with an increment 
of 0.1 mm by using two stepper motor stages (Standa, Vilnius, Lithuania) for finer 
alignment. The position of the maximum response in both directions was assumed as 
the centre of the radiation field. This procedure was carried out with each detector 
separately and it was repeated at each measurement depth to correct for axial 
displacement due to the couch movements 
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Table 14: Generalcharacteristics of the detectors used in this work. 
Detector Type Material density Zeff Active volume 
Packaging/wall 
material 
edgeless n-type (PN-XS-500) Silicon 2.33 14 
0.5 mm width, 0.5 mm 
length, 0.5 mm thick, 
0.125 mm3 volume 
Kapton 
IBA 
Razor  n-type Silicon 2.33 14 
Cylindrical, 0.6 mm 
Diameter, 20 um 
length 
ABS plastic & 
epoxy resin 
PTW 
Diamon
d 
CVD 
Diamond 
Diamon
d 3.5 6 
0.001 mm length, 2.2 
mm diameter resin 
IBA 
CC01 
Air-filled 
ionization 
chamber 
air 14 7.64 
1 mm Radius, 3.6 mm 
length, 0.01 mm3 
volume 
Shonka C-552  
 
7.2.2 Output factor 
The Output Factor (OF) was determined using the ratio of the reading of the detector 
at given field size to the reading at the reference field size (10 x 10 cm2). OF was 
measured with the edgeless diode, Razor diode, microDiamond and IBA CC01 ion 
chamber. The evaluation OF was performed with a square field size of 0.5, 1, 1.5, 2, 
3, 4, 5 ,6, 8 and 10 cm. the field sizes were defined by jaws in the Varian True Beam 
and Clinac while in the Elekta the field is defined by the MLC. Because the Elekta 
machine cannot create a 0.5 x 0.5 cm field, the smallest field evaluated was 1 cm.  Each 
measurement is performed at a depth of 10 cm (isocenter) with a source to detector 
distance (SDD) of 100 cm. In order to estimate mean values and standard deviations 
of the measurements, the response of each detector is readout three times for each field 
size. 
7.2.3 Measurement of output factor using Radiochromic EBT3 film 
EBT3 film (Lot # 12131702) was used to measure the output factor as a benchmark. 
The calibration of the film was carried out for each beam energy, with a total of six 
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different calibration measurements (two measurements on each linac machine). Eight 
pieces (3 x 3 cm2) of film were used in each calibration procedure which was 
performed by irradiating them with: 10, 25, 50, 75, 100, 150 and 200 MU under 
reference conditions (depth dmax, 100 cm SSD and 10 x 10 cm2 field size). One piece 
of film was left unexposed to use as a reference for zero exposure.  
Output factor measurements were performed for the field sizes of 0.5, 1, 1.5, 2, 3, 4,5, 
6, 8 and 10 cm using 10 pieces of 3 x 3 cm2 size for each photon beam (a total of 70 
pieces). The films were placed inside the phantom at the isocenter and irradiated with 
100 MU under the same irradiation conditions as the other detectors (10 depth and 100 
cm SDD). All the films’ orientations were marked to ensure consistency in the 
scanning (i.e. the calibration films, the output factors films and the unirradiated films). 
All the film pieces were scanned prior to and after irradiation (after 48 hours) with a 
flatbed EPSON XS11000 scanner (Seiko Epson Corporation, Nagano, Japan). The 
scanning procedure was performed with 48-bit depth color and a resolution of 72 dpi 
and without applying any corrections. A frame made from transparent plastic sheet 
was used to place the films in a repeatable position on the scanner. In order to avoid 
the warm-up effect, the scanner was warmed up for several minutes, each film was 
scanned six times, and the last three scans were used to evaluate the optical density. In 
order to minimize the effect of optical non-uniformity, the films were scanned taking 
care of the orientation and the position on the scanner bed. The dose calculations were 
performed on both Matlab™ software (The Math Works, Inc., Natick, MA) and 
ImageJ version 1.43U (National Institutes of Health, USA) using the red channel only. 
The error-bar values for the film dosimetry measurements were determined from the 
uncertainty confidence limits (two standard deviations) resulting from the conversion 
of pixel values to dose by the optical density function and taking into account the 
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second-order polynomial function used to fit the measured data to the dose calibration 
curve. 
7.2.4 Determination of beam quality index TPR20,10(10) 
The experimental data for beam quality indexes (TPR20,10) were obtained with three 
solid state detectors (edgeless diode, Razor diode and microDiamond) and theCC01 
ionization chamber. The responses of the detectors were measured at depths 10 and 20 
cm with 100 cm SDD and at ten different field sizes (0.5, 1, 1.5, 2, 3, 4, 5, 6, 8 and 10 
cm). On the True Beam and Clinac IX linacs, the field sizes were defined by jaws, 
whereas on the Elekta system the MLC was used to create the required field sizes. The 
responses of each detector for each measurement were repeated three times and the 
ratio of average values at depth 20 and 10 cm were used as TPR20,10. 
In this study, we also analytically derived the TPR20, 10(10) by Palman’s expression 
and compared with the data derived from Sauer and the linear fit expressions. The 
calculation of TPR20,10 (10)was based on experimental data obtained at various field 
sizes (0.5-10 cm) using CC01, edgeless, Razor and microdiamond detectors.  
The Palman’s equation adopted by TRS 384 is defined as follows: 
 
 TPR10,20	 10 = TPR20,10	 S + c(10 − 	S)1 + c(10 − 	S)  (5) 
 
where c = (16.15 ±0.12) x 10-3  , valid for 4 ≤  S ≤ 12 cm, S being the equivalent square 
msr field size in cm with photon beam energy up to 25 MV. 
Sauer also proposed an expression for the calculation of TPR20,10(10) from the 
measured TPR20,10(S) of different field sizes: 
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 TPR20,10 = TPR20,10 S − b1 + A1	. 	 1	 − e − :;[b2 + A2	. 	(1	 − e − s/t)]  (6) 
 
Where: S is the equivalent square field size in cm2, b1 = -0.208, b2 = 1.213 , A1= 
0.625, A2= -0.679  and t = 19.5. The Sauer expression is valid for 0.62< TPR20,10(10) 
< 0.8. 
Another solution for determination of TPR20,10 (10) from small field sizes was 
proposed by Maniet al. In this method, a simple linear fit is obtained from plotting the 
field sizes (x-axis) versus the TPR20,10 measured from a range of field sizes. The TPR 
20,10 (10) can be determined by substituting x = 10 in the linear function y = mx + c 
which is derived from the field size versus TPR20,10 (S) relation. The square field size 
range of 1-5 cm was used to extract the value of TPR20,10 (10). 
7.3 Results and discussion 
7.3.1 Output Factor: 
Figure 39and Figure 40show jaw-defined output factors obtained on the TrueBeam 
and Clinac IX machines, using edgeless diode (black squares) , microDiamond (purple 
triangles) , Razor diode (blue triangles) and CC01 ion chamber (green diamonds) and 
compared to EBT3 film (red circles). The x axis shows the dimension of the square 
equivalent field size ranging from 0.5 cm to 10 cm. The percentage deviation was 
obtained by comparing the detectors’ response to the film response. To demonstrate 
the original response of the detectors in small field sizes, no correction factor has been 
applied to the measured signals. The measurements were performed under reference 
conditions (100 SDD, 10 cm depth) recommended by the IAEA-AAPMTRS 384 code 
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of practice. The statistical uncertainties of the measurement were calculated with one 
standard deviation and were within 0.2 % for all detectors. 
 
 
(a) 
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(b) 
 
 
(c) 
Figure 39: Comparison of Detector output factors obtained on TrueBeam Linac for jaw-defined 
field size (0.5 - 10 cm) with: (a) 6 MV FF, (b) 10 MV (FF), (c) 10 MV (FFF) 
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(a) (b) 
Figure 40: Comparison of Detector output factors obtained on Clinac IX for jaw-defined field 
sizes (0.5 - 10 cm) with: (a) 6 MV FF, (b) 10 MV (FF). 
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Figure 41 shows the MCL-defined output factor measured on an Elekta Synergy linac 
by the same detectors and under the same reference conditions. 
  
  
(a) (b)  
Figure 41: Comparison of Detectoroutput factors obtained on Elekta Synergy for MLC-defined 
field sizes (1 - 10 cm) with: (a) 6 MV FF, (b) 18 MV (FF). 
 
It is observable, as expected, that the output factor values of all detector types show 
sharp decreases at small fields (less than 2 cm) irregardless of the beam energy or 
machine used. This is mainly owing to the loss of lateral electronic disequilibrium and 
partial occlusion of the radiation source. It can be also noticed from the figures that 
the output factors measured with FFF beams were found to be higher than FF beam at 
same energy. This higher output, which is measurable with all detectors, is due to the 
beam spectrums of softening associated with non-filtered beams. The dose response 
data recorded by all detectors demonstrates a reduction in output factors with 
increasing of the beam energy regardless to the machine or collimation system (Jaws 
or MLC) used. This is primarily due to that the increasing of beam energy will increase 
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the range of secondary electrons and extending the volume in which lateral electron 
disequilibrium occurs. As a result of this effect, the reduction of energy deposition 
(absorbed dose) will be larger with smaller field sizes and with higher beam energy. 
Additionally, the output factor measured with multileaf collimators is larger than the 
one determined with Jaw collimators. The prime reason is from the “tongue effect” 
associated with a MLC collimation system that increases radiation leakage but also 
increases electron contamination. The dose response ratios of the microdiamond and 
razor solid-state detectors with EBT3 film shows a pronounced over-response in small 
fields sizes. The highest over-response was observed at a field size of 0.5 cm with 
disagreements of the Microdiamond and Razor detectors with respect to the EBT film 
within 26% and 20%, respectively. The overall over-response of their sensitivity 
decreased with increasing field size until it became 2% in field sizes larger than 3 cm. 
This over-response is not to be attributed to the density of the detector sensitive volume 
(the edgeless detectors are silicon-based but they do not present a pronounced over-
response in respect to EBT3 films) but mainly to the density of the surrounding extra-
cameral materials which have higher density than water. On the other hand, the 
edgeless diode showed good agreement with a small over-response not exceeding 3%. 
This is mainly due to the edgeless diode being packed with low Z materials (mainly 
Kapton) using the drop-in technology developed in CMRP, which reduces the 
perturbation effects by the packaging. In contrast to solid-state detectors, an under-
response was observed in the response ratios of theCC01 ion chamber. The largest 
underestimations observed were -16.8% and -7.1% for field sizes of 0.5 and 1 cm 
respectively. However, good agreement was observed in larger field sizes which were 
within 2.9%.  The large under-response of CC01 is due to the volume averaging effect 
and the low density of its sensitive volume compared to water. 
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7.3.2 Beam quality index (TPR20,10) 
7.3.2.1 Experimental determination of the TPR20,10 
Figure 42shows the TPR20,10 as function of field size (0.5 – 10 cm) measured with three 
different photon beams energies (6 MV, 10 MV and 18 MV )in a solid water phantom. 
The measurement of 6 MV and 10 MV were performed on Varian TrueBeam and 
Clinac IX machines while the 18 MV measurement was performed on the Elekta 
Synergy. TPR20,10 data of solid-state detectors were compared to the data from the 
CC01 ion chamber. Each measurement was repeated three times to estimate the 
statistical uncertainty, which was calculated using one standard deviation. All 
detectors show a repeatability within 0.2%. 
 
 
 
Figure 42: Field size dependence of TPR20,10 obtained by CC01, edgeless, Razor 
and microDiamond detectors with 6 MV, 10 MV and 18 MV photon beams. The 
data for 6 MV and 10 MV beams were obtained on a Clinac IX while the 18 MV 
beam result was obtained on the Elekta Synergy. 
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Figure 43 shows the field size dependence of the TPR20,10  determined with flattened 
and non-flattened 10 MV beams from measurements made on a Varian True Beam 
linac using the same set of detectors.  
 
Figure 43: Field size dependence of TPR20,10 obtained by CC01, edgeless, Razor and 
microdiamond detectors with flattened and non-flattened 10 MV photon beams. 
 
As could be expected, the measured TPR20,10 decreases with decreasing field size. The 
entire set of detectors follow very well the behaviour and trends of the CC01 response 
at field sizes of 1.5 – 10 cm with agreement within 0.95%, 1% and 0.39% for edgeless, 
razor and microdiamond detectors respectively. However, the discrepancy is found to 
be high in very small fields (0.5 – 1 cm) with discrepancies of 13.9%, 6.6% and 9.9% 
for edgeless, razor and microdiamond detectors, respectively. Our results confirm the 
findings of most other investigators (235, 236), i.e. the decrease of the TPR20,10(S) 
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values with decreasing the field size. This can be attributed to the fact that the primary 
photon beam becomes harder as the field size decreases. 
Table 15shows the TPR20,10 obtained at reference fields size (10x10 cm2) on all linacs 
investigated in this study (truebeam, clinic IX and Elekta synergy) using the solid-state 
detectors and the CC01 ion chamber.  
 
Table 15: Experimental TPR20,10 (10) measured by CC01, edgless and microdiamond detectors with 
different beam energies produced with TrueBream, Clinac IX and ElektaSynergy linac machines 
Linac Beam		 CC01	 edgeless	 Razor	 uD	 %Δ	(Edg)	
%Δ	
(Raz)	
%Δ	
(uD)	
Va
ria
n	 6FF	 0.662	 0.669	 0.663	 0.663	 0.55	 -0.28	 -0.2	
10FF	 0.736	 0.738	 0.738	 0.735	 -0.23	 -0.32	 0.17	
10FFF	 0.701	 0.706	 0.701	 0.7	 -0.76	 0.06	 0.18	
Cl
in
ac
	X
I	
6XFF	 0.661	 0.666	 0.664	 0.66	 -0.86	 -0.47	 0.05	
10XFF	 0.736	 0.74	 0.735	 0.734	 -0.5	 0.12	 0.26	
El
ek
ta
	
Sy
ne
rg
y	
6XFF	 0.675	 0.673	 0.675	 0.674	 -0.75	 -0.12	 0.04	
18XFF	 0.766	 0.77	 0.764	 0.762	 -0.61	 0.28	 0.52	
 
Resulting values are compared to reference ion chamber (CC01) results in the last three 
columns of Table 15. It can be seen that the solid-state detectors were able to replicate 
TPR20,10 values of the reference dosimeter within 0.76 % in the photon energy range 
investigated in this study.  
The high precision of the solid-state detectors in obtaining the above results, which is 
within the tolerance recommended by TR-384 for detectors used for standard and 
nonstandard field dosimetry, and their excellent agreement with the “benchmark” 
dosimeter (ion chamber) confirms the reliability of the investigated detectors to be 
implemented in determinations of the beam quality index under these conditions with 
negligible errors.  
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7.3.2.2 Analytical determination of TPR20,10  
The analytical derivations of the TPR20,10 (10) were obtained using Palman’s, Sauer’s 
and linear fit expressions. The values predicted using these expressions are based on 
the experimental data (see Table 31 - Table 58 in appendix A) obtained from different 
detectors (edgeless, Razor, microdiamond and CC01 ion chamber) at various field 
sizes. Each TPR20,10(10) calculated using the TPR20,10(S) at a given field size S was 
compared with the experimental TPR20,10 (10) data measured at reference field size (10 
x 10 cm2). 
In order to analyse the results in terms of field size related variations, we identified 
three categories of field sizes: 0.5cm, between 1 and 2 cm and above 3cm. Figure 44to 
Figure 47show the percentage of derived TPR20,10(S)from each expression in different 
categories, which agree within 1% with the reference measured TPR20,10 (10). The 
accuracy of 1% is chosen as maximum acceptable error inTPR20,10(10) values derived 
from TPR20,10(S) in this study, as this uncertainty corresponds to 0.1% and 0.5 MV 
change in the stopping-power ratio and the nominal linear accelerator energy, 
respectively(236, 237). In addition, this level of accuracy will also maintain the change 
in quality conversion factor (kQ) to be as low as 0.3%(235). 
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Figure 44: the percentage of derived TPR20,10  (10) calculated by Palman’s,  Sauer’s and 
linear expression with accuracy of 1% at different field sizes.  
 
 
Figure 44 shows the percentage of the derived TPR20,10 (10) at different fields sizes 
with discrepancy from the experimental results of 1% or less. Less than 35% of the 
values predicted by the investigated expressions (Palman’s and Sauer’s only) in a field 
of 0.5 cm show an accuracy within 1%. It can also be noticed that the deviations from 
experimental results become less pronounced with increasing field sizes whereby the 
percentage of the derived data with the specified accuracy increases until the derived 
TPR20,10 (10) become 95.6% and 96.9% at field sizes from 3-10 cm by Palman’s and 
Sauer’s expressions respectively.  The Palman’s expression show better performance 
at field sizes ranging from 1-2 cm compared to the other expressions with percentage 
of 85.7% which extend its validity to be implemented down to field sizes of 1 cm.  
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Figure 45: the percentage of derived TPR20,10  (10) calculated by Palman’s,  Sauer’s and 
linear expression with accuracy of 1% at different beam energy. 
 
In the analysis of the effect of the energy range in the accuracy of the TPR20,10 (10) 
calculations in respect to the experimental results (Figure 45), it can be noticed that 
Palman’s expression shows percentages up to 88.9 % (at beam energy of 18 MV) with 
a small variation in respect to the beam energy. On the other hand, the Sauer’s and 
linear fit expressions were able to produce such a high percentage at beam energy of 
18 MV and 6 MV respectively.  However, in the case of Sauer’s expression, a large 
variation can be observed where the percentage of accurate values decreases by 30% 
when decreasing the beam energy, while the linear fit expression shows approximately 
50% decreasing between 6 and 18 MV energies with opposite trend. 
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Figure 46: the percentage of derived TPR20,10  (10) calculated by Palman’s,  Sauer’s and 
linear expression with accuracy of 1% with flattened and nonflattened beams 
 
All expressions were able to predict the reference experimental TRP20,10 (10) with 
percentage higher than 87.4% with a flattened beam, but in case of the non-flattened 
beam the results of both Sauer’s and linear fit methods reduced to 59.5% and 25% 
respectively (see Figure 46). In contrast to these, the Palman’s calculations replicate 
the reference values in the 89.2 % of cases. 
 
Figure 47: the percentage of derived TPR20,10  (10) calculated by Palman’s,  Sauer’s and 
linear expression with an accuracy of 1% using the experimental data obtained by CC01, 
edgeless,  razor and microdiamond detectors.  
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Figure 47 shows data-derived TPR20,10 (10) based on the measurements obtained by 
CC01, edgeless, Razor and microdiamond detectors. It can be seen from the figure that 
the predictability of a linear fit expression with edgeless diode measurement was 
significantly low (26%). This might be due to the fact that the linear fit expression 
calculates the TPR20,10(10) based on TPR20,10 measured at several small fields sizes 
where the contribution of low energy photons to the fluence is relatively high. Hence, 
this will affect the response of edgeless diode as it is not shielded (in contrast to the 
Razor diode) from this type of photons. Despite the above disagreement, all detectors 
show very similar agreement in obtaining the TPR20,10(10) with respect to all the 
expressions proposed in this work, confirming the capability of the solid-state 
detectors to be employed for determining the TRP20,10(10) from small fields with 
acceptable accuracy. 
7.4 Conclusion 
The aim of this study was to assess the performance of various detector types when 
measuring the field output factor following the recommendations of the new TRS 384 
code of practice published by IAEA-AAPM. One of the most significant findings of 
this study is that edgeless diode, in contrast to other solid-state detectors, obtained 
accurate output factors with negligible over-response of less than 3.2% at 5mm lateral 
edge field sizes for all energies and modalities. On the other hand, the air-filled ion 
chamber CC01 suffered from severe under-response at very small field size (0.5 
cm).The measurements of TPR20,10 obtained by the solid-state detector have 
demonstrated an agreement with ionization chamber values within 0.78%. An 
implication of this result is the possibility of implementing solid-state detectors to 
carry out reference dosimetry, particularly in small fields, with acceptable accuracy. It 
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has been also been shown in this investigation that the Palman’s expression which was 
adopted by TRS 384 reproduces the TPR20,10(10) with high accuracy compared with 
other expressions developed for the same purpose. 
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8 EVALUATION OF A PREPLIMINARY DESIGN OF A 2D EDGELESS 
ARRAY DETECTOR 
 
8.1 Introduction 
Dose verification using a point dosimeter is not adequate for advanced radiation 
therapy techniques (IMRT, VMAT and SRS) as the beam with these treatment 
techniques is highly modulated and conformed. Therefore, several 2D dosimetry 
methods and technologies (Film, IC, silicon-based array) were developed to evaluate 
the full dose distribution for radiotherapy treatments. However, planar array detectors 
manufactured from dense material such as silicon diodes exhibit high angular 
dependence (82), due to the attenuation of the beam by adjacent silicon pixels, which 
will be difficult to correct for, particularly, in case of non-coplanar and non-isocentric 
delivery modalities. In this chapter, a preliminary design of a 2D array detector 
designed and manufactured by CMRP is presented. The array detector is composed of 
9 elements arranged in a cross-shaped geometry and is evaluated for patient-specific 
treatment plan verification in non-isocentric robotic SRS modalities (e.g. Cyberknife) 
usingthe anthropomorphic phantom RANDO and the EasyCube QA phantoms. 
Material and method 
8.1.1 2D Edgeless Array detector 
The 2D edgeless array is composed of nine non-irradiated n-type edgeless diodes (NP-
S-500) with sensitive volume sizes of 1 x 1 mm2 and thickness 0.5 mm. this chapter 
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focuses on investigation of n-type diodes (NP-S-500) only, as the edgeless samples of 
the other type and geometries (p-type, PN-S-500 and PP-S-100) were not available at 
the time of performing the experiments of this chapter. The diodes are arrange in two 
lines (90owith respect to each other) to form an “X” shape with 5 diodes along each 
intersecting arm (see Figure 48). The distance between the pixels in the direction of 
the linear axis is 3.6 mm and each element in the array is embedded in solid Kapton 
substrate that has an area of 10 x 3 mm2 (each probe).  The diodes are distributed 
according with this geometry to minimise the influence of each silicon diode on its 
adjacent neighbour.  
 
 
 
Figure 48: Left: Diagram of edgeless array pixels arrangement and their dimensions. The red 
coloured numbers are the sample identity of the diodes. Right: image of the edgeless array 
detector. 
 
The signal of the diodes were readout independently using a multichannel data 
acquisition system (TERA) (234). 
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8.1.2 Patient-specific measurement 
The performance of the edgeless arrays was investigated on a Cyberknife with beam 
of 6 MV and dose rate of 1000 MU/min.  The measurement were performed using both 
the EasyCube and the RANDO anthropomorphic phantoms (see Figure 49).  
 
 
(a) 
 
(b) 
Figure 49: edgeless array inserted inside: (a) EasyCube phantom, (b) Rando phantom. 
 
To accommodate the edgeless array inside EasyCube, it was encapsulated into a 
PMMA holder (5 x 2 x 2 cm3) that has grooves to accommodate the edgeless array 
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elements (see Figure 50). In order to have an accurate localization of the diodes and to 
determine the doses calculated by the TPS in such positions, EasyCube and RANDO 
anthropomorphic phantoms were CT-scanned while edgeless array inserted in both 
phantoms. The scanning was performed on a Philips Brilliance CT Simulator (Philips 
Electronics N.V., Netherlands) using adopted clinical parameters (1 mm slice 
thickness, contiguous slices, 120 kVp, 400 mAs). 
 
 
 
Figure 50: Left: edgeless array mounted on small PMMA holder to insert it within EasyCube 
phantom; Right: 3D model of the PMMA holder with its build-up cover. 
 
The CT images were used with six real patient plans (see Table 16) selected to have 
various radiation clinical indications (oncological and functional disorders) and target 
radiation dose levels between 5 and 73 Gy. Also, different dose distribution geometries 
were considered, from a narrow target (used for functional brain disorder treatment) 
to a broader target volume (used for melangioma treatment) with clinical target sizes 
from 3 mm to 2cm in diameter. All plans were created using Ray Tracing (RTrac) 
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method adopted by Multiplan software (Accuray Inc., Sunnyvale, CA, USA). The 
locations of the diodes and the regions of interest (ROIs) such as planning treatment 
volume (PTV) were defined and delineated on CT images and the average, minimum 
and maximum doses were calculated at the defined locations by TPS.  Plans 1 to 5 
were delivered to the EasyCube phantom only and plan 6 was delivered to both 
EasyCube and Rando phantoms, to investigate the effect of the tissue heterogeneity, 
introduced by the Rando phantom, on the accuracy of edgeless array measurement. 
Table 16. Summary of the plans generated by the Multiplan system. 
Plan# Clinical indication 
 
PTV 
size 
(mm) 
Prescribed 
dose (Gy) 
No. 
of 
nodes 
SAD 
(mm) 
Collimator 
type/size 
(mm) 
phantom 
 
1 cancer	 	 25	 5	 86 800 IRIS/20 EasyCube 
2 cancer	  23 18.63	 80 800 IRIS/20 EasyCube 
3 Functional	disorder	
 
8 22.86	 80 800 IRIS/5 EasyCube 
4 cancer	  65 4.81	 80 800 IRIS/25 EasyCube 
5 Functional	disorder	
 
4 77.82	 80 800 IRIS/5 EasyCube 
6 Functional	disorder	
 
8 64	 80 800 IRIS/20 EasyCube/Rando 
 
 
Real-time monitoring of target positions were provided by Cyberknife via an 
orthogonal pair of digital x-ray imaging devices tracking the bony structures of the 
skull of the Rando phantom using the 6DSkull algorithm and by landmark features in 
EasyCube phantom. The treatment plans were delivered using different Iris field sizes 
and number of nodes and beamlets at 800 mm SAD. 
 180 
 
8.1.3 Dose per pulse measurement 
The radiation beam produced by Cyberknife M6 linac is delivered with 5.9 µs pulses 
at frequency of 170 Hz. The variation of dose rate within the pulses of the beam is 
responsible to introduce the dose per pulse dependence in response of some type of 
radiation dosimeters. N-type silicon-based diodes show dose per pulse dependence 
(DPP) with over response at low dose per pulse range. In this work, dose per pulse 
measurement were performed on the planar edgeless diodes in order to calculate the 
corresponding DPP correction factors to correct for the over response of the diodes at 
the very low DDP range. The responses of the diodes were measured in a range 
including the DPP expected for the patient-specific measurements which is 
approximately in the range between 7.9 x 10-4 to 2 x 10-5 Gy/pulse. The measurements 
were carried out within a solid water phantom at a field size of 10 x 10 cm2 using a 
6MV Varian Truebeam linear accelerator. The diodes were inserted within the 
phantom at depth 1.5 cm and irradiated with FFF 6 MV beam at a dose rate of 1400 
MU/Min. The responses of the edgeless diodes were compared to the response of 
reference ionization chamber (Farmer). 
8.2 Results and discussion 
Table 17to Table 23 show the dose measured by edgeless array pixels for 6 different 
plans and compared to dose estimated by the TPS at the same locations in a GTV 
where the array elements were inserted. The plan 6 (Table 22 and Table 23) was 
delivered to EasyCube and Rando phantoms while the other plans were delivered to 
an EasyCube phantom only. The results showed that all diodes of the edgeless array 
detector suffer from significant over-response in all plans. This over-response is due 
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to the fact that the diodes were not pre-irradiated and the dose rate in calibration 
conditions is several orders of magnitude different than in the patient-specific QA 
modality. Under these conditions, n-type silicon detectors usually shows high DPP 
dependence, particularly at very low DPP levels (73). This phenomenon caused the 
non-preirradiated diodes of the edgeless array to overestimate the planned dose.  
 
Figure 51: Dose Per Pulse dependence of edgeless array diodes 
 
Figure 51 shows the DPP dependence of edgeless array diodes with instantaneous dose 
rates ranging from 7.9 x 10-4 to 6.5 x 10-5 Gy/pulse. It can be observed that all diodes 
are significantly overresponse with a maximum variation at DPP of 2.97 x 10-4 to 5.64 
x 10-5Gy/pulse which is similar to the DPP range in which the edgeless array diodes 
were measuring the dose in this work. Data shown in Figure 51 have been used to 
calculate the correction factors to mitigate the overresponse of each individual diode 
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in each plan using the information provided by Accuray regarding  the frequency of 
pulsed beams (170 Hz) produced by a Cyberknife linac and their nominal dose rate 
(900 MU.Min-1). After the corresponding correction factors were applied to the diode 
responses, the discrepancies have been reduced as shown in Table 17 to Table 23 in 
the last column. The discrepancy from the TPS values is still significantly high with 
noticeable overresponse by most diodes, particularly the peripheral ones.  
This residual discrepancy is due to the fact that the “correction factors” have been 
applied to the integral dose accumulated by each diode during the full plan delivery 
which consists of many beamlets with different dose rates. The Cyberknife delivers 
the radiation in approximately 20,000 multiple beamlets for a complete plan. Because 
the beamlets are delivered from different directions and angles, they produce different 
dose rate in each diode for each beamlet. Each diode experiences a varying dose rate 
according to its location inside the PTV (e.g. central or peripheral locations experience 
different dose rates during the delivery of the plan).  
Figure 52shows the distribution of the dose for the central pixel and for a peripheral 
pixel for the same plan, as registered by the data acquisition system as a function of 
time. 
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(a) 
 
 
(b) 
Figure 52: a) response of the central diode “pixel” of the array as a function of time for a brain 
functional treatment (Plan 3); b) response for a peripheral diode to the same treatment plan. The 
instantaneous dose rate for the central pixel is fairly uniform and the correction for DPP 
dependence is effective for the central pixel, while for a peripheral pixel, it under-estimates the 
effect of DPP dependence because the variation of the dose rate during the treatment is wider. 
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The method of calculation of the correction factor based on the integral dose is not 
effective and it could be improved by calculating the DPP correction factor for the 
diode for each beamlet of each plan. However, this method will create high uncertainty 
in calculated correction factors and will possibly produce a high uncertainty on the 
final measured values which have to be compared with the TPS values. 
 
Figure 53: Dose per pulse of pre-irradiated (4 Mrad) and non-preirradiated n-type edgeless diodes. 
Inset graph is zoomed depiction of the DPP from 2 x 10-4 to 2.4 x 10-5Gy/pulse. 
 
Figure 53 shows a comparison of the DPP dependence of a pre-irradiated (4 MRad 
using a Co-60 gamma source) n-type edgeless diode reported in chapter 4 (see Figure 
24) and the non-preirradiated n-type edgeless diode (central pixel). It can be noticed 
that the DPP dependence of pre-irradiated and non-preirradiated diodes are very 
different. The accumulated dose of 4 MRad varies the sensitivity of the pre-irradiated 
diode within 5% over all the range of DPP except at very low DPP (2.4 x 10-5) where 
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the overresponse reached approximately 10%. On the other hand, the non-preirradiated 
diode shows very high sensitivity over the entire DPP range and the over-response 
varies between 31% and 66% for dose per pulse levels of 2 x 10 -4 and 2.4 x 10 -
5Gy/pulse. Therefore, the pre-irradiation of the diodes mitigates the overresponse, 
stabilising the sensitivity of the diodes from 65-70% overresponse to less than 10 % 
overresponse, even at the lowest dose rate achievable in stereotactic radiosurgery 
modalities.  
 
Table 17. Comparison of data obtained by TPS calculations and edgeless measurements on 
EasyCube phantom for plan 1. 
diode	#	 TPS	(Gy)	 CF	
edgeless	
(Gy)	
edgeless		(Gy)	
(corr.)	 %Diff	(corr.)	
1	 2.47	 1.34	 2.86	 2.13	 -13.96	
2	 4.45	 1.32	 5.48	 4.15	 -6.63	
3	 4.10	 1.72	 5.39	 3.14	 -23.47	
4	 4.11	 	 4.90	 4.90	 19.30	
5	 4.37	 1.57	 6.00	 3.83	 -12.30	
6	 4.25	 1.21	 2.37	 1.96	 -53.87	
7	 4.17	 	 9.01	 9.01	 116.17	
8	 4.12	 1.50	 13.34	 8.89	 115.79	
9	 4.06	 1.72	 1.94	 1.13	 -72.14	
 
Table 18. Comparison of data obtained by TPS calculations and edgeless measurements on 
EasyCube phantom for plan 2. 
diode	#	 TPS	(Gy)	 CF	
edgeless	
(Gy)	
edgeless		(Gy)	
(corr.)	 %Diff	(corr.)	
1	 16.28	 1.34	 18.75	 14.03	 -13.83	
2	 3.88	 1.32	 3.51	 2.65	 -31.70	
3	 19.16	 1.62	 23.31	 14.36	 -25.07	
4	 14.21	 	 13.10	 13.10	 -7.78	
5	 18.63	 1.53	 22.78	 14.87	 -20.21	
6	 18.64	 1.18	 20.29	 17.26	 -7.40	
7	 21.06	 	 19.45	 19.45	 -7.64	
8	 6.11	 1.29	 22.36	 17.33	 183.64	
9	 18.81	 1.66	 7.58	 4.55	 -75.79	
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Table 19. Comparison of data obtained by TPS calculations and edgeless measurements on 
EasyCube phantom for plan 3. 
diode	#	 TPS	(Gy)	 CF	
edgeless	
(Gy)	
edgeless		(Gy)	
(corr.)	 %Diff	(corr.)	
1	 8.97	 1.34	 10.74	 8.02	 -10.61	
2	 9.66	 1.31	 7.52	 5.74	 -40.63	
3	 21.25	 1.56	 25.87	 16.63	 -21.74	
4	 20.79	 	 22.21	 22.21	 6.85	
5	 22.86	 1.46	 30.57	 20.93	 -8.43	
6	 19.80	 1.17	 17.60	 15.06	 -23.95	
7	 18.80	 	 20.54	 20.54	 9.27	
8	 5.69	 1.50	 11.82	 5.91	 3.85	
9	 9.37	 1.70	 7.11	 4.18	 -55.36	
 
Table 20. Comparison of data obtained by TPS calculations and edgeless measurements on 
EasyCube phantom for plan 4. 
diode	#	 TPS	(Gy)	 CF	
edgeless	
(Gy)	
edgeless		(Gy)	
(corr.)	 %Diff	(corr.)	
1	 4.80	 1.32	 4.97	 3.77	 -21.53	
2	 5.26	 1.29	 4.78	 3.71	 -29.49	
3	 4.73	 1.61	 5.40	 3.36	 -28.98	
4	 4.87	 	 4.86	 4.86	 -0.31	
5	 4.81	 1.52	 5.42	 3.57	 -25.72	
6	 4.86	 1.17	 4.52	 3.85	 -20.70	
7	 4.87	 	 4.79	 4.79	 -1.61	
8	 5.10	 1.41	 5.55	 3.94	 -22.83	
9	 5.00	 1.65	 5.24	 3.18	 -36.30	
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Table 21. Comparison of data obtained by TPS calculations and edgeless measurements on 
EasyCube phantom for plan 5. 
diode	#	 TPS	(Gy)	 CF	
edgeless	
(Gy)	
edgeless		(Gy)	
(corr.)	 %Diff	(corr.)	
1	 6.12	 1.34	 5.83	 4.34	 -29.06	
2	 1.38	 1.33	 1.60	 1.21	 -12.55	
3	 17.04	 1.59	 21.54	 13.56	 -20.45	
4	 11.94	 	 5.70	 5.70	 -52.24	
5	 77.82	 1.11	 88.85	 79.84	 2.59	
6	 5.96	 1.20	 10.43	 8.66	 45.35	
7	 13.90	 	 8.65	 8.65	 -37.74	
8	 1.24	 1.53	 6.99	 4.57	 268.61	
9	 5.08	 1.72	 1.95	 1.14	 -77.58	
 
Table 22. Comparison of data obtained by TPS calculations and edgeless measurements on 
EasyCube phantom for plan 6. 
diode	#	 TPS	(Gy)	 CF	
edgeless	
(Gy)	
edgeless		(Gy)	
(corr.)	 %Diff	(corr.)	
1	 2.57	 1.34	 2.87	 2.14	 -16.87	
2	 1.58	 1.33	 1.99	 1.50	 -4.83	
3	 14.65	 1.59	 18.69	 11.72	 -20.00	
4	 14.55	 	 10.18	 10.18	 -30.07	
5	 76.99	 1.08	 93.91	 86.87	 12.83	
6	 9.18	 1.18	 8.73	 7.38	 -19.61	
7	 12.34	 	 10.09	 10.09	 -18.20	
8	 1.42	 1.51	 3.13	 1.53	 7.94	
9	 1.71	 1.73	 2.09	 1.21	 -29.19	
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Table 23. Comparison of data obtained by TPS calculations and edgeless measurements on Rando 
phantom for plan 6. 
diode	#	 TPS	(Gy)	 CF	
edgeless	
(Gy)	
edgeless		(Gy)	
(corr.)	 %Diff	(corr.)	
1	 12.4	 1.34	 0.90	 0.67	 -92.73	
2	 1.19	 1.33	 7.13	 5.37	 498.90	
3	 23.75	 1.59	 7.06	 4.42	 -70.29	
4	 4.35	 	 25.03	 25.03	 475.31	
5	 81.84	 1.08	 86.64	 80.14	 5.87	
6	 11.3	 1.18	 5.59	 4.73	 -50.54	
7	 12.34	 	 30.03	 30.03	 143.37	
8	 31.78	 1.51	 1.60	 1.06	 -94.97	
9	 11.03	 1.73	 12.23	 7.07	 10.90	
 
8.3 Conclusion 
The preliminary 2D array fabricated with nine preirradiated n-type edgeless diodes 
was evaluated on robotic non-coplanar SRS using Cyberknife. The results showed that 
edgeless diode array suffer from severe over-response due to high DPP dependence of 
its diodes if they were not being preirradiated. Thus, based upon the findings of this 
work, future work will focus on minimising the dose rate-dependence of the edgeless 
diodes by using a low resistivity substrate and a strong pre-irradiatiation of all the 
detector elements. 
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9 EVALUATION OF THE PTW MICRODIAMOND IN EDGE-ON 
ORIENTATION FOR SMALL FIELD DOSIMETRY 
 
9.1 Introduction 
According to the requirements of the IAEATRS-483 and the manufacturer’s 
instructions, the PTW microDiamond is recommended to be used in face-one 
orientation. However, as the sensitive volume of microDiamond is manufactured in a 
disk-shape with diameter of 2.2 mm (see Figure 54), the measurements from a 
microdiamond detector with face-on orientation suffer from low spatial resolution due 
to the volume-averaging effect. Therefore, implementing a microdiamond detector in 
an edge-on orientation would take advantage of the small thickness of the device 
(1µm) which will enhance the spatial resolution and reduce its angular dependence, 
particularly in small field dosimetry. In this study, the dosimetric performance of the 
PTW microDiamond in different orientations (face-on and edge-on) in the context of 
small field dosimetry were investigated. A PTW microDiamond detector was assessed 
primarily in term of output factor (OF), percentage depth dose (PDD) and beam 
profile. The angular dependence of the device and its stem effect were also 
investigated.  
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Figure 54: Left: face-on orientation for PTW microDiamond detector with an incident photon 
beamof field edge size 5 mm. Right: edge-on orientation. The scale model of the microDiamond 
detector has a centred rectangular representing the diamond size with a central disc (blue) 
representing 1 µmthick sensitive volume. 
 
9.2 Material and method 
9.2.1 Beam parameters measurement 
Beam parameters measurements (OF, PDD and beam profile) were performed on a 
TrueBeam linac (Varian Medical Systems, Palo Alto, CA) using 6 MV filtering filter 
(6XFF) and 6 MV flattening filter free (6XFFF) beams. All the measurement were 
performed using an IBA ’blue phantom2’ (Figure 55) at Source-to-surface distance 
(SSD) of 100 cm. 
 191 
 
 
Figure 55: Experimental set-up for beam parameters measurements on Varian True Beam with the 
PTW microdiamond detector in the IBA blue phantom2. 
 
The determination of the output factor was performed with Jaw-defined field sizes 
ranging from 0.5 cm to 10 cm at dmax. PDD were investigated in two different small 
field sizes (1 and 3 cm2) with depths ranging from 0 to 31 cm. Beam profiles of 0.5, 1 
and 3 cm2 field sizes were measured at 10 cm depth. The alignment of the detector 
along the central axis of the beam was obtained by performing beam profiling of a 0.5 
cm2 field size. The response of the PTW microDiamond was compared to the response 
of three different IBA ionization chambers (CC13, CC01 and Razor) and Razor diode. 
The main features of detectors are summarized in Table 24 
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Table 24. General characteristics of the detectors used in this work. 
Detector Type Material density Zeff Active volume 
Packaging/wall 
material 
IBA Razor 
IC 
Air-filled 
ionization 
chamber 
air 14 7.64 
1 mm Radius, 3.6 mm 
length, 0.01 mm3 
volume 
C552 
IBA Razor 
diode 
Unshielded 
n-type Silicon 2.33 14 
Cylindrical, 0.6 mm 
Diameter, 20 um 
length 
ABS plastic & 
epoxy resin 
PTW 
Diamond 
CVD 
Diamond Diamond 3.5 6 
0.001 mm length, 2.2 
mm diameter resin 
IBA CC01 
Air-filled 
ionization 
chamber 
air 14 7.64 
1 mm Radius, 3.6 mm 
length, 0.01 mm3 
volume 
Shonka C-552  
IBA CC13 
 
Air-filled 
ionization 
chamber 
air 14 7.64 
3 mm Radius, 5.8 mm 
length, 0.13 mm3 
volume 
C552 
 
9.2.2 Angular dependence 
The effect of detector orientation (edge-on and face-on) on the angular response of a 
PTW microDiamond detector in several small field sizes was investigated on a Varian 
Clinac IX (Varian Medical Systems, Palo Alto, CA). The measurements were 
performed using two different cylindrical PMMA phantoms (face-on and edge-on 
phantoms) of similar dimensions (30cm diameter and 10cm thickness). In order to 
place the microDiamond in the face-on position, the sensitive volume of the detector 
was inserted into the centre of face-on phantom (isocenter of the measurement) 
through the access hole from the side of the phantom (see Figure 56).  The top side of 
the detector was facing the linac head at a “270 degrees” orientation, which is 
considered the reference orientation for face-on measurement. For the edge-on 
measurement, the detector was placed into the centre of the edge-on phantom through 
an insert created in the face of the phantom (see Figure 56).  
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Figure 56: Experimental set-up for angular dependence measurements. Left: Face-onphantom and 
Right: Edge-on phantom. 
 
The response of the detector as function of angle was investigated by rotating the linac 
gantry around the phantom with angles ranging from 0o to 275o. Angular dependence 
measurements for both detector orientations were obtained with four different field 
sizes (0.5, 1, 2, 3 and 10 cm2) and at 100 cm source to detector distance (SDD) and 15 
cm depth. All the measurements were obtained when delivering of 100 MU produced 
by the 6XFF radiation beam at dose rate of 600 MU/Min. 
9.2.3 Stem effect 
Stem effect is a leakage current created when the stem of the chamber is irradiated. 
Stem effect can occur via two different mechanisms: stem scatter and stem leakage. 
The stem scatter is a result of interaction of scattered radiation with the chamber stem 
while the stem leakage is due to the direct irradiation of the chamber as well as the 
insulators and cables in the chamber (48). The IAEA TRS-483 CoP does not 
recommend using devices in an edge-on orientation for profile scanning because of an 
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increase in response due to the stem effect, but if an edge-on orientation has to be used, 
this effect should be corrected for. The stem effect was quantified for the 
microDiamond detector in edge-on orientation for both 6X and 6FFF. Rectangular 
field sizes of 1x10, 3x10 and 1x3 cm2 were used to measure the impact on the 
microDiamond output factor. The fields were defined with the collimator and centred 
on the sensitive volume of the microDiamond using stepper motor stages. A 
measurement was taken with the long field edge aligned parallel to the cable and then 
the collimator was rotated 90o to have the long edge perpendicular to the cable. The 
percentage difference in output factor was taken as a measure of the stem effect. The 
microDiamond was inserted at the centre of 30x30cm2solid water slabs at 10 cm depth 
with SSD 100cm. 
9.3 Results 
9.3.1 Percentage depth dose 
Figure 57 – 60 show percentage depth doses measured by a PTW microdiamond 
detector in face-on orientation (blue triangle), in edge-on orientation (red circle), IBA 
Razor diode (black square) and IBA Razor chamber (green triangle) at depths ranging 
from zero to 31 cm. The data were obtained in an IBA blue water phantom with two 
different beams (6XFF and 6XFFF) in two different square field sizes (1 x 1 and 3 x 3 
cm2). It can be noticed that the measurement of microDiamond in edge-on orientation 
in the build-up region show prominent over-response compared to the data obtained 
from face-on orientation and from the IBA razor diode and chamber. This discrepancy 
is due to that the microDiamond in edge-on orientation being placed in depths 
shallower than 3.5 mm, and part of sensitive volume was above the surface of the 
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water. The over-response can be mitigated by applying the appropriate depth 
correction factor.  
 
Figure 57: Percentage depth dose measurements of 1x1cm2 jaw-defined field performed in an IBA 
blue water phantom on a Varian TrueBeam. 6XFF (left) and 6XFFF (right). 
 
 
Figure 58: Zoomed depictions of the first 50mm of percentage depth dose measurementsas presented 
in Figure 57. 
 
Table 25. Dose measurements of dmax and D20/D5 ratio for a 1x1cm2square field. 
Detector Energy (MV) Dmax(mm) D20/D5 
IBA Razor Diode 6XFF 11.65 0.38 
IBA Razor Chamber 6XFF 11.5 0.39 
PTW microDiamond 
(edge-on) 6XFF 11.55 0.38 
PTW microDiamond 
(face-on) 6XFF 12.2 0.38 
IBA Razor Diode 6XFFF 12.6 0.34 
IBA Razor Chamber 6XFFF 10.45 0.36 
PTW microDiamond 
(edge-on) 6XFFF 10.9 0.35 
PTW microDiamond 
(face-on) 6XFFF 11.9 0.35 
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The good agreement between the results of the microDiamond in face-on orientation 
with the one of IBA Razor diodes and the ionization chamber in the buildup region 
indicate that there is not any significant perturbation effect produced by the detector 
and its packaging. It is worth noting that the volume-averaging effect can be seen in 
both orientations. In edge-on orientation, the response of the detector will be averaged 
across a large range of depths but this does not appear to be significant as the response 
agrees closely with the of razor and ionization chamber responses after depths of 5 and 
10 mm for field sizes of 1 and 3 cm2 field size respectively. In face-on orientation, the 
averaging occurs across the beam but it is less critical as the field diverges at deeper 
depths. The depth of dmax and the dose ratio at depths of 20 and 5 cm (D20/D5) for 
square field sizes of 1 and 3 cm2 are reported in Table 25and Table 26 respectively. 
The value of dmax measured by all four detectors varied within 2.2 mm. The dmax 
measured by microDiamond in edge-on orientation is the closest value to the one 
measured by the razor chamber. The D20/D5 value remains consistent for both field 
sizes and beams (6XFF and 6XFFF) with noticeable decrease in the dose ratio of 
6XFFF. The lower dose ratio values of the 6XFFF beam due to the hardening and 
attenuation with increased depth will have greater effect on the dose in the unfiltered 
spectrum. 
 
Figure 59: Percentage depth dose measurements of 3x3cm2 jaw-defined field performed in an IBA 
blue water phantom on a Varian TrueBeamlinac. 
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Figure 60: Zoomed depiction of the first 50mm of the percentage depth dose measurementsas 
presented in Fig. 59. 
 
Table 26: Dose measurements of dmax and D20/D5 ratio for a 3x3cm2square field. 
Detector beam Dmax (mm) D20/D5 
IBA Razor Diode 6XFF 13.5 0.39 
IBA Razor Chamber 6XFF 15.4 0.4 
PTW microDiamond (edge-on) 6XFF 15.5 0.38 
PTW microDiamond (face-on) 6XFF 15.2 0.37 
IBA Razor Diode 6XFFF 12.9 0.35 
IBA Razor Chamber 6XFFF 13.2 0.37 
PTW microDiamond (edge-on) 6XFFF 12.4 0.36 
PTW microDiamond (face-on) 6XFFF 13.9 0.36 
 
9.3.2 Beam profile 
The beam profiles of jaw-defined field sizes of 0.5 x 0.5, 1x1 and 3x3 cm2 are shown 
in Figure 61. The measurements were performed with both 6XFF and 6XFFF beams 
at 10 cm depth and 100 cm SSD. The edge-on orientation data was compared with data 
acquired with face-on orientation and Razor diode. Table 27 demonstrates the full 
width half maximum (FWHM) and average penumbra widths of the measured in-plane 
and cross-plane profiles. It can be notice that the FWHM and penumbra width 
measured in edge-on orientation is smaller than those measured by face-on orientation 
and Razor diode with maximum difference in order of 4.5% and 8.5% respectively. 
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However, the difference decreases with increasing field size until it become 
approximately 1%. This result proves that using of the microdiamond with the edge-
on orientation beam profile measurement will increase the spatial resolution which in 
turn will reduce the volume-averaging effect and improve the accuracy of the 
measurement. 
 
Figure 61: Cross-plane profile measurements of 0.5x0.5, 1x1 and 3x3 cm2 jaw-defined fields, 
performed at 100mm depth in an IBA blue water phantom on a Varian TrueBeam withPTW 
microDiamond in edge-on and face-on orientations and Razor Diode for 6FFX (left) and6XFFF 
(right). 
 
Table 27: FWHM (mm) and penumbra width (mm) measured from the inplane and crossplane profile 
scans of a 0.5x0.5, 1x1 and 3x3cm2 jaw defined field measured at a depthof 10 cm. Values are 
reported to two decimal places. 
Field	size	
(cm2)	
	 	 FWHM	(mm)	 average	penumbra	(mm)	
Detector	 Beam	 Inplane	 Crossplane	 Inplane	 Crossplane	
0.5	
µD	(edge)	 6XFF	 5.37	 5.2	 2.25	 2.42	
µD	(face)	 6XFF	 5.5	 5.44	 2.42	 2.58	
µD	(edge)	 6XFFF	 28	 5.21	 2.21	 2.42	
µD	(face)	 6XFFF	 5.34	 5.36	 2.34	 2.64	
1	
Razor	diode	 6XFF	 10.46	 10.21	 2.8	 3.07	
µD	(edge)	 6XFF	 10.4	 10.16	 2.86	 3.03	
µD	(face)	 6XFF	 10.48	 10.19	 3.05	 3.28	
Razor	diode	 6XFFF	 10.4	 10.15	 2.63	 2.99	
µD	(edge)	 6XFFF	 10.32	 9.94	 2.77	 3.13	
µD	(face)	 6XFFF	 10.43	 10.21	 2.95	 3.26	
3	
Razor	diode	 6XFF	 32.7	 32.09	 3.53	 3.87	
µD	(edge)	 6XFF	 32.61	 31.95	 3.4	 3.67	
µD	(face)	 6XFF	 32.57	 31.97	 3.64	 3.94	
Razor	diode	 6XFFF	 32.62	 31.92	 3.41	 3.99	
µD	(edge)	 6XFFF	 32.56	 31.89	 3.32	 3.69	
µD	(face)	 6XFFF	 32.54	 31.86	 3.53	 4.04	
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9.3.3 Output factor 
The Jaw-defined output factor measured by edge-on orientation for 6XFF and 6XFFF 
beams are depicted in Figure 62 and Figure 63. The measurements were obtained for 
field sizes ranging from 0.5 to 10 cm and compared with those obtained in face-on 
orientation and with one performed by Razor diode and ionization chamber. The OF 
was acquired by normalizing data from each field size to the one measured at reference 
field size (10 x 10 cm2) and presented without applying any other correction factors to 
the detector’s response. It can be observed that both orientations of microDiamond 
agree within 1% down to the 2x2 cm2 field size for both beams (6XFF and 6XFFF). 
At smaller field sizes (1-0.5 cm), the microDiamond in the edge-on orientation shows 
higher response ratio compared to the response in face-on orientation, creating a large 
percentage difference which increases when decreasing the field size until reaching 
approximately 6.8% at a field size of 0.5 cm. A good agreement (within 1%) can be 
also observed in large field sizes (10-2 cm2) between the response of the 
microDiamond and razor chamber in both orientations. However,  at smaller field size 
(1 x 1 cm2), the percentage difference between edge-on orientation and  Razor chamber 
(~4.1%) , for both 6XFF and 6XFFF beams, is larger than the difference between the 
response in face-on orientation and Razor chamber (~2.8%). The variation in the 
relative response ratio between both orientations compared to the Razor chamber is 
because the microdiamond detector, in both orientations, overestimates the dose in 
small fields due to the density and charge imbalance effects. However, in face-on 
orientation the area that is exposed to the radiation is a large (≈ 2.2 mm), compared to 
one in edge-on orientation ( ≈ 1um),  which will introduce an averaging effect which 
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will in turn reduce the response of the detector (in face-on orientation) and mitigate 
the effects of density perturbation. 
 
Figure 62: OF measurements of jaw defined field performed in IBA blue water phantom on Varian 
TrueBeam with PTW microDiamond face-on (Black square), PTW microDiamond edge-on (Red 
dot), Razor diode (Blue triangle), Razor chamber (pink triangle), CC01 ionisation chamber (green 
diamond) and CC13 ionization chamber (dark blue triangle). OF measurements are presented for 
6XFF (left) and 6XFFF (right). 
 
 
Figure 63: Percentage difference of OF for the PTW microDiamond in face-on (black 
square), edge-on (red circle), Razor diode (blue triangle), CC01 (pink triangle) and CC13 
(green diamond) as compared to the IBA Razor chamber for 6XFF (left) and 6XFFF (right). 
 
9.3.4 Angular dependence 
The angular response of the microDiamond in face-on and edge-on orientations at 0.5, 
1, 3 and 10 cm2 field sizes is shown in Figure 64 and Figure 65. The relative response 
was obtained by normalizing the response at a given angle to the response at the 
reference angle. The angle is considered to be zero when the gantry head is vertically 
positioned above the treatment couch. In the edge-on measurement, the angles were 
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defined in the plane perpendicular to the long axis of the detector and 0o was used as 
the normalization orientation. On the other hand, with the face-on setup, the angles 
were made at the plane lies horizontally to the long axis of the detector and the 
reference angle was chosen to be 270o gantry angle as at this angle the top side of the 
detector is facing the radiation source. Moreover, in the face-on setup the 
microDiamond is in an edge-on orientation at “0o” gantry angle. Seventeen angle points 
were investigated which ranging from 0-120o and 360-240o. As the angle is realized 
by gantry rotation, the angle range between 120o and 240o was not investigated to 
prevent the effect of the couch attenuation on the response of the detector that might 
occur in this angle range. The largest deviation (up to ≈31%) for all field sizes was 
within ± of 90o which might be due to the stem effect. The microDiamond is in edge-
on orientation for all gantry angles in the edge-on phantom (see Figure 65) where no 
significant angular dependence is observed through the entire 240o range. The 
variation in the response for face on-orientation is reported in Table 28 with the data 
between 70o and 120o excluded to exclude the region where the Stem effect is 
prevalent.  
 
Table 28.Face-on angular dependence of microdiamond detector for 6X square field ofa 
VarianClinac IX. Angles include range from 240o_to 60o_normalised to the 0o_measurement. 
		 0.5	cm2	 1	cm2	 2	cm2	 3	cm2	 10	cm2	
Maximum	response	 1.21	 1.16	 1.15	 1.14	 1.1	
minimum	response	 0.99	 0.98	 0.98	 0.98	 0.98	
Range	 0.22	 0.18	 0.17	 0.16	 0.12	
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The angular dependence of the microDiamond in face-on orientation still has a 
significant angular dependence with the range of response as large as 12% even for the 
10x10 cm2field size. In face-on orientation the microDiamond is therefore highly 
angular dependent and would be inappropriate for use in any non-static QA. For edge-
on orientation, the range in angular response through 240o (reported in Table 29) shows 
only a 2% variation for the 2x2cm2 and 3x3cm2 field sizes. This increases up to 28% 
for a 0.6x0.6 cm2 field size. The main advantage of using the microDiamond in edge-
on orientation is therefore the almost angular-independent response even down to 
small field of 2x2cm2. In Figure 64, it is observed that smallest deviation in angular 
response is around the 0o position where the orientation has transitioned to edge-on. In 
edge-on orientation, the microDiamond is therefore also insensitive to detector tilt. 
 
Table 29: Variation of response in the edge-on phantom for ± 120oaround 0o. The PTW 
microDiamond is continuously in edge-on orientation for all gantry angles in a 6XFF square _field 
ofa Varian Clinac IX. 
0o	±	120o	 0.6	cm2	 1	cm2	 2	cm2	 3	cm2	
Maximum	response	 1.01	 1.03	 1.01	 1	
minimum	response	 0.72	 0.94	 0.99	 0.98	
Range	 0.28	 0.08	 0.02	 0.02	
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Figure 64: Angular dependence measurements as a function of gantry angle for 0.5x0.5 to 
10x10cm2Jaw-defined field performed with PTW microDiamond detector in Face-on phantom (left) 
and diagram of microDiamond orientation in relation to beam direction in Face-on phantom (right). 
 
 
 
Figure 65: Angular dependence measurements as a function of gantry angle for 0.6x0.6 to 
3x3cm2Jaw-defined field performed with PTW microDiamond detector in Edge-on phantom (left) 
and diagram of microDiamond sensitive volume relative to beam direction in Edge-on phantom 
(right). 
 
9.3.5 Stem effect 
The values of the stem effect for the microDiamond detector are presented in Table 30 
with the largest observed stem effect of 1% for the 1x3 cm2 field size. By the 3x10 
cm2 field size, the stem effect in the beam is negligible, showing as a less than 0.2% 
increase in OF when the beam runs parallel to the cable. The close agreement of the 
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stem effect between the 1x10 cm2 and the 1x3 cm2 suggests that the increased signal 
is primarily coming from interactions around the electrodes of the microDiamond and 
not the cable. 
 
Table 30: Percentage increase in output factor for a range of rectangular fields positioned along the 
cable of the microDiamond detector relative to when positioned perpendicular to the cable. 
		 Stem	effect	(%)	
Field	size	(cm2)	 6XFF	 6XFFF	
1	x	10	 0.83	 0.93	
3	x	10	 0.19	 0.17	
1	x	3	 0.8	 1	
 
9.4 Discussion 
It is evident the microDiamond detector in edge-on orientation is not always 
appropriate for smallfield dosimetry. Nevertheless it provides a distinct advantage for 
particular measurements. The microDiamond is suitable for PDD measurements only 
after the build-up region in edge-on orientation, however typical QA practices are not 
performed within the build-up region. When performing profile measurements, 
particularly at small field sizes, the edge-on orientation allows the high spatial 
resolution of the detector to be utilized, providing improved FWHM and yielding 
penumbra data for small fields. While this measurement setup is not recommended by 
the IAEA TRS-483 CoP due to the influence of stem effect, this work has shown that 
this effect results in less than 1% increase in measured response. The main advantage 
of the adoption of an edge-on orientation is an angular-independent response for field 
sizes of 2x2 cm2 or greater. Therefore only in edge-on mode would the microDiamond 
detector be appropriate for full arc QA using coplanar deliveries. It is observed that 
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the OF measurements of the microDiamond over-respond at small field sizes for both 
orientations. The volume-averaging effect will be more prominent in face-on 
orientation which reduces the response, countering the over-response produced by 
densityperturbation and radiation-induced charge imbalance effects. These two over 
responding effects will be orientation-dependent, as is the volume averaging. 
Empirical and simulation-based correction factors for the microDiamond OF in face-
on orientation have been created, but future work will be required to quantitatively 
determine separate corrections for each of thesethree effects based on the orientation 
of the device. 
9.5 Conclusions 
Despite the IAEA TRS-483 CoP requirements that the PTW microDiamond be used 
in face-on orientation, this study has shown there are benefits to using the 
microDiamond in an edge-on orientation. The microDiamond in an edge-on 
orientation has an angular-independent response down to a 2x2 cm2 with a maximum 
deviation in angular response of 2%. For an edge-on microDiamond in a 0.5x0.5 
cm2field, on average the FWHM and penumbra were measured between 1.1-4.4 % and 
5.6-8.3 % narrower respectively, compared to the recommended face-on orientation. 
The stem effect introduced when using the detector in edge-on orientation only 
produced a 1%increase in response. Both orientations require correction factors when 
taking measurements in field sizes less than 2x2 cm2 due to an observed over-response. 
Correction factors have been studied for the face-on orientation but not for edge-on 
and will be the focus of future work. 
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10 CONCLUSIONS AND FUTURE WORK 
This thesis focuses on developing and characterizing single and 2D array angular-
independent edgeless silicon detectors in terms of operational and dosimetric 
performance in different irradiation and clinical situations. It, also comprises original 
work on dosimetric evaluation of a commercial CVD diamond detector (PTW 
microDiamond) in different orientations (face-on and edge-on) within the context of 
small field dosimetry and its evaluation as reference dosimeter in respect to the TRS 
483. This chapter summarises the main outcomes of this thesis regarding using the 
edgeless and PTW microDiamond detectors. Further, this chapter presents future 
potential work for the 2D edgeless array detector. 
10.1 Geometrical and dosimetric characterization of the edgeless diode 
The edgeless detector is a silicon-based detector which was fabricated using a lateral 
implantation technique instead of a standard planar semiconductor fabrication 
processes. The lateral implantation produces a 3D p-n junction (or ohmic contact) 
surrounding the die that leads to full charge collection. The edgeless single diodes were 
manufactured using both n-type and p-type silicon substrates with 0.5 mm and 0.1 mm 
thicknesses and the top junction being p+-n and the lateral junction n+-n  or vice versa. 
The diodes have area dimensions of 1 x 1 and 0.5 x 0.5 mm3and were packaged using 
the “drop-in” proprietary technology developed at CMRP. The packaging is water tight 
and allows for measurements in a water phantom. The edgeless diodes were readout 
by a custom designed acquisition system based on a commercially-available TERA 
multichannel electrometer (Tera Foundation, Turin, Italy). 
In the chapter 3, the edgeless diodes were characterized in terms of current-voltage 
(IV), capacitance-voltage (CV) and charge collection efficiency. A model of the 
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edgeless device was developed to simulate the distribution of the electric field for 
different geometries using TCAD. IV and CV characteristics of the diodes indicated 
appropriate operational conditions and provided a means to assess the 
consistency/quality of the edgeless diode technology. TCAD model showed a good 
agreement with experimental results, demonstrating the accuracy of the model in 
simulating the behaviour of the edgeless diodes. IBIC measurements performed on the 
PP and NP edgeless devices showed that the devices exhibit good CCE, indicative of 
the quality of the manufacturing process and the edgeless device structure. 
In the chapter 4, the angular response, basic dosimetric characterization (linearity, dose 
rate, PDD, dose per pulse and output factor) and radiation hardness of edgeless diode 
were evaluated. The PDDs measured by the edgeless detectors showed an agreement 
with the data obtained using ion chambers within ±2%. The output factor obtained 
with the edgeless diodes of smallest sensitive volume (0.5 ×0.5 mm2,0.1 and 0.5 mm 
thick) matches EBT3 film response to within 2% for field size ranging from 10 to 0.5 
cm. Dose rate-dependence of p-type and n-type edgeless diodes in a dose per pulse 
range of 0.9 ×10−5–2.7 ×10−4 Gy/pulse was less than −7% and +10%, respectively, 
showing that pre-irradiated devices are almost completely dose rate-independent. The 
importance of pre-irradiation in mitigating the dose rate-dependence of silicon diodes 
is also proved in chapter 8 where an array of n-type edgeless diodes was tested by 
using patient-specific plans delivered by a Cyberknife. The p-type edgeless diodes 
exhibited response variations as a function of irradiation within 5%–15%, whilst n-
type diodes show a degradation of about 30% after 40 kGy. The angular dependence 
of all edgeless diodes was small (within 2%) but the N on N and P on P configurations 
show the best performances with variation of angular response within ±1.0% between 
0◦ and 180◦ in the transverse direction. In this configuration, the space charge region 
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of the passive diode extends from the bottom junction and sidewall junction toward 
the anode on the top, providing beneficial electric field distribution in the peripheral 
area of the diode. Such performance has also been tested after irradiation by Co-60 up 
to 40 kGy with no measurable change in angular response. 
10.2 Clinical implementation of edgeless diodes in Robotic Stereotactic 
Radiosurgery 
The application of edgeless diodes in a robotic SRS Cyberknife with patient-specific 
QA was described in chapter 5. Edgeless diodes were evaluated in terms of basic 
quality assurance parameters such as tissue-phantom ratio (TPR), output factor, off 
axis ratio (OAR) and beam profiling. In addition, three absolute dose measurements 
were performed using four different patient-specific plans. The TPR performed by the 
edgeless diodes showed agreement within 2.2% with data obtained with PTW 60016 
diode for all the field sizes. Output factors of the edgeless diodes agrees within 2.6% 
with those measured by SN EDGE diodes corrected for their field size dependence. 
The beam profile measurements of edgeless diodes match SN EDGE diodes with a 
measured full width half maximum (FWHM) within 2.3% and penumbra widths 
within 0.148 mm. Patient-specific QA results demonstrated an agreement within 
4.72% in comparison with TPS. The promising results of edgeless diodes proved that 
they are an excellent candidate for machine and patient QA in the Cyberknife system, 
reproducing commercial dosimetry device measurements without need for angular 
dependence corrections. However, further investigation is required to evaluate the 
effect of their dose rate-dependence on complex brain cancer dose verification.  
The potential of edgeless detector was also evaluated in chapter 6for QA of very high 
dose SRS treatment. The evaluation was performed by delivering several functional 
neurological disorder plans on Cyberknife using the anthropomorphic phantom 
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RANDO. A CC01 ionization chamber was used for baseline measurements to compare 
with those performed by the edgeless diodes and calculated by the treatment planning 
system. The measurement of patient plans delivered to the EasyCube phantom 
equipped with a CC01 ionisation chamber showed a discrepancy, in respect to the 
calculation of the TPS, from -6.7% to -11.8% while the edgeless detectors measured a 
dose discrepancy of approximately 3.6% from the mean value calculated by the TPS. 
Larger discrepancies are obtained in very steep gradient dose regions when the sensors 
are placed outside the PTV and in proximity to the brainstem. 
10.3 Evaluation of edgeless diode in reference and relative dosimetry of small 
radiation fields 
Chapter 7aimed at describing the determination of the field output factor and beam 
quality index (TPR20,10) in small fields, using edgeless detectors and other commercial 
detectors on various commercial linear accelerators under the measurement conditions 
recommended by the international Code of practice TRS-483 for small static fields.  It 
has been found in general for all linacs, that edgeless diodes, in contrast to the other 
solid-state detectors, show small overresponse of approximately 3%. The CC01 
ionization chamber suffers from underestimation of 16.8% in 0.5 cm field size. The 
edgeless detectors and the other solid-state detectors were able to replicate the 
measurement of TPR20,10 obtained by a reference ionization chamber (CC01) with an 
accuracy of 1%. Even though all investigated analytical expressions predicted the 
TPR20,10 (10) from different field sizes with good accuracy, the Palman’s expression 
results show the closet agreement to the experimental TPR20, 10 (10) values. 
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10.4 Dosimetric evaluation of preliminary 2D edgeless array in non-coplanar 
SRS treatments. 
The developing of 2D edgeless array detectors and their dosimetric evaluation on 
Robotic SRS modalities (e.g. Cyberknife) using several real clinical plans has been 
described in chapter8. It was shown that as the array elements are made from n-type 
diodes, they suffer from severe over-response due to high DPP dependence which can 
be mitigated by preirradiating the array diodes to a suitable amount of accumulated 
dose which will be performed in future work. 
10.5 Evaluation of the PTW microdiamond detector in edge-on orientation for 
small field dosimetry. 
In chapter 9, The PTW microDiamond in both orientations (face-on and edge-on) was 
evaluated for use in small field dosimetry. Output factor (OF), percentage depth dose 
(PDD) and beam profile measurements down to a 0.5 cm2field size using6 MV beams 
(FF and FFF) were investigated. An extensive angular-dependence study for the two 
orientations was also undertaken, along with a quantification of the stem effect. The 
OF of the PTW microDiamond in both orientations agrees within 1% down to the 2 
cm2field size for both beams (FF and FFF). The edge-on orientation over-responds in 
the build-up region making it less appropriate for PDD measurements but provides 
improved FWHM and penumbra data for the smallest field size of 0.5 cm2, with a 
maximum stem effect of 1%. The angular dependence in edge-on mode has angular-
independent response with a maximum of 2% variation down to a 2 cm2 field. The 
PTW microDiamond in edge-on orientation for TPR measurements agrees with the 
CC01 ionization chamber within 1% for all field sizes.
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APPENDIX A 
 
Table 31: Comparison of the TPR20,10  (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  and 
linear fi t  expressions based on experimental data obtained by edgeless diode on Clinac IX 
linac. 
Fiel
d 
size 
(cm) 
measured 
TPR20,10 
(10) 
Palman 
TPR20,10 
(10) 
Sauer 
TPR20,10(10) 
lin fit 
TPR20,10(10)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s
) 
%diff 
(lin 
fit’s) 
0.5 
 
0.669 0.678  -0.42 -1.72  
1 0.658 0.666 
0.671 
1.27 0.1 
-0.64 
1.5 0.662 0.669 0.61 -0.37 
2 0.665 0.671 0.15 -0.65 
3 0.663 0.666 0.5 0 
4 0.661 0.663 0.74 0.51 
5 0.659 0.659 1.09 1.1 
6 0.666 0.665  0.11 0.28  
8 0.666 0.663  0.1 0.53  
10 0.666 0.666 0.663   0 0.5   
 
Table 32: Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  expressions based on experimental data obtained by microdiamond detectoron 
Clinac IX linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.644 0.654  2.44 0.99  
1 0.662 0.67 
0.659 
-0.25 -1.42 
0.17 
1.5 0.666 0.672 -0.85 -1.83 
2 0.666 0.671 -0.85 -1.66 
3 0.663 0.667 -0.47 -0.97 
4 0.662 0.663 -0.19 -0.43 
5 0.662 0.662 -0.26 -0.26 
6 0.662 0.66  -0.2 -0.01  
8 0.661 0.658  -0.14 0.32  
10 0.66 0.66 0.657   0 0.57   
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Table 33: Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  expressions based on experimental data obtained by Razor diode on Clinac IX 
linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.653 0.663  1.56 0.17  
1 0.664 0.671 
0.663 
0.01 -1.14 
0.16 
1.5 0.667 0.673 -0.43 -1.4 
2 0.666 0.671 -0.34 -1.15 
3 0.665 0.668 -0.13 -0.63 
4 0.665 0.666 -0.16 -0.4 
5 0.664 0.664 0.01 0 
6 0.664 0.663  -0.08 0.1  
8 0.664 0.661  0.02 0.47  
10 0.664 0.664 0.66   0 0.53   
 
Table 34: Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  expressions based on experimental  data obtained by CC01 ionization chamber on 
Clinac IX linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.64 0.65  3.1 1.63  
1 0.662 0.67 
0.658 
-0.2 -1.37 
0.43 
1.5 0.664 0.671 -0.5 -1.48 
2 0.664 0.669 -0.47 -1.29 
3 0.664 0.667 -0.42 -0.93 
4 0.662 0.663 -0.13 -0.36 
5 0.661 0.661 -0.01 0 
6 0.661 0.66  -0.02 0.18  
8 0.661 0.658  -0.06 0.4  
10 0.661 0.661 0.657   0 0.56   
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Table 35: Comparison of the TPR20,10 (10) of 10 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  expressions based on experimental data obtained by edgeless diode on Clinac IX 
linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.77 0.761  -4.08 -1.58  
1 0.735 0.727 
0.738 
0.64 0.92 
0.24 
1.5 0.733 0.738 0.93 0.14 
2 0.733 0.738 0.88 0.16 
3 0.734 0.738 0.75 0.18 
4 0.735 0.738 0.61 0.17 
5 0.736 0.737 0.52 0.18 
6 0.736 0.737  0.52 0.21  
8 0.739 0.739  0.15 0.03  
10 0.74 0.74 0.741   0 -0.1   
 
Table 36: Comparison of the TPR20,10 (10) of 10 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  expressions based on experimental data obtained by microdiamond on Clinac IX 
linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.734 0.74  0.04 -0.83  
1 0.729 0.735 
0.74 
0.7 -0.09 
-0.73 
1.5 0.731 0.736 0.4 -0.28 
2 0.733 0.738 0.12 -0.47 
3 0.733 0.737 0.11 -0.32 
4 0.732 0.734 0.27 -0.03 
5 0.734 0.735 0.09 -0.11 
6 0.734 0.735  0.03 -0.09  
8 0.734 0.734  0.06 -0.01  
10 0.734 0.734 0.735   0 -0.13   
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Table 37: Comparison of the TPR20,10 (10) of 10 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  expressions based on experimental data obtained by Razor diode on Clinac IX 
linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.716 0.723  2.58 1.63  
1 0.724 0.73 
0.743 
1.51 0.7 
-0.98 
1.5 0.73 0.735 0.73 0.04 
2 0.732 0.736 0.46 -0.13 
3 0.732 0.736 0.4 -0.03 
4 0.733 0.735 0.36 0.06 
5 0.732 0.733 0.47 0.27 
6 0.733 0.734  0.34 0.22  
8 0.734 0.734  0.19 0.13  
10 0.735 0.735 0.736   0 -0.14   
 
Table38: Comparison of the TPR20,10 (10) of 10 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  expressions based on experimental data obtained by CC01 ionization chamber on 
Clinac IX linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
  
0.68 0.688  7.65 6.52  
1 0.719 0.725 
0.751 
2.4 1.57 
-1.96 
1.5 0.728 0.733 1.16 0.46 
2 0.733 0.737 0.47 -0.12 
3 0.733 0.736 0.49 0.06 
4 0.732 0.734 0.55 0.25 
5 0.733 0.734 0.42 0.23 
6 0.734 0.735  0.3 0.18  
8 0.735 0.736  0.16 0.09  
10 0.736 0.736 0.737   0 -0.14   
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Table 39: Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by edgeless diode on 
TrueBeam linac. 
Field 
size 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.644 0.653  3.71 2.27  
1 0.669 0.676 
0.6802 
0.02 -1.11 
-1.73 
1.5 0.668 0.675 0.06 -0.9 
2 0.668 0.674 0.07 -0.73 
3 0.666 0.67 0.35 -0.16 
4 0.664 0.666 0.71 0.47 
5     
6       
8       
10 0.669 0.669 0.665   0 0.48   
 
Table 40: Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by microDiamond 
detector on TrueBeam linac. 
Field 
size 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.657 0.666  0.93 -0.45  
1 0.665 0.673 
0.6659 
-0.37 -1.52 
-0.45 
1.5 0.667 0.674 -0.69 -1.66 
2 0.667 0.672 -0.56 -1.36 
3 0.665 0.668 -0.31 -0.82 
4 0.664 0.666 -0.17 -0.41 
5 0.662 0.662 0.08 0.08 
6 0.66 0.659  0.4 0.61  
8 0.661 0.658  0.34 0.81  
10 0.663 0.663 0.659   0 0.54   
 
 
 
 
 
 216 
 
Table 41: Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by Razordiode on 
TrueBeam linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.656 0.665  1.1 -0.28  
1 0.665 0.673 
0.668 
-0.31 -1.46 
-0.45 
1.5 0.668 0.674 -0.69 -1.66 
2 0.668 0.673 -0.69 -1.49 
3 0.666 0.669 -0.35 -0.86 
4 0.664 0.665 -0.06 -0.29 
5 0.663 0.663 0.06 0.06 
6 0.663 0.662  0.01 0.2  
8 0.663 0.66  0.12 0.58  
10 0.663 0.663 0.66   0 0.53   
 
Table 42: Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by CC01 ion 
chamber on TrueBeam linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.636 0.646  3.85 2.36  
1 0.668 0.675 
0.657 
-0.93 -2.07 
0.71 
1.5 0.663 0.67 -0.28 -1.26 
2 0.664 0.669 -0.35 -1.17 
3 0.663 0.667 -0.25 -0.76 
4 0.662 0.663 -0.02 -0.25 
5 0.661 0.661 0.06 0.07 
6 0.661 0.659  0.15 0.35  
8 0.66 0.657  0.23 0.71  
10 0.662 0.662 0.658   0 0.55   
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Table 43: Comparison of the TPR20,10 (10) of 10 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by edgeless diode on 
TrueBeam linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
      
0.5 
 
0.706 0.714 
0.757 
4.26 3.26  
1 0.736 0.742 0.17 -0.59 
-1.89 
1.5 0.729 0.734 1.17 0.48 
2 0.73 0.735 1.01 0.41 
3 0.731 0.734 0.89 0.46 
4 0.737 0.739 0.1 -0.2  
5       
6       
8       
10 0.738 0.738 0.739   0 -0.16   
 
Table 44: Comparison of the TPR20,10 (10) of 10 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by microdiamond 
detector on TrueBeam linac. 
Field 
size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(10
) 
Sauer 
TPR20,10(10
) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s
) 
%diff 
(lin 
fit’s) 
0.5 
 
0.714 0.721  2.73 1.77  
1 0.726 0.732 
0.742 
1.06 0.26 
-0.73 
1.5 0.73 0.735 0.62 -0.07 
2 0.731 0.735 0.44 -0.15 
3 0.732 0.735 0.31 -0.13 
4 0.732 0.735 0.26 -0.04 
5 0.733 0.735 0.15 -0.04 
6 0.735 0.736  -0.07 -0.19  
8 0.734 0.734  0.07 0  
10 0.735 0.734 0.736   0 -0.19   
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Table 45: Comparison of the TPR20,10 (10) of 10 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by Razor diode on 
TrueBeam linac. 
Field size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’
s) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.724 0.731  1.92 1.01  
1 0.732 0.738 
0.74 
0.78 0.01 
-0.16 
1.5 0.734 0.739 0.58 -0.09 
2 0.735 0.74 0.38 -0.2 
3 0.735 0.738 0.41 -0.01 
4 0.737 0.739 0.24 -0.06 
5 0.735 0.737 0.4 0.2 
6 0.735 0.736  0.41 0.28  
8 0.737 0.737  0.21 0.13  
10 0.738 0.738 0.739   0 -0.16   
 
Table 46: Comparison of the TPR20,10 (10) of 10 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by CC01 ion 
chamber on TrueBeam linac. 
Field size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.706 0.714  4.04 3.03  
1 0.735 0.741 
0.739 
0.1 -0.67 
-0.36 
1.5 0.728 0.734 1.02 0.33 
2 0.731 0.735 0.69 0.1 
3 0.733 0.737 0.34 -0.09 
4 0.735 0.737 0.17 -0.13 
5 0.734 0.736 0.25 0.05 
6 0.734 0.735  0.21 0.08  
8 0.735 0.736  0.1 0.03  
10 0.736 0.736 0.737   0 -0.14   
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Table 47: Comparison of the TPR20,10 (10) of 10 MV (FFF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by edgeless diode on 
TrueBeam linac. 
Field size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’
s) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.663 0.672  6.1 4.84  
1 0.704 0.711 
0.696 
0.31 -0.61 
1.05 
1.5 0.701 0.707 0.68 -0.13 
2 0.71 0.714 -0.48 -1.15 
3 0.71 0.713 -0.5 -0.95 
4 0.702 0.704 0.59 0.32 
5     
6       
8       
10 0.706 0.718 0.705   -1.65 0.12   
 
Table 48: Comparison of the TPR20,10 (10) of 10 MV (FFF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by microdiamond 
detector on TrueBeam linac. 
Field 
size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(10
) 
Sauer 
TPR20,10(10
) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s
) 
%diff 
(lin 
fit’s) 
0.5 
 
0.687 0.695  1.85 0.7  
1 0.697 0.704 
0.7101 
0.37 -0.59 
-1.02 
1.5 0.704 0.71 -0.61 -1.41 
2 0.706 0.71 -0.82 -1.49 
3 0.706 0.709 -0.87 -1.34 
4 0.705 0.707 -0.7 -0.98 
5 0.703 0.704 -0.44 -0.56 
6 0.704 0.704  -0.6 -0.6  
8 0.703 0.702  -0.46 -0.31  
10 0.7 0.7 0.699   0 0.18   
 
 
 
 
 
 220 
 
Table 49: Comparison of the TPR20,10 (10) of 10 MV (FFF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by Razor diode on 
TrueBeam linac. 
Field size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’
s) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.689 0.697  1.72 0.58  
1 0.703 0.709 
0.7318 
-0.3 -1.23 
-3.11 
1.5 0.706 0.712 -0.8 -1.6 
2 0.707 0.711 -0.85 -1.53 
3 0.707 0.71 -0.92 -1.38 
4 0.705 0.706 -0.54 -0.82 
5 0.705 0.705 -0.54 -0.66 
6 0.704 0.704  -0.51 -0.51  
8 0.703 0.702  -0.32 -0.17  
10 0.701 0.701 0.7   0 0.17   
 
Table 50: Comparison of the TPR20,10 (10) of 10 MV (FFF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by CC01 ion 
chamber on TrueBeam linac. 
Field size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’
s) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
0.67 0.679  4.4 3.17  
1 0.705 0.712 
0.7033 
-0.61 -1.54 
-0.3 
1.5 0.701 0.706 0.09 -0.72 
2 0.704 0.709 -0.41 -1.09 
3 0.705 0.709 -0.62 -1.08 
4 0.705 0.707 -0.51 -0.78 
5 0.704 0.705 -0.39 -0.51 
6 0.704 0.704  -0.37 -0.37  
8 0.702 0.701  -0.12 0.04  
10 0.701 0.701 0.7   0 0.17   
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Table 51: Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by edgeless diode on 
Elekta Synergy linac.  
Field size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’
s) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
      
1 0.68 0.688 
0.689 
-1.15 -2.22 
-2.41 
1.5 0.68 0.687 -1.15 -2.06 
2 0.679 0.684 -0.93 -1.69 
3 0.677 0.68 -0.57 -1.06 
4 0.674 0.676 -0.25 -0.5 
5 0.673 0.673 -0.05 -0.09 
6 0.673 0.672  -0.1 0.04  
8 0.673 0.67  -0.03 0.34  
10 0.673 0.673 0.67   0 0.44   
 
Table 52:  Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by microdiamond 
detector on Elekta Synergy linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(10
) 
Sauer 
TPR20,10(10
) 
lin fit 
TPR20,10(10
)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s
) 
%diff 
(lin fit’s) 
1 
 
0.677 0.684 
0.674 
-0.42 -1.5 
0 
1.5 0.676 0.683 -0.29 -1.22 
2 0.676 0.682 -0.3 -1.07 
3 0.676 0.679 -0.19 -0.68 
4 0.642 0.676 4.74 -0.19 
5 0.648 0.674 3.95 0.01 
6 0.653 0.673  3.2 0.21  
8 0.664 0.672  1.53 0.33  
10 0.674 0.674 0.672   0 0.42   
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Table 53:  Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by Razor diode on 
Elekta Synergy linac. 
Field size 
(cm) 
measured 
TPR20,10 
(10) 
Palman 
TPR20,10(10) 
Sauer 
TPR20,10(10) 
lin fit 
TPR20,10(10)   
%diff 
(Palman’s) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5 
 
   -0.05 -1.14  
1 0.676 0.683 
0.673 
-0.45 -1.37 
0.37 
1.5 0.679 0.685 -0.3 -1.06 
2 0.677 0.683 -0.33 -0.82 
3 0.678 0.681 0.01 -0.24 
4 0.675 0.677 0.01 -0.03 
5 0.675 0.676 0.04 0.17 
6 0.675 0.674  -0.08 0.27  
8 0.676 0.674  0 0.41  
10 0.675 0.675 0.673   0 0.41   
 
Table 54:  Comparison of the TPR20,10 (10) of 6 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by CC01 ion 
chamber on Elekta Synergy linac. 
Field size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’
s) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
1  0.677 0.684 
0.669 
-0.38 -1.42 
0.86 
1.5  0.676 0.682 -0.25 -1.02 
2  0.676 0.681 -0.26 -0.99 
3  0.676 0.678 -0.15 -0.49 
4  0.674 0.675 0.1 -0.01 
5  0.674 0.675 0.09 0.02 
6  0.674 0.674  0.11 0.09  
8  0.675 0.673  0.01 0.27  
10 0.675 0.674 0.672   0.04 0.42   
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Table 55: Comparison of the TPR20,10 (10) of 18 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by edgeless diode on 
Elekta Synergy linac. 
Field size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’
s) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
1  0.763 0.768 
0.787 
0.88 0.15 
-2.14 
1.5  0.767 0.771 0.44 -0.06 
2  0.77 0.764 -0.05 0.49 
3  0.771 0.763 -0.16 0.51 
4  0.764 0.767 0.75 0.26 
5  0.766 0.768 0.55 0.17 
6  0.767 0.769  0.36 0.06  
8  0.768 0.77  0.26 -0.01  
10 0.77 0.77 0.773   0 -0.25   
 
Table 56:Comparison of the TPR20,10 (10) of 18 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by microdiamond 
detector on Elekta Synergy linac. 
Field size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
1  0.751 0.756 
0.77 
1.36 0.68 
-1.04 
1.5  0.758 0.762 0.53 -0.05 
2  0.758 0.762 0.41 -0.11 
3  0.758 0.762 0.42 0.01 
4  0.736 0.762 3.38 0 
5  0.741 0.762 2.74 -0.06 
6  0.746 0.763  2.1 -0.16  
8  0.754 0.764  1 -0.25  
10 0.762 0.762 0.764   0 -0.35   
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Table 57: Comparison of the TPR20,10 (10) of 18 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by Razor diode on 
Elekta Synergy linac. 
Field size 
(cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’
s) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
1  0.763 0.768 
0.761 
0.09 -0.54 
0.28 
1.5  0.763 0.767 0.11 -0.45 
2  0.762 0.766 0.17 -0.34 
3  0.762 0.765 0.17 -0.23 
4  0.762 0.765 0.17 -0.15 
5  0.762 0.764 0.16 -0.1 
6  0.763 0.765  0.02 -0.21  
8  0.763 0.765  0.09 -0.16  
10 0.764 0.764 0.766   0 -0.36   
 
Table 58: Comparison of the TPR20,10 (10) of 18 MV (FF) beam derived by Palman's,  Suer 's  
and linear fi t  analytical expressions based on experimental data obtained by CC01 ion 
chamber on Elekta Synergy linac. 
Field 
size (cm) 
measure
d 
TPR20,1
0 (10) 
Palman 
TPR20,10(1
0) 
Sauer 
TPR20,10(1
0) 
lin fit 
TPR20,10(1
0)   
%diff 
(Palman’s
) 
%diff 
(Sauer’s) 
%diff 
(lin fit’s) 
0.5        
1  0.761 0.766 
0.769 
0.64 0 
-0.48 
1.5  0.761 0.765 0.65 0.07 
2  0.762 0.765 0.53 0.02 
3  0.764 0.767 0.26 -0.14 
4  0.764 0.767 0.21 -0.12 
5  0.763 0.765 0.3 0.03 
6  0.765 0.766  0.13 -0.11  
8  0.765 0.767  0.02 -0.24  
10 0.766 0.766 0.769   0 -0.38   
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APPENDIX B 
 
Table 59. FWHM (mm) and penumbra width (mm) measured from the inplane and crossplane profile 
scans of a 0.5x0.5cm2jaw-defined field measured at a depth of 10 cm with collimator at 90o rotation. 
Values are reported to two decimal places. 
		 		 FWHM	(mm)	 average	penumbra	(mm)	
Detector	 Beam	 Inplane	 Crossplane	 Inplane	 Crossplane	
µD	(edge-on)	 6XFF	 5.46	 5.19	 2.27	 2.11	
µD	(edge-on)	 6XFFF	 5.5	 5.24	 2.59	 2.23	
µD	(face-on)	 6XFF	 5.66	 5.4	 2.7	 2.32	
µD	(face-on)	 6XFFF	 5.46	 5.35	 2.62	 2.23	
 
Table 60. FWHM (mm) and penumbra width (mm) measured from the inplane and crossplane 
profile scans of a 1x1cm2field measured at a depth of 10 cm with collimator at 90o rotation. 
Values are reported to two decimal places. 
		 		 FWHM	(mm)	 average	penumbra	(mm)	
Detector	 Beam	 Inplane	 Crossplane	 Inplane	 Crossplane	
µD	(edge-on)	 6XFF	 10.07	 10.34	 3.3	 2.69	
µD	(edge-on)	 6XFFF	 10.15	 10.37	 3.15	 2.63	
µD	(face-on)	 6XFF	 10.25	 10.36	 3.52	 2.88	
µD	(face-on)	 6XFFF	 10.19	 10.46	 3.34	 2.83	
 
Table 61. FWHM (mm) and penumbra width (mm) measured from the inplane and crossplane profile 
scans of a 1x1cm2MLC defined field measured at a depth of 10 cm. Values are reported to two 
decimal places. 
		 		 FWHM	(mm)	 average	penumbra	(mm)	
Detector	 Beam	 Inplane	 Crossplane	 Inplane	 Crossplane	
Razor	diode	 6XFF	 12.12	 10.63	 3.53	 2.58	
Razor	diode	 6XFFF	 11.83	 10.52	 3.05	 2.36	
µD	(edge-on)	 6XFF	 12.07	 10.61	 3.46	 2.48	
µD	(edge-on)	 6XFFF	 11.9	 10.54	 3.2	 2.35	
µD	(face-on)	 6XFF	 12.27	 10.61	 3.68	 2.74	
µD	(face-on)	 6XFFF	 12.05	 10.57	 3.34	 2.66	
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Table 62. FWHM (mm) and penumbra width (mm) measured from the inplane and crossplane profile 
scans of a 1x1cm2MLC defined field measured at a depth of 10 cm with collimator at 90o rotation. 
Values are reported to two decimal places. 
		 		 FWHM	(mm)	 average	penumbra	(mm)	
Detector	 Beam	 Inplane	 Crossplane	 Inplane	 Crossplane	
µD	(edge-on)	 6XFF	 10.07	 10.34	 3.3	 2.69	
µD	(edge-on)	 6XFFF	 10.58	 11.79	 2.55	 3.14	
µD	(face-on)	 6XFF	 10.75	 12.08	 2.93	 3.72	
µD	(face-on)	 6XFFF	 10.56	 11.86	 2.74	 3.42	
 
Table 63. FWHM (mm) and penumbra width (mm) measured from the inplane and crossplane profile 
scans of a 3x3cm2 field measured at a depth of 10 cm with collimator at 90orotation. Values are 
reported to two decimal placs. 
		 		 FWHM	(mm)	 average	penumbra	(mm)	
Detector	 Beam	 Inplane	 Crossplane	 Inplane	 Crossplane	
µD	(edge-on)	 6XFF	 32	 32.56	 3.92	 3.21	
µD	(edge-on)	 6XFFF	 32.01	 32.49	 3.77	 3.18	
µD	(face-on)	 6XFF	 32.06	 32.55	 4.17	 3.47	
µD	(face-on)	 6XFFF	 32.01	 32.51	 3.93	 3.57	
 
Table 64. FWHM (mm) and penumbra width (mm) measured from the inplane and crossplane profile 
scans of a 3x3cm2MLC defined field measured at a depth of 10 cm. Values are reported to two 
decimal places. 
		 		 FWHM	(mm)	 average	penumbra	(mm)	
Detector	 Beam	 Inplane	 Crossplane	 Inplane	 Crossplane	
Razor	diode	 6XFF	 34.36	 32.5	 4.51	 3.38	
Razor	diode	 6XFFF	 34.09	 32.37	 4.05	 3.12	
µD	(edge-on)	 6XFF	 34.26	 32.4	 4.11	 2.96	
µD	(edge-on)	 6XFFF	 33.45	 32.29	 3.81	 2.86	
µD	(face-on)	 6XFF	 34.47	 32.42	 4.56	 3.5	
µD	(face-on)	 6XFFF	 33.49	 32.34	 4.06	 3.27	
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Table 65. FWHM (mm) and penumbra width (mm) measured from the inplane and crossplane profile 
scans of a 3x3cm2MLC defined field measured at a depth of 10 cm with collimator at 90o rotation. 
Values are reported to two decimal places. 
		 		 FWHM	(mm)	 average	penumbra	(mm)	
Detector	 Beam	 Inplane	 Crossplane	 Inplane	 Crossplane	
µD	(edge-on)	 6XFF	 32	 32.56	 3.92	 3.21	
µD	(edge-on)	 6XFFF	 32.56	 31.89	 3.32	 3.69	
µD	(face-on)	 6XFF	 32.47	 33.63	 3.46	 4.45	
µD	(face-on)	 6XFFF	 32.3	 33.36	 3.25	 3.98	
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